0001019687-13-001128.txt : 20130401 0001019687-13-001128.hdr.sgml : 20130401 20130401134914 ACCESSION NUMBER: 0001019687-13-001128 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20121231 FILED AS OF DATE: 20130401 DATE AS OF CHANGE: 20130401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RadNet, Inc. CENTRAL INDEX KEY: 0000790526 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 133326724 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33307 FILM NUMBER: 13730230 BUSINESS ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 3104787808 MAIL ADDRESS: STREET 1: 1516 COTNER AVE CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: PRIMEDEX HEALTH SYSTEMS INC DATE OF NAME CHANGE: 19930518 FORMER COMPANY: FORMER CONFORMED NAME: CCC FRANCHISING CORP DATE OF NAME CHANGE: 19920703 10-K/A 1 rdnt_10ka-123112.htm AMENDMENT TO FORM 10-K

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

FORM 10-K/A

AMENDMENT NO. 1

(Mark One)

þANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2012

 

OR

 

¨TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 0-19019

RadNet, Inc.

(Exact name of registrant as specified in charter)

 

Delaware 13-3326724

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

   
1510 Cotner Avenue  
Los Angeles, California 90025
(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (310) 478-7808

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class Name of each exchange on which registered
Common Stock, $.0001 par value NASDAQ Global Market

 

Securities registered pursuant to Section 12(g) of the Act:  None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes    ¨   No x

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) or the act.  Yes   ¨  No   x

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes x      No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x     No ¨

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

  Large   Accelerated   Filer    ¨   Accelerated   Filer   x
  Non-Accelerated   Filer    ¨   (Do   not   check   if   a   smaller   reporting   company)   Smaller   Reporting   Company    ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Exchange Act Rule 12b-2) Yes   ¨ No x

 

The aggregate market value of the registrant’s common stock held by non-affiliates of the registrant was approximately $81,917,304 on June 29, 2012 (the last business day of the registrant’s most recently completed second quarter) based on the closing price for the common stock on the NASDAQ Global Market on June 29, 2012.

 

The number of shares of the registrant’s common stock outstanding on March 8, 2013, was 38,990,482 shares.

 

 

 
 

 

DOCUMENTS INCORPORATED BY REFERENCE

The information required by Part III of the Form 10-K, to the extent not set forth herein or in the Annual Report on Form 10-K filed on March 18, 2013, is incorporated herein by reference from the registrant’s definitive proxy statement for the Annual Meeting of Stockholders, to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant’s fiscal year.

EXPLANATORY NOTE

We are filing this Form 10-K/A (Amendment No. 1) to our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, originally filed with the U.S. Securities and Exchange Commission on March 18, 2013 (the "Original Filing"), solely for the purpose of complying with Rule 3-09 of Regulation S-X.  Rule 3-09 requires that we file financial statements of certain unconsolidated joint ventures in which we hold equity interests of 50% or less and account for them under the equity method to the extent that the unconsolidated joint ventures are individually significant.  Under Rule 3-09 of Regulation S-X, we are permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business.

We have determined that as of and for the year ended December 31, 2012, four of our unconsolidated joint venture interests including   Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and Greater Baltimore Diagnostic Imaging Partnership, (collectively, the “Group”), were significant unconsolidated joint ventures under Rule 3-09.  Accordingly, we are filing in this Amendment No. 1 to include the combined financial statements of the Group under Item 8 – Financial Statements and Supplementary Data, and we are amending Item 15 - Exhibits and Financial Statement Schedules, to include a list of the financial statements and exhibits being filed herewith. We are also filing updated Certificates of our Chief Executive Officer and Chief Financial Officer under Sections 302 and 906 of the Sarbanes Oxley Act of 2002.

Except as described above, no other changes have been made to the Original Filing, and this Form 10-K/A does not amend, update or change any other items or disclosures in the Original Filing.  This Form 10-K/A does not reflect events occurring after the Original Filing.   Accordingly, this Amendment should be read in conjunction with the Original Filing and our other filings with the SEC subsequent to the Original Filing

 

2
 

PART II.

 

Item 8. Financial Statements and Supplementary Data

 

The Financial Statements are attached hereto and begin on page 4.

 

Report of Independent Registered Public Accounting Firm

 

To the partners of:

 

Franklin Imaging Joint Venture;

Carroll County Radiology, LLC;

MRI at St. Joseph Medical Center, LLC; and

Greater Baltimore Diagnostic Imaging Partnership

 

We have audited the accompanying combined balance sheet of certain RadNet, Inc. affiliates including Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and Greater Baltimore Diagnostic Imaging Partnership (collectively, the “Group”), as of December 31, 2012, and the related combined statements of income, partners’ capital, and cash flows for the year ended December 31, 2012. These financial statements are the responsibility of the Group’s management. Our responsibility is to express an opinion on these financial statements based on our audit.

We conducted our audit in accordance with the auditing standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. We were not engaged to perform an audit of the Group’s internal control over financial reporting. Our audit included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s internal control over financial reporting. Accordingly, we express no such opinion. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in all material respects, the combined financial position of the Group at December 31, 2012, and the combined results of their operations and their cash flows for the year ended December 31, 2012, in conformity with U.S. generally accepted accounting principles.

/s/ Ernst & Young, LLP

 

April 1, 2013

Los Angeles, California

 

3
 

 

CERTAIN RADNET, INC. AFFILIATES

COMBINED BALANCE SHEETS

(IN THOUSANDS)

 

   December 31,   December 31, 
   2012   2011 
       (unaudited) 
ASSETS
CURRENT ASSETS          
Cash and cash equivalents  $1,778   $2,089 
Accounts receivable, net   8,597    8,326 
Due from affiliates   1,121    2,414 
Prepaid expenses and other current assets   602    337 
   Total current assets   12,098    13,166 
PROPERTY AND EQUIPMENT, NET   19,358    22,074 
OTHER ASSETS          
Goodwill   9,923    7,816 
Other intangible assets   724    844 
   Total assets  $42,103   $43,900 
LIABILITIES AND PARTNERS' CAPITAL          
CURRENT LIABILITIES          
Accounts payable and accrued expenses  $2,043   $3,612 
Current portion of deferred rent   167    134 
Current portion of equipment notes payable   909    2,698 
Current portion of obligations under capital leases   270    278 
   Total current liabilities   3,389    6,722
LONG-TERM LIABILITIES          
Deferred rent, net of current portion   1,594    1,749 
Equipment notes payable, net of current portion   1,006    1,916 
Obligations under capital leases, net of current portion   144    414 
   Total liabilities   6,133    10,801 
COMMITMENTS AND CONTINGENCIES          
PARTNERS' CAPITAL          
RadNet, Inc.   17,717    16,458 
Other partners   18,253    16,641 
   Total partners' capital   35,970    33,099 
      Total liabilities and partners' capital  $42,103   $43,900 

 

The accompanying notes are an integral part of these financial statements.

 

4
 

 

CERTAIN RADNET, INC. AFFILIATES

COMBINED STATEMENTS OF INCOME

(IN THOUSANDS)

 

   Years Ended December 31, 
   2012   2011   2010 
NET SERVICE FEE REVENUE        (unaudited)    (unaudited) 
Service fee revenue, net of contractual allowances and discounts  $58,122   $46,212   $46,321 
Provision for bad debts   (2,752)   (2,211)   (2,112)
Net service fee revenue   55,370    44,001    44,209 
                
OPERATING EXPENSES               
Cost of operations   38,161    31,557    31,291 
Depreciation and amortization   4,607    3,856    3,703 
(Gain) loss on sale of equipment   (35)   195    125 
Total operating expenses   42,733    35,608    35,119 
                
INCOME FROM OPERATIONS   12,637    8,393    9,090 
                
Net interest expense   245    381    702 
                
NET INCOME  $12,392   $8,012   $8,388 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

5
 

 

CERTAIN RADNET, INC. AFFILIATES

COMBINED STATEMENTS OF PARTNERS' CAPITAL

(IN THOUSANDS)

 

   RadNet, Inc.   Other Partners   Total 
             
BALANCE - January 1, 2010 (unaudited)  $11,168   $13,393   $24,561 
Net Income   3,771    4,617    8,388 
Distributions   (5,957)   (7,128)   (13,085)
BALANCE - December 31, 2010 (unaudited)   8,982   10,882    19,864 
Net Income   3,714    4,298    8,012 
Contributions   6,551    4,652    11,203 
Distributions   (2,789)   (3,191)   (5,980)
BALANCE - December 31, 2011 (unaudited)   16,458   16,641   33,099 
Net Income   5,757    6,635    12,392 
Contributions   920    1,380    2,300 
Distributions   (5,418)   (6,403)   (11,821)
BALANCE - December 31, 2012  $17,717  $18,253  $35,970 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

6
 

 

CERTAIN RADNET, INC. AFFILIATES

COMBINED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

 

   Years Ended December 31, 
   2012   2011   2010 
       (unaudited)   (unaudited) 
CASH FLOWS FROM OPERATING ACTIVITIES               
                
Net income  $12,392   $8,012   $8,388 
Adjustments to reconcile net income to net cash provided by operating activities:               
Depreciation and amortization   4,607    3,856    3,703 
Provision for bad debts   2,752    2,211    2,112 
Deferred rent amortization   (122)   (112)   1,048 
(Gain) loss on sale of equipment   (35)   195    125 
Changes in operating assets and liabilities               
Accounts receivable   (3,022)   (3,036)   (2,415)
Prepaid expenses and other current assets   (264)   (31)   748 
Due from affiliates   1,293    (372)   4,110 
Accounts payable and accrued expenses   (1,424)   878    517 
Net cash provided by operating activities   16,177    11,601    18,336 
CASH FLOWS FROM INVESTING ACTIVITIES               
Purchase of property and equipment   (1,091)   (2,576)   (2,495)
Purchase of imaging facilities   (2,935)   –    (133)
Proceeds from sale of equipment   35    –    305 
Net cash used in investing activities   (3,991)   (2,576)   (2,323)
CASH FLOWS FROM FINANCING ACTIVITIES               
Principal payments on notes and leases payable   (2,976)   (2,764)   (2,576)
Contributions from partners   2,300    –    – 
Distributions to partners   (11,821)   (5,980)   (13,085)
Net cash used in financing activities   (12,497)   (8,744)   (15,661)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS   (311)   281    352 
CASH AND CASH EQUIVALENTS, beginning of period   2,089    1,808    1,456 
CASH AND CASH EQUIVALENTS, end of period  $1,778   $2,089   $1,808 
                
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION               
Cash paid during the period for interest  $245   $381   $702 

 

 

The accompanying notes are an integral part of these financial statements.

 

7
 

 

CERTAIN RADNET, INC. AFFILIATES

 

COMBINED STATEMENTS OF CASH FLOWS (CONTINUED)

 

Supplemental Schedule of Non-Cash Investing and Financing Activities

 

The Group entered into capital leases and equipment notes for approximately $733,000 (unaudited), during the year ended December 31, 2010.

 

Detail of non-cash contributions made during the year ended December 31, 2011 can be found in Note 4.

 

Detail of investing activity related to acquisitions can be found in Note 4.

 

 

 

 

8
 

 

CERTAIN RADNET, INC. AFFILIATES

NOTES TO COMBINED FINANCIAL STATEMENTS

NOTE 1 – DESCRIPTION OF BUSINESS

Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and Greater Baltimore Diagnostic Imaging Partnership, (collectively, the “Group”), are joint ventures between RadNet, Inc. and, as applicable, hospitals, health systems or radiology practices operating within the state of Maryland and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Each joint venture within the Group is an affiliate of RadNet, Inc. as follows:

 

    % owned by RadNet, Inc.
     
Franklin Imaging Joint Venture   49%
Carroll County Radiology, LLC   40%
MRI at St. Joseph Medical Center, LLC   49%
Greater Baltimore Diagnostic Imaging Partnership   50%

 

The financial information for 2011 and 2010 included herein has been prepared by management of RadNet, Inc. without audit. Management of RadNet, Inc. believes that such financial information has been prepared in conformity with U.S. generally accepted accounting principles, and includes all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows as of and for the years ended December 31, 2011 and 2010.

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

PRINCIPLES OF COMBINATION – Under Rule 3-09 of Regulation S-X, RadNet, Inc. is permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business. The combined financial statements include the assets, liabilities, and operations of each member of the Group. The operating activities of each of these joint ventures are completely separate from one another and are in no way affiliated with one another. Accordingly there are no intercompany transactions and balances to be eliminated when combining each together.

 

USE OF ESTIMATES - The preparation of these financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters including the Group’s reported amounts of assets and liabilities in the combined balance sheets at the dates of the financial statements; disclosure of contingent assets and liabilities at the dates of the financial statements; and reported amounts of revenues and expenses in the combined statements of income during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management’s control. As a result, actual amounts could materially differ from these estimates.

 

REVENUES – Combined service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. This service fee revenue is earned through providing the use of diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

 

The Group's combined service fee revenues are recorded during the period the services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage with third-party payers.

 

9
 

 

The Group’s service fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended December 31, are summarized in the following table (in thousands):

 

   Years Ended December 31, 
   2012   2011   2010 
       (unaudited)   (unaudited) 
Commercial Insurance/Managed Care Capitation  $40,220   $32,302   $32,054 
Medicare   12,089    9,242    9,774 
Medicaid   1,976    1,525    1,529 
Workers' Compensation/Personal Injury   2,615    1,987    1,992 
Other   1,221    1,155    973 
Service fee revenue, net of contractual allowances and discounts   58,122    46,212   46,321 
                
Provision for bad debts   (2,752)   (2,211)   (2,112)
Net service fee revenue  $55,370   $44,001   $44,209 

 

The break-out of the Group’s combined service fee revenue, net of contractual allowances and discounts, is calculated based upon global payments received from consolidated imaging centers from dates of service from each respective period illustrated.

 

ACCOUNTS RECEIVABLE - Substantially all of the Group’s accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.  Services are generally provided pursuant to one-year contracts with healthcare providers.  Receivables generally are collected within industry norms for third-party payors.  The Group continuously monitors collections from payors and maintains an allowance for bad debts based upon specific payor collection issues that have been identified as well as historical collection experience.

 

PROVISION FOR BAD DEBTS - Although outcomes vary, the Group’s policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service. The Group provides for an allowance against accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Group estimates this allowance based on the aging of accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of the provision for bad debt relates to co-payments and deductibles owed to the Group by patients with insurance. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and the Group’s estimation process. The combined allowance for bad debts at December 31, 2012 and 2011 were $393,000 and $395,000 (unaudited), respectively.

 

CONCENTRATION OF CREDIT RISKS - Financial instruments that potentially subject the Group to credit risk are primarily cash equivalents and accounts receivable. Each joint venture places its cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. The Group continuously monitors collections from its clients and maintains an allowance for bad debts based upon any specific payor collection issues that are identified and historical experience.

 

CASH AND CASH EQUIVALENTS – The Group considers all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates their fair market value.

 

PROPERTY AND EQUIPMENT – Property, furniture and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the shorter of the related lease term or their estimated useful lives which range from 3 to 30 years.

 

GOODWILL – Combined goodwill of the Group at December 31, 2012 totaled $9.9 million. Goodwill is recorded by each member of the Group as a result of business combinations. Management of each member of the Group evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable.  Each member of the Group adopted the provisions of ASU 2011-08 effective January 1, 2011. Each member of the Group evaluated its respective share of the combined goodwill at October 1, 2012 for signs of impairment under the provisions of ASU 2011-08. By utilizing certain qualitative measures outlined in the guidance, each member determined that its respective share of the combined goodwill was not impaired.

 

10
 

INCOME TAXES - Each member of the Group is treated as a partnership for federal and state income tax purposes where all taxable income is allocated to the partners in accordance with the respective partnership agreement and so accordingly federal and state taxes on income are the responsibility of the Joint partners individually. Accordingly, no income tax provision is recorded by any joint ventures in the Group. Effective January 1, 2009, the Group adopted Accounting Standards Codification ASC 740, Income Taxes, formerly known as Financial Accounting Standards Board (FASB) Interpretation No. 48, Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109 (FIN 48). ASC 740 requires the impact of a tax position to be recognized in the financial statements if that position is more-likely-than-not to be sustained by the taxing authority. Tax positions not deemed to meet the “more likely than not” threshold would be recorded as a tax benefit or expense in the current year. Management of the Group is required to analyze all open tax years, as defined by the statute of limitations, for all major jurisdictions, which includes federal and certain states. Open tax years are those that are open for exam by taxing authorities, and include all returns subsequent to tax years ending after December 31, 2009, for federal returns and December 31, 2009, for Maryland returns. The Partnership has no examinations in process and has not been notified of any future examinations at this time. Management of the Group has reviewed all open tax years and major jurisdictions, and has concluded that the adoption of ASC 740 did not have a material effect on the Group’s financial position or its results of operations. There is no tax liability resulting from unrecognized tax benefits relating to uncertain-income tax positions taken or expected to be taken in future tax returns. The Group has recognized no interest or penalties related to uncertain tax positions taken or
expected to be taken.

 

FAIR VALUE MEASUREMENTS –The combined balance sheets include the following financial instruments: cash and cash equivalents, receivables, trade accounts payable, capital leases, equipment notes payable and other liabilities. The Group considers the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, the Group considers the carrying amount of its equipment notes payable and capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.

 

NOTE 3 – RECENT ACCOUNTING STANDARDS

 

On January 1, 2012, the Group adopted ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for doubtful accounts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. Such additional disclosures are included in Note 2. The adoption of this ASU had no impact on the Group’s combined financial position, results of operations or cash flows, although it did change the financial statement presentation.

On January 1, 2012, each member of the Group adopted ASU 2011-08, “Intangibles—Goodwill and Other (Topic 350): Testing Goodwill for Impairment”, simplifying how a company is required to test goodwill for impairment. Companies will now have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary.

 

In July 2012, the FASB modified existing rules to allow entities to use a qualitative approach to test indefinite-lived intangible asset for impairment.  The revised standard allows an entity the option to first assess qualitatively whether it is more likely than not (that is, a likelihood of more than 50 percent) that an indefinite-lived intangible asset is impaired.  An entity is not required to calculate the fair value of an indefinite-lived intangible asset and perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired.  This guidance will be effective for the Group in 2013.

 

In February 2013, the FASB issued new guidance which requires disclosure of information about significant reclassification adjustments from accumulated other comprehensive income in a single note or on the face of the financial statements.  This guidance will be effective for the Group in 2013.  Adoption of this standard, which is related to disclosure only, will not have an impact on the Group’s combined financial position, results of operations, or cash flows.

 

NOTE 4 – FACILITY ACQUISITIONS

 

On February 22, 2012, the members of Carroll County Radiology, LLC completed its acquisition of a multi modality imaging center from RadNet, Inc. located in Westminster, Maryland for $2.3 million. The members made a fair value determination of the assets acquired and the liabilities assumed and approximately $200,000 of fixed assets, $2.1 million of goodwill was recorded with respect to this transaction.

 

11
 

On November 1, 2012, the partners of Franklin Imaging Joint Venture completed its acquisition of a multi modality imaging center located in Baltimore, Maryland for $635,000. The members made a fair value determination of the assets acquired and the liabilities assumed and approximately $635,000 of fixed assets was recorded with respect to this transaction.

 

On December 31, 2011, the partners of Greater Baltimore Diagnostic Imaging Partnership (GBDIP) contributed their aggregate 100% interest in MIB Partnership, LLP, valued at $10.2 million, to GBDIP. Immediately prior to this contribution, the partners of GBDIP, who in aggregate held a 50% interest in MIB Partnership, LLP, acquired the remaining 50% interest in MIB Partnership, LLP for $5.6 million. As a result, GBDIP began consolidating this contributed partnership on December 31, 2011, recording all of its assets and liabilities at fair value on the date of contribution. As a result, $1.4 million of current assets, $2.8 million of fixed assets, $522,000 of intangible assets, and $7.6 million of goodwill was recorded with respect to this transaction. Also recorded were approximately $210,000 of accounts payable and accrued expenses, and $2.0 million of equipment notes and leases payable.

 

On December 31, 2011, the partners of Franklin Imaging Joint Venture (Franklin) contributed their aggregate 100% interest in Health Imaging Systems, LLC, valued at $1.0 million, to Franklin. As a result, Franklin began consolidating this contributed partnership on December 31, 2011, recording all of its assets and liabilities. As a result, $861,000 of current assets, $279,000 of fixed assets, and $137,000 of accounts payable and accrued expenses was recorded with respect to this transaction.

 

NOTE 5 – GOODWILL AND OTHER INTANGIBLE ASSETS

 

Combined goodwill of the Group at December 31, 2012 totaled $9.9 million. Goodwill is recorded as a result of business combinations.  Activity in goodwill for the years ended December 31, 2011 and 2012 is provided below (in thousands):

 

Balance as of January 1, 2011 (unaudited)  $223 
Goodwill acquired through GBDIP's acquisition of MIB Partnership, LLP   7,593 
Balance as of December 31, 2011 (unaudited)   7,816 
Goodwill acquired through Carroll County Radiology's acquisition of Westminster from RadNet, Inc.   2,107 
Balance as of December 31, 2012  $9,923 

 

Other intangible assets are primarily related to the value of management service contracts on the books of MRI at St. Joseph Medical Center, LLC and covenant not to compete contracts acquired through GBDIP’s acquisition of a controlling interest of a previously held non-consolidated joint venture investment and totaled $522,000 on the date of acquisition. Accumulated amortization of the management service contract and covenant not to compete contract intangible assets through December 31, 2012 was $79,000 and $104,000, respectively. Amortization expense for the year ended December 31, 2012 was $120,000.  The value of these covenant not to compete contracts are amortized using the straight-line method over five years.  Management service contracts are amortized over 25 years.

 

The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):

 

   2013   2014   2015   2016   2017   Thereafter   Total   Weighted average amortization period remaining in years 
                                         
Management service contracts   16    16    16    16    16    226    306    19.0 
Covenant not to compete contracts   104    104    105    105    –    –    418    4.0 
Total annual amortization  $120   $120   $121   $121  $16   $226   $724      
                                         

 

12
 

NOTE 6 - PROPERTY AND EQUIPMENT

 

Property and equipment and accumulated depreciation and amortization are as follows (in thousands):

 

   December 31, 
   2012   2011 
       (unaudited) 
Medical equipment  $31,804   $31,514 
Office equipment, furniture and fixtures   2,949    3,051 
Leasehold improvements   14,253    13,567 
Equipment under capital leases   1,982    1,982 
    50,988    50,114 
Accumulated depreciation and amortization   (31,630)   (28,040)
   $19,358   $22,074 

 

Depreciation and amortization expense on property and equipment, including amortization of equipment under capital leases, for the years ended December 31, 2012, 2011 and 2010 totaled $4.5 million, $3.8 million (unaudited) and $3.7 million (unaudited), respectively.

 

NOTE 7 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES (IN THOUSANDS)

 

   December 31, 
   2012   2011 
       (unaudited) 
Accounts payable  $839   $873 
Accrued expenses   229    1,937 
Accrued payroll and vacation   975    802 
    Total  $2,043   $3,612 

 

NOTE 8 – EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES

Three members of the Group, MRI at St. Joseph Medical Center, LLC, Franklin Imaging Joint Venture, and Greater Baltimore Diagnostic Partnership hold eleven promissory notes issued by three financing companies for the purpose of acquiring imaging equipment. These notes have interest rates between 3.5% and 9.0%, mature on or before June 2016 and are collateralized by the acquired equipment.

 

The following is a listing of annual principal maturities of the equipment notes discussed above for years ending December 31 (in thousands):

 

2013  $909 
2014   487 
2015   504 
2016   15 
   $1,915 

 

The Group leases equipment under capital lease arrangements. Future minimum lease payments under capital leases for years ending December 31 (in thousands) is as follows:

 

2013  $295 
2014   148 
Total minimum payments   443 
Amount representing interest   (29)
Present value of net minimum lease payments   414 
Less current portion   (270)
Long-term portion  $144 

 

13
 

NOTE 9 – COMMITMENTS AND CONTINGENCIES

 

Leases – The Group leases various operating facilities and certain medical equipment under operating leases with renewal options expiring through 2022. Certain leases contain renewal options from two to ten years and escalation clauses based either on the consumer price index or fixed rent escalators. Leases with fixed rent escalators are recorded on a straight-line basis. The Group records deferred rent for tenant leasehold improvement allowances received from a lessor and amortizes the deferred rent expense over the term of the lease agreement. Minimum annual payments under operating leases for future years ending December 31 follow (in thousands):

 

   Facilities   Equipment   Total 
2013  $2,563   $1,082   $3,645 
2014   2,298    770    3,068 
2015   2,343    639    2,982 
2016   1,835    245    2,080 
2017   1,489    –    1,489 
Thereafter   1,028    –    1,028 
   $11,556   $2,736   $14,292 

 

Total rent expense, including equipment rentals, for the years ended December 31, 2012, 2011 and 2010 was $4.3 million, $3.7 million (unaudited) and $3.9 million (unaudited), respectively.

 

NOTE 10 – RELATED PARTY TRANSACTIONS

 

See Note 4 with respect to related party facility combinations.

 

RadNet, Inc. contracts with each joint venture within the Group to provide certain administrative services including assistance with accounting, payroll and employee benefits processing, and billing and collection functions on behalf of these joint ventures. RadNet Inc. remits to the joint ventures all amounts collected through its administration of the billing and collection functions.

 

RadNet, Inc., as administrator over payroll and employee benefits, pays salary and benefit obligations on behalf of these joint ventures and then bills each joint venture for its respective portion.

 

RadNet, Inc. contracts certain members of its contracted radiologist groups to perform professional services for the joint ventures. RadNet, Inc. assures that these radiologists are adequately covered under medical malpractice insurance policies. RadNet, Inc., on behalf of its contracted radiologist groups, bills each joint venture for its respective share of the professional fees incurred through its utilization of these contracted radiologists. RadNet, Inc. remits to its contracted radiologist groups all amounts collected from the joint ventures for the billed professional fees.

 

Amounts receivable from and payable to RadNet Inc. for the activities listed above are summarized in due from affiliates on the Group’s combined balance sheets and was $1.1 million and $2.4 million (unaudited) at December 31, 2012 and 2011, respectively. Due from affiliates of $1.1 million at December 31, 2012 consists of a receivable from RadNet, Inc. of $4.3 million for amounts collected through its administration of the billing and collection functions not yet remitted to the joint ventures at December 31, 2012. This receivable is offset by amounts payable to RadNet, Inc. of $525,000 for the unpaid portion of billed administrative services performed, $1.2 million for the unpaid portion of professional fees which RadNet, Inc. must in turn remit to its contracted radiologists, and $1.4 million for unpaid payroll and employee benefit costs.

 

NOTE 11 – SUBSEQUENT EVENTS

 

The member of the Group evaluated subsequent events through April, 1, 2013 and concluded that no additional disclosures were required.

 

14
 

PART IV 

(a) Financial Statements – The following financial statements are filed herewith:

 

Item 15.                Exhibits and Financial Statement Schedules   Page N o.
     
(a) Financial Statements – The following financial statements are filed herewith:    
     
Report of Independent Registered Public Accounting Firm   3
     
Combined Balance Sheets of Certain RadNet, Inc. Affiliates   4
     
Combined Statements of Income of Certain RadNet, Inc. Affiliates   5
     
Combined Statements of Partners’ Capital of Certain RadNet, Inc. Affiliates   6
     
Combined Statements of Cash Flows of Certain RadNet, Inc. Affiliates   7 to 8
     
Notes to Combined Financial Statements   9 to 14

 

 (a)(3) Exhibits – The following exhibits are filed herewith or incorporated by reference herein:

 

Exhibit No.   Description of Exhibit  
       
2.1   Membership Interests Purchase Agreement dated September 7, 2010 by and among New Jersey Imaging Partners, Inc., RadNet, Inc., Progressive Health, LLC and the other parties named therein (incorporated by reference to exhibit filed with Form 8-K on January 7, 2011).†  
       
2.2   Purchase Agreement dated September 7, 2010 by and between New Jersey Imaging Partners, Inc. and Progressive Medical Imaging of Rutherford, LLC (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)). †  
       
2.3   Merger Agreement dated September 13, 2010 by and among RadNet Managed Imaging Services, Inc. INC Merger Sub, Inc. and Image Medical Corporation (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).†  
       
2.4   Stock Purchase Agreement dated November 7, 2011 by and between RadNet Management, Inc. and CML Healthcare Inc., and joined by RadNet, Inc. (incorporated by reference to exhibit filed with Form 8-K/A on January 18, 2012).†  
       
3.1   Certificate of Incorporation of RadNet, Inc., a Delaware corporation (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).  
       
3.2   Certificate of Amendment to Certificate of Incorporation of RadNet, Inc., a Delaware corporation, dated September 2, 2008 (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).  
       
3.3   Bylaws of RadNet, Inc., a Delaware corporation (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).  
       
4.1   Indenture, dated as of April 6, 2010, by and among RadNet Management, Inc., RadNet, Inc., the subsidiary guarantors thereunder, and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Form 8-K on April 6, 2010).  
       
4.2   Form of Exchange 10 3/8% Senior Note (included in Exhibit 4.1).  

 

15
 

 

4.3   Form of Original 10 3/8% Senior Note (included in Exhibit 4.1).  
       
4.4   Registration Rights Agreement, dated April 6, 2010, by and among RadNet Management, Inc., RadNet, Inc., the subsidiary guarantors thereunder, and Deutsche Bank Securities Inc. and Barclays Capital Inc., as representatives of the initial purchasers (incorporated by reference to exhibit filed with Form 8-K on April 6, 2010).  
       
4.5   Supplemental Indenture, dated as of July 6, 2010, by and between Advanced Radiology, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.6   Supplemental Indenture, dated as of August 19, 2010 by and between Health Diagnostics of New Jersey, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.7   Supplemental Indenture, dated as of January 10, 2011, by and between Image Medical Corporation and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.8   Supplemental Indenture, dated as of January 10, 2011, by and between eRAD, Inc. and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.9   Supplemental Indenture, dated as of January 10, 2011, by and between East Bergen Imaging, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.10   Supplemental Indenture, dated as of January 10, 2011, by and between Progressive Medical Imaging of Bloomfield, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.11   Supplemental Indenture, dated as of January 10, 2011, by and between Progressive Medical Imaging of Hackensack, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.12   Supplemental Indenture, dated as of January 10, 2011, by and between Progressive Medical Imaging of Union City, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.13   Supplemental Indenture, dated as of January 10, 2011, by and between Progressive X-Ray of Englewood, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.14   Supplemental Indenture, dated as of January 10, 2011, by and between Progressive X-Ray of Kearney, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.15   Supplemental Indenture, dated as of January 10, 2011, by and between Imaging On Call, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.16   Supplemental Indenture, dated as of January 10, 2011, by and between Advanced NA, LLC and U.S. Bank, National Association, as Trustee (incorporated by reference to exhibit filed with Amendment No. 1 to Registration Statement on Form S-4 (File No. 333-169107)).  
       
4.17   Standstill Agreement, dated as of August 30, 2011, by and between RadNet, Inc. and RMCP LLC (incorporated by reference to exhibit filed with Amendment No. 1  to Schedule 13D for Red Mountain Capital Partners LLC).  

 

16
 

 

       
4.18     Supplemental Indenture, dated as of November 21, 2011, among Raven Holdings U.S., Inc., RadNet Management, Inc., RadNet, Inc., U.S. Bank and the other parties named therein (incorporated by reference to exhibit filed with Form 8-K on November 22, 2011).    
       
4.19   Supplemental Indenture, dated as of November 21, 2011, among American Radiology Services of Delaware, Inc., RadNet Management, Inc., RadNet, Inc., U.S. Bank and the other parties named therein (incorporated by reference to exhibit filed with Form 8-K on November 22, 2011).  
       
4.20   Supplemental Indenture, dated as of November 21, 2011, among CML HealthCare Rhode Island LLC, RadNet Management, Inc., RadNet, Inc., U.S. Bank and the other parties named therein (incorporated by reference to exhibit filed with Form 8-K on November 22, 2011).  
       
4.21   Supplemental Indenture, dated as of November 21, 2011, among American Radiology Services LLC, RadNet Management, Inc., RadNet, Inc., U.S. Bank and the other parties named therein (incorporated by reference to exhibit filed with Form 8-K on November 22, 2011).  
       
4.22   Supplemental Indenture, dated as of November 21, 2011, among Radiology Alliance Delivery System, LLC, RadNet Management, Inc., RadNet, Inc., U.S. Bank and the other parties named therein (incorporated by reference to exhibit filed with Form 8-K on November 22, 2011).  
       
10.1   Credit and Guaranty Agreement, dated October 10, 2012, by and among RadNet Management, Inc., RadNet, Inc., the guarantors thereunder, General Electric Capital Corporation, Deutsche Bank Securities, Inc., RBC Capital Markets and Barclays Bank PLC (incorporated by reference to exhibit filed with Form 8-K on October 12, 2012).  
       
10.2   Pledge and Security Agreement, dated October 10, 2012, by and among RadNet Management, Inc., RadNet, Inc., the guarantors thereunder, and Barclays Bank PLC (incorporated by reference to exhibit filed with Form 8-K on October 12, 2012).  
       
10.3   Form of Trademark Security Agreement by and among the guarantors thereunder and Barclays Bank PLC (filed as an exhibit to the Pledge and Security Agreement, dated October 10, 2012, by among the guarantors thereunder and Barclays Bank PLC, included as Exhibit 10.2).  
       
10.4   2000 Incentive Stock Option Plan (as amended) (incorporated by reference to exhibit filed with the Form 10-K for the year ended October 31, 2003).*  
       
10.5   2006 Equity Incentive Plan, amended and restated as of April 19, 2011 (incorporated by reference to exhibit filed with Form S-8 registration statement on August 15, 2011).*  
       

10.6

 

 

10.7

   Form of Stock Option Agreement for the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form S-8 registration statement on August 15, 2011).*   Form of Restricted Stock Award for the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended March 31, 2012).*  
       
10.8   Form of Warrant recharacterized as under the 2006 Equity Incentive Plan –  Form A (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended June 30, 2008).*  
       
10.9   Form of Warrant recharacterized as under the 2006 Equity Incentive Plan –   Form B (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended June 30, 2008).*  
       
10.10   Form of Indemnification Agreement between the registrant and each of its officers and directors (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended March 31, 2008).*  
       
10.11   Employment Agreement dated as of June 12, 1992 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with an amendment to Form 8-K report for June 12, 1992).*  
       
10.12   Amendment to Employment Agreement dated January 30, 2004 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*  

 

17
 

 

       
10.13   Employment Agreement dated as of April 16, 2001 with Jeffrey L. Linden (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2001).*  
       
10.14   Amendment to Employment Agreement dated January 30, 2004 with Jeffrey L. Linden (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*  
       
10.15   Employment Agreement dated as of May 1, 2001 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2001).*  
       
 10.16   Amendment to Employment Agreement dated January 30, 2004 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*  
       
10.17   Employment Agreement with Mark Stolper effective January 1, 2009 (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2009).*  
       
10.18   Retention Agreement with Stephen Forthuber dated November 15, 2006 (incorporated by reference to exhibit filed with Form 10-K/T for the year ended December 31, 2006).*  
       
10.19   Amended and Restated Management and Service Agreement between RadNet Management, Inc. and Beverly Radiology Medical Group III dated January 1, 2004 (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2003).  
       
14.1   Code of Financial Ethics (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2003).  
       
21.1   List of Subsidiaries (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2012).  
       
23.1   Consent of Registered Independent Public Accounting Firm (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2012).  
       
23.2   Consent of Registered Independent Public Accounting Firm.  
       
24.1   Power of Attorney (included on signature page attached hereto).  
       
31.1   CEO Certification pursuant to Section 302.  
       
31.2   CFO Certification pursuant to Section 302.  
       
32.1   CEO Certification pursuant to Section 906.  
       
32.2   CFO Certification pursuant to Section 906.  
       
101.INS   XBRL Instance Document  
       
101.SCH   XBRL Schema Document  
       
101.CAL   XBRL Calculation Linkbase Document  
       
101.LAB   XBRL Label Linkbase Document  
       
101.PRE   XBRL Presentation Linkbase Document  
       
101.DEF   XBRL Definition Linkbase Document  

 

* Indicates management contract or compensatory plan.

 

†Certain schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). The company agrees to furnish supplementally a copy of all omitted schedules to the SEC upon its request.

 

18
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  RADNET, INC.  
Date:  April 1, 2013   / s/    HOWARD G . BERGER, M.D.  
    Howard G. Berger, M.D., President,  
    Chief Executive Officer and Director  

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of registrant in the capacities and on the dates indicated.

 

By / s/   HOWARD  G . BERGER, M.D. Date:  April 1, 2013
  Howard G. Berger, M.D., Director, Chief Executive Officer and President  
     
     
By /s/ MARVIN S. CADWELL * Date:  April 1, 2013
  Marvin S. Cadwell, Director  
     
     
By /s/ JOHN V. CRUES, III, M.D. * Date:  April 1, 2013
     
  John V. Crues, III, M.D., Director  
     
By /s/ N ORMAN R. HAMES * Date:  April 1, 2013
  Norman R. Hames, Director  
     
     
By /s/ DAVID L. SWARTZ * Date:  April 1, 2013
  David L. Swartz, Director  
     
     
By /s/ LAWRENCE L. LEVITT * Date:  April 1, 2013
  Lawrence L. Levitt, Director  
     
     
By /s/ MICHAEL L. SHERMAN, M.D. * Date:  April 1, 2013
  Michael L. Sherman, M.D., Director  
     
     
By /s/ MARK D. STOLPER Date:  April 1, 2013
  Mark D. Stolper, Chief Financial Officer (Principal Accounting Officer)  

 

 

 * By Mark D. Stolper, as attorney- in- fact

 

 

19

 EX-23.2 2 rdnt_10ka-ex2302.htm CONSENT

 

EXHIBIT 23.2

 

CONSENT OF REGISTERED INDEPENDENT PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statements (Form S-8 Nos. 333-176324, 333-61876, 333-160100, 333-143652 and 333-153228) pertaining to the 2000 Long-Term Incentive Plan, the 2006 Equity Incentive Plan, and certain warrants of RadNet Inc., of our report dated April 1, 2013 with respect to the combined financial statements of certain RadNet, Inc. affiliates including Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and Greater Baltimore Diagnostic Imaging Partnership, included in this Annual Report (Form 10-K/A) for the year ended December 31, 2012.

 

/s/ Ernst & Young LLP 

       
       
Los Angeles, California      
April 1, 2013      

 

 EX-31.1 3 rdnt_10ka-ex3101.htm CERTIFICATION

 

EXHIBIT 31.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Howard G. Berger, M.D., certify that:

 

1.     I have reviewed this report on Form 10-K/A (Amendment No. 1) to the Annual Report of RadNet, Inc.

 

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.     The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: April 1, 2013

 

       
  By: /s/ Howard G. Berger, M.D.  
    Howard G. Berger, M.D.  
    President, Chief Executive Officer and Chairman of the Board of Directors  
       

 

 

 EX-31.2 4 rdnt_10ka-ex3102.htm CERTIFICATION

 

 

EXHIBIT 31.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Howard G. Berger, M.D., certify that:

 

1.     I have reviewed this report on Form 10-K/A (Amendment No. 1) to the Annual Report of RadNet, Inc.

 

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.     The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.     The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: April 1, 2013

 

       
  By: /s/ Mark D. Stolper  
    Mark D. Stolper  
   

Executive Vice President

andChief Financial Officer

  
       

 EX-32.1 5 rdnt_10ka-ex3201.htm CERTIFICATION

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of RadNet, Inc. (the “Company”) on Form 10-K/A (Amendment No. 1) for the twelve month period ended December 31, 2012, as filed with the Securities and Exchange Commission on April 1, 2013 (the “Report”), I, Howard G. Berger, M.D., Chairman and Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.

 

     
  /s/ Howard G. Berger, M.D.  
  Howard G. Berger, M.D.  
 

Chairman, President and Chief Executive Officer

(Principal Executive Officer)

April 1, 2013

  
     

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 

 

 

 

 EX-32.2 6 rdnt_10ka-ex3202.htm CERTIFICATION

 

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of RadNet, Inc. (the “Company”) on Form 10-K/A (Amendment No. 1) for the twelve month period ended December 31, 2012, as filed with the Securities and Exchange Commission on April 1, 2013 (the “Report”), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.

 

     
  /s/ Mark D. Stolper  
  Mark D. Stolper  
 

Mark D. Stolper

Chief Financial Officer

(Principal Financial Officer)

April 1, 2013

  
     

 

A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.

 

 EX-101.INS 7 rdnt-20121231.xml XBRL INSTANCE FILE 0000790526 2012-01-01 2012-12-31 0000790526 2012-12-31 0000790526 2011-12-31 0000790526 2011-01-01 2011-12-31 0000790526 2010-12-31 0000790526 2013-03-08 0000790526 2010-01-01 2010-12-31 0000790526 us-gaap:SupportEquipmentAndFacilitiesMember 2012-12-31 0000790526 us-gaap:EquipmentMember 2012-12-31 0000790526 2009-12-31 0000790526 rdnt:RadNetIncMember 2010-01-01 2010-12-31 0000790526 rdnt:RadNetIncMember 2011-01-01 2011-12-31 0000790526 rdnt:RadNetIncMember 2012-01-01 2012-12-31 0000790526 rdnt:RadNetIncMember 2009-12-31 0000790526 rdnt:RadNetIncMember 2010-12-31 0000790526 rdnt:RadNetIncMember 2011-12-31 0000790526 rdnt:RadNetIncMember 2012-12-31 0000790526 rdnt:OtherPartnersMember 2010-01-01 2010-12-31 0000790526 rdnt:OtherPartnersMember 2011-01-01 2011-12-31 0000790526 rdnt:OtherPartnersMember 2012-01-01 2012-12-31 0000790526 rdnt:OtherPartnersMember 2009-12-31 0000790526 rdnt:OtherPartnersMember 2010-12-31 0000790526 rdnt:OtherPartnersMember 2011-12-31 0000790526 rdnt:OtherPartnersMember 2012-12-31 0000790526 2012-06-29 0000790526 rdnt:MibPartnershipLlpMember 2011-01-01 2011-12-31 0000790526 rdnt:WestminsterMember 2012-01-01 2012-12-31 0000790526 rdnt:ManagementServiceContractsMember 2012-12-31 0000790526 rdnt:CovenantNotToCompeteContractsMember 2012-12-31 0000790526 rdnt:FranklinImagingJointVentureMember 2012-12-31 0000790526 rdnt:CarrollCountyRadiologyLlcMember 2012-12-31 0000790526 rdnt:MriAtStJosephMedicalCenterLlcMember 2012-12-31 0000790526 rdnt:GreaterBaltimoreDiagnosticImagingPartnershipMember 2012-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares rdnt:Integer xbrli:pure 2012 Accelerated Filer Yes No No --12-31 true 2012-12-31 0000790526 RadNet, Inc. FY 38990482 42103000 43900000 724000 844000 306000 418000 19358000 22074000 12098000 13166000 602000 337000 8597000 8326000 1778000 2089000 1808000 1456000 6133000 10801000 144000 414000 1006000 1916000 1594000 1749000 3389000 6722000 270000 278000 167000 134000 909000 2698000 2043000 3612000 42103000 43900000 12637000 8393000 9090000 42733000 35608000 35119000 35000 -195000 -125000 4607000 3856000 3703000 2752000 2211000 2112000 12392000 8012000 8388000 3771000 3714000 5757000 4617000 4298000 6635000 -3991000 -2576000 -2323000 35000 305000 1091000 2576000 2495000 2935000 133000 16177000 11601000 18336000 -1424000 878000 517000 -264000 -31000 748000 -3022000 -3036000 -2415000 -35000 195000 125000 -311000 281000 352000 -12497000 -8744000 -15661000 11821000 5980000 13085000 2976000 2764000 2576000 3645000 2563000 1082000 3068000 2298000 770000 2982000 2343000 639000 2080000 1835000 245000 1489000 1489000 1028000 1028000 14292000 11556000 2736000 -31630000 -28040000 295000 148000 414000 <p style="font: 8pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0; text-align: justify">We are filing this Form 10-K/A (Amendment No. 1) to our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, originally filed with the U.S. Securities and Exchange Commission on March 18, 2013 (the &#34;Original Filing&#34;), solely for the purpose of complying with Rule 3-09 of Regulation S-X.&#160; Rule 3-09 requires that we file financial statements of certain unconsolidated joint ventures in which we hold equity interests of 50% or less and account for them under the equity method to the extent that the unconsolidated joint ventures are individually significant.&#160; Under Rule 3-09 of Regulation S-X, we are permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0; text-align: justify">We have determined that as of and for the year ended December 31, 2012, four of our unconsolidated joint venture interests including&#160;&#160; Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and Greater Baltimore Diagnostic Imaging Partnership, (collectively, the &#147;Group&#148;), were significant unconsolidated joint ventures under Rule 3-09.&#160; Accordingly, we are filing in this Amendment No. 1 to include the combined financial statements of the Group under Item 8 &#150; Financial Statements and Supplementary Data, and we are amending Item 15 - Exhibits and Financial Statement Schedules, to include a list of the financial statements and exhibits being filed herewith. We are also filing updated Certificates of our Chief Executive Officer and Chief Financial Officer under Sections 302 and 906 of the Sarbanes Oxley Act of 2002.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0; text-align: justify">Except as described above, no other changes have been made to the Original Filing, and this Form 10-K/A does not amend, update or change any other items or disclosures in the Original Filing.&#160; This Form 10-K/A does not reflect events occurring after the Original Filing.&#160;&#160; Accordingly, this Amendment should be read in conjunction with the Original Filing and our other filings with the SEC subsequent to the Original Filing</p> 1121000 2414000 38161000 31557000 31291000 245000 381000 702000 1293000 -372000 4110000 2300000 245000 381000 702000 81917304 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><font style="color: black">Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and </font>Greater Baltimore Diagnostic Imaging Partnership<font style="color: black">,</font> (collectively, the &#147;Group&#148;), are joint ventures between RadNet, Inc. and, as applicable, hospitals, health systems or radiology practices operating within the state of Maryland and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Each joint venture within the Group is an affiliate of RadNet, Inc. as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 3%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="width: 35%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>% owned by Radnet, Inc.</b></font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td nowrap="nowrap" style="padding-right: 5.4pt"><font style="font-size: 8pt">Franklin Imaging Joint Venture</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">49%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt"><font style="font-size: 8pt">Carroll County Radiology, LLC</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">40%</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td nowrap="nowrap" style="padding-right: 5.4pt"><font style="font-size: 8pt">MRI at St. Joseph Medical Center, LLC</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">49%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt"><font style="font-size: 8pt">Greater Baltimore Diagnostic Imaging Partnership</font></td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><font style="font-size: 8pt">50%</font></td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">The financial information for 2011 and 2010 included herein has been prepared by management of RadNet, Inc. without audit. Management of RadNet, Inc. believes that such financial information has been prepared in conformity with U.S. generally accepted accounting principles, and includes all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows as of and for the years ended December 31, 2011 and 2010.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">PRINCIPLES OF COMBINATION &#150; Under Rule 3-09 of Regulation S-X, Radnet, Inc. is permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business. The combined financial statements include the assets, liabilities, and operations of each member of the Group. The operating activities of each of these joint ventures are completely separate from one another and are in no way affiliated with one another. Accordingly there are no intercompany transactions and balances to be eliminated when combining each together.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">USE OF ESTIMATES - The preparation of these financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters including the Group&#146;s reported amounts of assets and liabilities in the combined balance sheets at the dates of the financial statements; disclosure of contingent assets and liabilities at the dates of the financial statements; and reported amounts of revenues and expenses in the combined statements of income during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#146;s control. As a result, actual amounts could materially differ from these estimates.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">REVENUES &#150; Combined service fee revenue, net of contractual allowances and discounts, consists of net patient fees&#160;received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. This service fee revenue is earned through providing the use of diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">The Group's combined service fee revenues are recorded during the period the services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage with third-party payers.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">The Group&#146;s service fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended December 31, are summarized in the following table (in thousands):</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="font-weight: bold">&#160;</td> <td colspan="10" style="font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>Years Ended December 31,</b></font></td> <td style="font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>2012</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>2011</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>2010</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 8pt">(unaudited)</font></td> <td style="text-align: center">&#160;</td> <td style="text-align: center">&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 8pt">(unaudited)</font></td> <td style="text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 49%"><font style="font-size: 8pt">Commercial Insurance/Managed Care Capitation</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">40,220</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">32,302</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">32,054</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Medicare</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">12,089</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">9,242</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">9,774</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">Medicaid</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,976</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,525</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,529</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Workers' Compensation/Personal Injury</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,615</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,987</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,992</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Other</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,221</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,155</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">973</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt; text-indent: -11pt"><font style="font-size: 8pt">Service fee revenue, net of contractual allowances and discounts</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">58,122</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">46,212</font></td> <td><font style="font-size: 8pt"></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">46,321</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Provision for bad debts</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(2,752</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(2,211</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(2,112</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Net service fee revenue</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">55,370</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">44,001</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">44,209</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">The break-out of the Group&#146;s combined service fee revenue, net of contractual allowances and discounts, is calculated based upon global payments received from consolidated imaging centers from dates of service from each respective period illustrated.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>&#160;</i></b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">ACCOUNTS RECEIVABLE - Substantially all of the Group&#146;s accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.&#160;&#160;Services are generally provided pursuant to one-year contracts with healthcare providers.&#160;&#160;Receivables generally are collected within industry norms for third-party payors.&#160;&#160;The Group continuously monitors collections from payors and maintains an allowance for bad debts based upon specific payor collection issues that have been identified as well as historical collection experience.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">PROVISION FOR BAD DEBTS - Although outcomes vary, the Group&#146;s policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service. The Group provides for an allowance against accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Group estimates this allowance based on the aging of accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of the provision for bad debt relates to co-payments and deductibles owed to the Group by patients with insurance. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and the Group&#146;s estimation process. The combined allowance for bad debts at December 31, 2012 and 2011 were $393,000 and $395,000 (unaudited), respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">CONCENTRATION OF CREDIT RISKS - Financial instruments that potentially subject the Group to credit risk are primarily cash equivalents and accounts receivable. Each joint venture places its cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. The Group continuously monitors collections from its clients and maintains an allowance for bad debts based upon any specific payor collection issues that are identified and historical experience.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">CASH AND CASH EQUIVALENTS &#150; The Group considers all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates their fair market value.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">PROPERTY AND EQUIPMENT &#150; Property, furniture and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the shorter of the related lease term or their estimated useful lives which range from 3 to 30 years.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">GOODWILL &#150; Combined goodwill of the Group at December&#160;31, 2012 totaled $9.9 million. Goodwill is recorded by each member of the Group as a result of business combinations. Management of each member of the Group evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable.&#160;&#160;Each member of the Group adopted the provisions of ASU 2011-08 effective January 1, 2011. Each member of the Group evaluated its respective share of the combined goodwill at October 1, 2012 for signs of impairment under the provisions of ASU 2011-08. By utilizing certain qualitative measures outlined in the guidance, each member determined that its respective share of the combined goodwill was not impaired.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">INCOME TAXES - Each member of the Group is treated as a partnership for federal and state income tax purposes where all taxable income is allocated to the partners in accordance with the respective partnership agreement and so accordingly federal and state taxes on income are the responsibility of the Joint partners individually. Accordingly, no income tax provision is recorded by any joint ventures in the Group. Effective January 1, 2009, the Group adopted Accounting Standards Codification ASC 740, <i>Income Taxes</i>, formerly known as Financial Accounting Standards Board (FASB) Interpretation No. 48, <i>Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement</i> <i>No. 109 </i>(FIN 48). ASC 740 requires the impact of a tax position to be recognized in the financial statements if that position is more-likely-than-not to be sustained by the taxing authority. Tax positions not deemed to meet the &#147;more likely than not&#148; threshold would be recorded as a tax benefit or expense in the current year. Management of the Group is required to analyze all open tax years, as defined by the statute of limitations, for all major jurisdictions, which includes federal and certain states. Open tax years are those that are open for exam by taxing authorities, and include all returns subsequent to tax years ending after December 31, 2009, for federal returns and December 31, 2009, for Maryland returns. The Partnership has no examinations in process and has not been notified of any future examinations at this time. Management of the Group has reviewed all open tax years and major jurisdictions, and has concluded that the adoption of ASC 740 did not have a material effect on the Group&#146;s financial position or its results of operations. There is no tax liability resulting from unrecognized tax benefits relating to uncertain-income tax positions taken or expected to be taken in future tax returns. The Group has recognized no interest or penalties related to uncertain tax positions taken or<br /> expected to be taken.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">FAIR VALUE MEASUREMENTS &#150;The combined balance sheets include the following financial instruments: cash and cash equivalents, receivables, trade accounts payable, capital leases, equipment notes payable and other liabilities. The Group considers the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, the Group considers the carrying amount of its equipment notes payable and capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">On February 22, 2012, the members of Carroll County Radiology, LLC completed its acquisition of a multi modality imaging center from RadNet, Inc. located in Westminster, Maryland for $2.3 million. The members made a fair value determination of the assets acquired and the liabilities assumed and approximately $200,000 of fixed assets, $2.1 million of goodwill was recorded with respect to this transaction.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;&#9;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">On November 1, 2012, the partners of Franklin Imaging Joint Venture completed its acquisition of a multi modality imaging center located in Baltimore, Maryland for $635,000. The members made a fair value determination of the assets acquired and the liabilities assumed and approximately $635,000 of fixed assets was recorded with respect to this transaction.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">On December 31, 2011, the partners of Greater Baltimore Diagnostic Imaging Partnership (GBDIP) contributed their aggregate 100% interest in MIB Partnership, LLP, valued at $10.2 million, to GBDIP. Immediately prior to this contribution, the partners of GBDIP, who in aggregate held a 50% interest in MIB Partnership, LLP, acquired the remaining 50% interest in MIB Partnership, LLP for $5.6 million. As a result, GBDIP began consolidating this contributed partnership on December 31, 2011, recording all of its assets and liabilities at fair value on the date of contribution. As a result, $1.4 million of current assets, $2.8 million of fixed assets, $522,000 of intangible assets, and $7.6 million of goodwill was recorded with respect to this transaction. Also recorded were approximately $210,000 of accounts payable and accrued expenses, and $2.0 million of equipment notes and leases payable.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">On December 31, 2011, the partners of Franklin Imaging Joint Venture (Franklin) contributed their aggregate 100% interest in Health Imaging Systems, LLC, valued at $1.0 million, to Franklin. As a result, Franklin began consolidating this contributed partnership on December 31, 2011, recording all of its assets and liabilities. As a result, $861,000 of current assets, $279,000 of fixed assets, and $137,000 of accounts payable and accrued expenses was recorded with respect to this transaction.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Combined goodwill of the Group at December&#160;31, 2012 totaled $9.9 million. Goodwill is recorded as a result of business combinations.&#160;Activity in goodwill for the years ended December&#160;31, 2011 and 2012 is provided below (in thousands):</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 83%"><font style="font-size: 8pt">Balance as of January 1, 2011 (unaudited)</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">223</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Goodwill acquired through GBDIP's acquisition of MIB Partnership, LLP</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">7,593</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">Balance as of December 31, 2011 (unaudited)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">7,816</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 11pt; text-indent: -11pt"><font style="font-size: 8pt">Goodwill acquired through Carroll County Radiology's acquisition of Westminster from RadNet, Inc.</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">2,107</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Balance as of December 31, 2012</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">9,923</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 67.5pt">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Other intangible assets are primarily related to the value of management service contracts on the books of MRI at St. Joseph Medical Center, LLC and covenant not to compete contracts acquired through GBDIP&#146;s acquisition of a controlling interest of a previously held non-consolidated joint venture investment and totaled $522,000 on the date of acquisition. Accumulated amortization of the management service contract and covenant not to compete contract intangible assets through December 31, 2012 was $79,000 and $104,000, respectively. Amortization expense for the year ended December&#160;31, 2012 was $120,000.&#160;&#160;The value of these covenant not to compete contracts are amortized using the straight-line method over five years.&#160;&#160;Management service contracts are amortized over 25 years.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2013</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2014</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2015</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2016</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Thereafter</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Weighted average amortization period remaining in years</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 20%; padding-bottom: 1pt; padding-left: 11pt; text-indent: -11pt"><font style="font-size: 8pt">Management service contracts</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">226</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">306</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">19.0</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt; padding-left: 11pt; text-indent: -11pt"><font style="font-size: 8pt">Covenant not to compete contracts</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">104</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">104</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">105</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">105</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">418</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">4.0</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 22pt; text-indent: -11pt"><font style="font-size: 8pt">Total annual amortization</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">120</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">120</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">121</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">121</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt"></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">226</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">724</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 40pt"><b></b>Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>December 31,</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>2012</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>2011</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center">&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 8pt">(unaudited)</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 66%"><font style="font-size: 8pt">Medical equipment</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">31,804</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">31,514</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Office equipment, furniture and fixtures</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">2,949</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">3,051</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">Leasehold improvements</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">14,253</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">13,567</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Equipment under capital leases</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,982</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">1,982</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">50,988</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">50,114</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Accumulated depreciation and amortization</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(31,630</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(28,040</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt; text-align: right">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">19,358</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">22,074</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Depreciation and amortization expense on property and equipment, including amortization of equipment under capital leases, for the years ended December&#160;31, 2012, 2011 and 2010 totaled $4.5 million, $3.8 million (unaudited) and $3.7 million (unaudited), respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Leases</i> </b>&#150; The Group leases various operating facilities and certain medical equipment under operating leases with renewal options expiring <font style="color: black">through 2022. Certain leases contain renewal options from two to ten years and escalation clauses based either on the consumer price index or fixed rent escalators. Leases with fixed rent escalators are recorded on a straight-line basis. The Group records deferred rent for tenant leasehold improvement allowances received from a lessor and amortizes the deferred rent expense over the term of the lease agreement. Minimum annual payments under operating leases for future years ending December&#160;31 follow (in thousands): </font></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt; color: black"><b>Facilities</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt; color: black"><b>Equipment</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt; color: black"><b>Total</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 40%"><font style="font-size: 8pt; color: black">2013</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt; color: black">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 8pt; color: black">2,563</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt; color: black">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 8pt; color: black">1,082</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt; color: black">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 8pt; color: black">3,645</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt; color: black">2014</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">2,298</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">770</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">3,068</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt; color: black">2015</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">2,343</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">639</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">2,982</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt; color: black">2016</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">1,835</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">245</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">2,080</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt; color: black">2017</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">1,489</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">&#150;</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt; color: black">1,489</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt; color: black">Thereafter</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt; color: black">1,028</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt; color: black">&#150;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt; color: black">1,028</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt; color: black">11,556</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt; color: black">2,736</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt; color: black">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt; color: black">14,292</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Total rent expense, including equipment rentals, for the years ended December&#160;31, 2012, 2011 and 2010 was $4.3 million, $3.7 million (unaudited) and $3.9 million (unaudited), respectively.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">See Note 4 with respect to related party facility combinations.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">RadNet, Inc. contracts with each joint venture within the Group to provide certain administrative services including assistance with accounting, payroll and employee benefits processing, and billing and collection functions on behalf of these joint ventures. RadNet Inc. remits to the joint ventures all amounts collected through its administration of the billing and collection functions.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">RadNet, Inc., as administrator over payroll and employee benefits, pays salary and benefit obligations on behalf of these joint ventures and then bills each joint venture for its respective portion.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">RadNet, Inc. contracts certain members of its contracted radiologist groups to perform professional services for the joint ventures. RadNet, Inc. assures that these radiologists are adequately covered under medical malpractice insurance policies. RadNet, Inc., on behalf of its contracted radiologist groups, bills each joint venture for its respective share of the professional fees incurred through its utilization of these contracted radiologists. RadNet, Inc. remits to its contracted radiologist groups all amounts collected from the joint ventures for the billed professional fees.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Amounts receivable from and payable to RadNet Inc. for the activities listed above are summarized in due from affiliates on the Group&#146;s combined balance sheets and was $1.1 million and $2.4 million (unaudited) at December 31, 2012 and 2011, respectively. Due from affiliates of $1.1 million at December 31, 2012 consists of a receivable from Radnet, Inc. of $4.3 million for amounts collected through its administration of the billing and collection functions not yet remitted to the joint ventures at December 31, 2012. This receivable is offset by amounts payable to Radnet, Inc. of $525,000 for the unpaid portion of billed administrative services performed, $1.2 million for the unpaid portion of professional fees which Radnet must in turn remit to its contracted radiologists, and $1.4 million for unpaid payroll and employee benefit costs.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 24.5pt; text-align: justify">The member of the Group evaluated subsequent events through April, 1, 2013 and concluded that no additional disclosures were required.</p> 9923000 7816000 223000 1221000 1155000 973000 2615000 1987000 1992000 1976000 1525000 1529000 12089000 9242000 9774000 40220000 32302000 32054000 2752000 2211000 2112000 7593000 2107000 -226000 -226000 16000 16000 121000 16000 105000 121000 16000 105000 120000 16000 104000 120000 16000 104000 P19Y P4Y 909000 487000 504000 15000 443000 -29000 <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Under Rule 3-09 of Regulation S-X, Radnet, Inc. is permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business. The combined financial statements include the assets, liabilities, and operations of each member of the Group. The operating activities of each of these joint ventures are completely separate from one another and are in no way affiliated with one another. Accordingly there are no intercompany transactions and balances to be eliminated when combining each together.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of these financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters including the Group&#146;s reported amounts of assets and liabilities in the combined balance sheets at the dates of the financial statements; disclosure of contingent assets and liabilities at the dates of the financial statements; and reported amounts of revenues and expenses in the combined statements of income during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#146;s control. As a result, actual amounts could materially differ from these estimates.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Combined service fee revenue, net of contractual allowances and discounts, consists of net patient fees&#160;received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. This service fee revenue is earned through providing the use of diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Group's combined service fee revenues are recorded during the period the services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage with third-party payers.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The break-out of the Group&#146;s combined service fee revenue, net of contractual allowances and discounts, is calculated based upon global payments received from consolidated imaging centers from dates of service from each respective period illustrated.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Substantially all of the Group&#146;s accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.&#160;&#160;Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. The Group continuously monitors collections from payors and maintains an allowance for bad debts based upon specific payor collection issues that have been identified as well as historical collection experience.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Although outcomes vary, the Group&#146;s policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service. The Group provides for an allowance against accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Group estimates this allowance based on the aging of accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of the provision for bad debt relates to co-payments and deductibles owed to the Group by patients with insurance. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and the Group&#146;s estimation process. The combined allowance for bad debts at December 31, 2012 and 2011 were $393,000 and $395,000 (unaudited), respectively.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments that potentially subject the Group to credit risk are primarily cash equivalents and accounts receivable. Each joint venture places its cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. The Group continuously monitors collections from its clients and maintains an allowance for bad debts based upon any specific payor collection issues that are identified and historical experience.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Group considers all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates their fair market value.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property, furniture and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the shorter of the related lease term or their estimated useful lives which range from 3 to 30 years.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Combined goodwill of the Group at December&#160;31, 2012 totaled $9.9 million. Goodwill is recorded by each member of the Group as a result of business combinations. Management of each member of the Group evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable.&#160;&#160;Each member of the Group adopted the provisions of ASU 2011-08 effective January 1, 2011. Each member of the Group evaluated its respective share of the combined goodwill at October 1, 2012 for signs of impairment under the provisions of ASU 2011-08. By utilizing certain qualitative measures outlined in the guidance, each member determined that its respective share of the combined goodwill was not impaired.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Each member of the Group is treated as a partnership for federal and state income tax purposes where all taxable income is allocated to the partners in accordance with the respective partnership agreement and so accordingly federal and state taxes on income are the responsibility of the Joint partners individually. Accordingly, no income tax provision is recorded by any joint ventures in the Group. Effective January 1, 2009, the Group adopted Accounting Standards Codification ASC 740,&#160;<i>Income Taxes</i>, formerly known as Financial Accounting Standards Board (FASB) Interpretation No. 48,&#160;<i>Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement</i>&#160;<i>No. 109&#160;</i>(FIN 48). ASC 740 requires the impact of a tax position to be recognized in the financial statements if that position is more-likely-than-not to be sustained by the taxing authority. Tax positions not deemed to meet the &#147;more likely than not&#148; threshold would be recorded as a tax benefit or expense in the current year. Management of the Group is required to analyze all open tax years, as defined by the statute of limitations, for all major jurisdictions, which includes federal and certain states. Open tax years are those that are open for exam by taxing authorities, and include all returns subsequent to tax years ending after December 31, 2009, for federal returns and December 31, 2009, for Maryland returns. The Partnership has no examinations in process and has not been notified of any future examinations at this time. Management of the Group has reviewed all open tax years and major jurisdictions, and has concluded that the adoption of ASC 740 did not have a material effect on the Group&#146;s financial position or its results of operations. There is no tax liability resulting from unrecognized tax benefits relating to uncertain-income tax positions taken or expected to be taken in future tax returns. The Group has recognized no interest or penalties related to uncertain tax positions taken or<br /> expected to be taken.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The combined balance sheets include the following financial instruments: cash and cash equivalents, receivables, trade accounts payable, capital leases, equipment notes payable and other liabilities. The Group considers the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, the Group considers the carrying amount of its equipment notes payable and capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">On January 1, 2012, the Group adopted ASU 2011-07, &#147;<i>Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities</i>,&#148; which requires health care entities to present the provision for doubtful accounts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. Such additional disclosures are included in Note 2. The adoption of this ASU had no impact on the Group&#146;s combined financial position, results of operations or cash flows, although it did change the financial statement presentation.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 9pt 0 0; text-align: justify">On January&#160;1, 2012, each member of the Group adopted ASU 2011-08, &#147;<i>Intangibles&#151;Goodwill and Other (Topic 350): Testing Goodwill for Impairment</i>&#148;, simplifying how a company is required to test goodwill for impairment. Companies will now have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2012, the FASB modified existing rules to allow entities to use a qualitative approach to test indefinite-lived intangible asset for impairment. &#160;The revised standard allows an entity the option to first assess qualitatively whether it is more likely than not (that is, a likelihood of more than 50 percent) that an indefinite-lived intangible asset is impaired. &#160;An entity is not required to calculate the fair value of an indefinite-lived intangible asset and perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired. &#160;This guidance will be effective for the Group in 2013.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2013, the FASB issued new guidance which requires disclosure of information about significant reclassification adjustments from accumulated other comprehensive income in a single note or on the face of the financial statements. &#160;This guidance will be effective for the Group in 2013. &#160;Adoption of this standard, which is related to disclosure only, will not have an impact on the Group&#146;s combined financial position, results of operations, or cash flows.</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Each joint venture within the Group is an affiliate of RadNet, Inc. as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 27pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="width: 35%; border-bottom: windowtext 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%; font-weight: bold; text-align: center">% owned by Radnet, Inc.</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%">Franklin Imaging Joint Venture</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%; text-align: center">49%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%">Carroll County Radiology, LLC</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%; text-align: center">40%</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%">MRI at St. Joseph Medical Center, LLC</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%; text-align: center">49%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%">Greater Baltimore Diagnostic Imaging Partnership</td> <td nowrap="nowrap" style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%">&#160;</td> <td nowrap="nowrap" style="padding-right: 5.4pt; line-height: 115%; text-align: center">50%</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Activity in goodwill for the years ended December&#160;31, 2011 and 2012 is provided below (in thousands):</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 84%; line-height: 115%">Balance as of January 1, 2011 (unaudited)</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">223</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Goodwill acquired through GBDIP's acquisition of MIB Partnership, LLP</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">7,593</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Balance as of December 31, 2011 (unaudited)</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">7,816</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt; line-height: 115%; text-indent: -11pt">Goodwill acquired through Carroll County Radiology's acquisition of Westminster from RadNet, Inc.</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">2,107</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Balance as of December 31, 2012</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">9,923</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="margin: 0pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2013</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2014</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2015</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2016</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">2017</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Thereafter</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Total</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><font style="font-size: 8pt">Weighted average amortization period remaining in years</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 20%; padding-bottom: 1pt; padding-left: 11pt; text-indent: -11pt"><font style="font-size: 8pt">Management service contracts</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">226</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">306</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 7%; text-align: right"><font style="font-size: 8pt">19.0</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt; padding-left: 11pt; text-indent: -11pt"><font style="font-size: 8pt">Covenant not to compete contracts</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">104</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">104</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">105</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">105</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">&#150;</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">418</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">4.0</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt; padding-left: 22pt; text-indent: -11pt"><font style="font-size: 8pt">Total annual amortization</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">120</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">120</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">121</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">121</font></td> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt"></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">16</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">226</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">724</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">December 31,</td> <td style="line-height: 115%; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">2012</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">2011</td> <td style="line-height: 115%; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">(unaudited)</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 69%; line-height: 115%">Medical equipment</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">31,804</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">31,514</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Office equipment, furniture and fixtures</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">2,949</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">3,051</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Leasehold improvements</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">14,253</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">13,567</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Equipment under capital leases</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">1,982</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">1,982</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">50,988</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">50,114</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Accumulated depreciation and amortization</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(31,630)</td> <td style="line-height: 115%"></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(28,040)</td> <td style="line-height: 115%"></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; padding-left: 5.4pt; line-height: 115%; text-align: right">19,358</td> <td style="line-height: 115%">&#160;</td> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">22,074</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">December 31,</td> <td style="line-height: 115%; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">2012</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">2011</td> <td style="line-height: 115%; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">(unaudited)</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 69%; line-height: 115%">Accounts payable</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">839</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">873</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Accrued expenses</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">229</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,937</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Accrued payroll and vacation</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">975</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">802</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">&#160;&#160;&#160;&#160;Total</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">2,043</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">3,612</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The following is a listing of annual principal maturities of the equipment notes discussed above for years ending December&#160;31 (in thousands):</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 69%; line-height: 115%">2013</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 26%; line-height: 115%; text-align: right">909</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">487</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">2015</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">504</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2016</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">15</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-left: 5.4pt; line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">1,915</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Group leases equipment under capital lease arrangements. Future minimum lease payments under capital leases for years ending December&#160;31 (in thousands) is as follows:</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 69%; line-height: 115%">2013</td> <td style="width: 3%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 26%; line-height: 115%; text-align: right">295</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2014</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">148</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Total minimum payments</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">443</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Amount representing interest</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(29)</td> <td style="line-height: 115%"></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Present value of net minimum lease payments</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">414</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less current portion</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(270)</td> <td style="line-height: 115%"></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Long-term portion</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">144</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">Minimum annual payments under operating leases for future years ending December&#160;31 follow (in thousands):</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">Facilities</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">Equipment</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">Total</td> <td style="line-height: 115%; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 40%; line-height: 115%">2013</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; line-height: 115%; text-align: right">2,563</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; line-height: 115%; text-align: right">1,082</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; line-height: 115%; text-align: right">3,645</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2014</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">2,298</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">770</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">3,068</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">2015</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">2,343</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">639</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">2,982</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">2016</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,835</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">245</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">2,080</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">2017</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,489</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#150;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,489</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Thereafter</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">1,028</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">&#150;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">1,028</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">11,556</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">2,736</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">14,292</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: justify">The Group&#146;s service fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended December 31, are summarized in the following table (in thousands):</p> <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 36pt">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="10" style="line-height: 115%; font-weight: bold; text-align: center">Years Ended December 31,</td> <td style="line-height: 115%; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">2012</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">2011</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td style="line-height: 115%; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; line-height: 115%; font-weight: bold; text-align: center">2010</td> <td style="line-height: 115%; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%; text-align: center">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%; text-align: center">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">(unaudited)</td> <td style="line-height: 115%; text-align: center">&#160;</td> <td style="line-height: 115%; text-align: center">&#160;</td> <td colspan="2" style="line-height: 115%; text-align: center">(unaudited)</td> <td style="line-height: 115%; text-align: center">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 53%; line-height: 115%">Commercial Insurance/Managed Care Capitation</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">40,220</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 2%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">32,302</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">&#160;</td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; line-height: 115%; text-align: right">32,054</td> <td style="width: 1%; line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Medicare</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">12,089</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">9,242</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">9,774</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Medicaid</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,976</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,525</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,529</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Workers' Compensation/Personal Injury</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">2,615</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,987</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">1,992</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Other</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">1,221</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">1,155</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">973</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 11pt; line-height: 115%; text-indent: -11pt">Service fee revenue, net of contractual allowances and discounts</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">58,122</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">46,212</td> <td style="line-height: 115%"></td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">46,321</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%; text-align: right">&#160;</td> <td style="line-height: 115%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Provision for bad debts</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(2,752)</td> <td style="line-height: 115%"></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(2,211)</td> <td style="line-height: 115%"></td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%">&#160;</td> <td style="border-bottom: black 1pt solid; line-height: 115%; text-align: right">(2,112)</td> <td style="line-height: 115%"></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="line-height: 115%">Net service fee revenue</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">55,370</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">44,001</td> <td style="line-height: 115%">&#160;</td> <td style="line-height: 115%">&#160;</td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; line-height: 115%; text-align: right">44,209</td> <td style="line-height: 115%">&#160;</td></tr> </table> <p style="font: 8pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">&#160;</p> 0.49 0.40 0.49 0.50 10-K 35970000 33099000 19864000 24561000 11168000 8982000 16458000 17717000 13393000 10882000 16641000 18253000 17717000 16458000 18253000 16641000 2300000 11203000 6551000 920000 4652000 1380000 -11821000 -5980000 -13085000 -5957000 -2789000 -5418000 -7128000 -3191000 -6403000 -122000 -112000 1048000 <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">On January 1, 2012, the Group adopted ASU 2011-07, &#147;<i>Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities</i>,&#148; which requires health care entities to present the provision for doubtful accounts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. Such additional disclosures are included in Note 2. The adoption of this ASU had no impact on the Group&#146;s combined financial position, results of operations or cash flows, although it did change the financial statement presentation.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 9pt 0 0; text-indent: 0.5in; text-align: justify">On January&#160;1, 2012, each member of the Group adopted ASU 2011-08, &#147;<i>Intangibles&#151;Goodwill and Other (Topic 350): Testing Goodwill for Impairment</i>&#148;, simplifying how a company is required to test goodwill for impairment. Companies will now have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">In July 2012, the FASB modified existing rules to allow entities to use a qualitative approach to test indefinite-lived intangible asset for impairment. &#160;The revised standard allows an entity the option to first assess qualitatively whether it is more likely than not (that is, a likelihood of more than 50 percent) that an indefinite-lived intangible asset is impaired. &#160;An entity is not required to calculate the fair value of an indefinite-lived intangible asset and perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired. &#160;This guidance will be effective for the Group in 2013.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">In February 2013, the FASB issued new guidance which requires disclosure of information about significant reclassification adjustments from accumulated other comprehensive income in a single note or on the face of the financial statements. &#160;This guidance will be effective for the Group in 2013. &#160;Adoption of this standard, which is related to disclosure only, will not have an impact on the Group&#146;s combined financial position, results of operations, or cash flows.</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="6" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>December 31,</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>2012</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td> <td colspan="2" style="border-bottom: black 1pt solid; font-weight: bold; text-align: center"><font style="font-size: 8pt"><b>2011</b></font></td> <td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td colspan="2" style="text-align: center"><font style="font-size: 8pt">(unaudited)</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 66%"><font style="font-size: 8pt">Accounts payable</font></td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">839</font></td> <td style="width: 1%">&#160;</td> <td style="width: 2%">&#160;</td> <td style="width: 1%"><font style="font-size: 8pt">$</font></td> <td style="width: 13%; text-align: right"><font style="font-size: 8pt">873</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">Accrued expenses</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">229</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">1,937</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Accrued payroll and vacation</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">975</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">802</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">&#160;&#160;&#160;&#160;Total</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">2,043</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">3,612</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">Three members of the Group, MRI at St. Joseph Medical Center, LLC, Franklin Imaging Joint Venture, and Greater Baltimore Diagnostic Partnership hold eleven promissory notes issued by three financing companies for the purpose of acquiring imaging equipment. These notes have interest rates between 3.5% and 9.0%, mature on or before June 2016 and are collateralized by the acquired equipment.</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">The following is a listing of annual principal maturities of the equipment notes discussed above for years ending December&#160;31 (in thousands):</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 66%"><font style="font-size: 8pt">2013</font></td> <td style="width: 4%">&#160;</td> <td style="width: 2%"><font style="font-size: 8pt">$</font></td> <td style="width: 26%; text-align: right"><font style="font-size: 8pt">909</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 8pt">2014</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">487</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">2015</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">504</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">2016</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">15</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">1,915</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in; text-align: justify">The Group leases equipment under capital lease arrangements. Future minimum lease payments under capital leases for years ending December&#160;31 (in thousands) is as follows:</p> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="width: 66%"><font style="font-size: 8pt">2013</font></td> <td style="width: 4%">&#160;</td> <td style="width: 2%"><font style="font-size: 8pt">$</font></td> <td style="width: 26%; text-align: right"><font style="font-size: 8pt">295</font></td> <td style="width: 2%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">2014</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">148</font></td> <td style="padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">Total minimum payments</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">443</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Amount representing interest</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(29</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td><font style="font-size: 8pt">Present value of net minimum lease payments</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 8pt">414</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">Less current portion</font></td> <td style="padding-bottom: 1pt">&#160;</td> <td style="border-bottom: black 1pt solid">&#160;</td> <td style="border-bottom: black 1pt solid; text-align: right"><font style="font-size: 8pt">(270</font></td> <td style="padding-bottom: 1pt"><font style="font-size: 8pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #EEEEEE"> <td style="padding-bottom: 2.5pt"><font style="font-size: 8pt">Long-term portion</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 8pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 8pt">144</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p> 58122000 46212000 46321000 55370000 44001000 44209000 31804000 31514000 2949000 3051000 14253000 13567000 1982000 1982000 50988000 50114000 839000 873000 229000 1937000 975000 802000 1915000 EX-101.SCH 8 rdnt-20121231.xsd XBRL SCHEMA FILE 0001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 0002 - Statement - COMBINED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 0003 - Statement - COMBINED STATEMENTS OF INCOME link:presentationLink link:calculationLink link:definitionLink 0004 - Statement - COMBINED STATEMENTS OF PARTNERS' CAPITAL link:presentationLink link:calculationLink link:definitionLink 0005 - Statement - COMBINED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 0006 - Disclosure - 1. DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 0007 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 0008 - Disclosure - 3. RECENT ACCOUNTING STANDARDS link:presentationLink link:calculationLink link:definitionLink 0009 - Disclosure - 4. FACILITY ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 0010 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 0011 - Disclosure - 6. PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 0012 - Disclosure - 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 0013 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES link:presentationLink link:calculationLink link:definitionLink 0014 - Disclosure - 9. COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 0015 - Disclosure - 10. RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 0016 - Disclosure - 11. SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 0017 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 0018 - Disclosure - 1. DESCRIPTION OF BUSINESS (Tables) link:presentationLink link:calculationLink link:definitionLink 0019 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0020 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 0021 - Disclosure - 6. PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 0022 - Disclosure - 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (IN THOUSANDS) (Tables) link:presentationLink link:calculationLink link:definitionLink 0023 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 0024 - Disclosure - 9. COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 0025 - Disclosure - 1. DESCRIPTION OF BUSINESS (Details) link:presentationLink link:calculationLink link:definitionLink 0026 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 0027 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 0028 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details 1) link:presentationLink link:calculationLink link:definitionLink 0029 - Disclosure - 6. PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 0030 - Disclosure - 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Detalis) link:presentationLink link:calculationLink link:definitionLink 0031 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 1) link:presentationLink link:calculationLink link:definitionLink 0032 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 2) link:presentationLink link:calculationLink link:definitionLink 0033 - Disclosure - 9. COMMITMENTS AND CONTINGENCIES (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 rdnt-20121231_cal.xml XBRL CALCULATION FILE EX-101.DEF 10 rdnt-20121231_def.xml XBRL DEFINITION FILE EX-101.LAB 11 rdnt-20121231_lab.xml XBRL LABEL FILE Facilities Property, Plant and Equipment, Type [Axis] Equipment Land [Member] Computor and Office equipment, furniture and fixtures [Member] Software development costs [Member] Leasehold improvements [Member] Equipment under capital lease [Member] Medical equipment [Member] Computer and Office equipment, furniture and fixtures [Member] Revolving lines of credit [Member] CreditFacility [Axis] Senior secured term loan [Member] Senior unsecured notes [Member] Discount on Notes [Member] Promissory notes payable to the former shareholders [Member] Equipment notes payable [Member] Obligations under capital leases [Member] RadNet, Inc. Equity Components [Axis] Other Partners MIB Partnership, LLP [Member] Legal Entity [Axis] Westminster [Member] Management service contracts [Member] Contract [Axis] Covenant not to compete contracts [Member] Medical equipment [Member] Office equipment, furniture and fixtures [Member] Franklin Imaging Joint Venture [Member] Carroll County Radiology, LLC [Member] MRI at St. Joseph Medical Center, LLC [Member] Greater Baltimore Diagnostic Imaging Partnership [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Amendment Description Current Fiscal Year End Date Is Entity a Well-known Seasoned Issuer? Is Entity a Voluntary Filer? Is Entity's Reporting Status Current? Entity Filer Category Entity Public Float Entity Common Stock, Shares Outstanding Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents Accounts receivable, net Due from affiliates Prepaid expenses and other current assets Total current assets PROPERTY AND EQUIPMENT, NET OTHER ASSETS Goodwill Other intangible assets Total assets LIABILITIES AND PARTNERS' CAPITAL CURRENT LIABILITIES Accounts payable and accrued expenses Current portion of deferred rent Current portion of equipment notes payable Current portion of obligations under capital leases Total current liabilities LONG-TERM LIABILITIES Deferred rent, net of current portion Equipment notes payable, net of current portion Obligations under capital lease, net of current portion Total liabilities COMMITMENTS AND CONTINGENCIES PARTNERS' CAPITAL RadNet, Inc. Other partners Total partners' capital Total liabilities and partners' capital Income Statement [Abstract] NET SERVICE FEE REVENUE Service fee revenue, net of contractual allowances and discounts Provision for bad debts Net service fee revenue OPERATING EXPENSES Cost of operations Depreciation and amortization (Gain) loss on sale of equipment Total operating expenses INCOME FROM OPERATIONS Net interest expense NET INCOME Statement [Table] Statement [Line Items] Beginning Balance Net Income Contributions Distributions Ending Balance Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net income Adjustments to reconcile net income to net cash provided by operating activities: Provision for bad debt Deferred rent amortization (Gain) loss on sale of equipment Changes in operating assets and liabilities Accounts receivable Prepaid expenses and other current assets Due from affiliates Accounts payable, accrued expenses Net cash provided by operating activities CASH FLOWS FROM INVESTING ACTIVITIES Purchase of property and equipment Purchase of imaging facilities Proceeds from sale of equipment Net cash used in investing activities CASH FLOWS FROM FINANCING ACTIVITIES Principal payments on notes and leases payable Contributions from partners Distributions to partners Net cash used in financing activities NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Cash paid during the period for interest Notes to Financial Statements NOTE 1 - DESCRIPTION OF BUSINESS Accounting Policies [Abstract] NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES NOTE 3 - RECENT ACCOUNTING STANDARDS Facility Acquisitions NOTE 4 - FACILITY ACQUISITIONS Goodwill and Intangible Assets Disclosure [Abstract] NOTE 5 - GOODWILL AND OTHER INTANGIBLE ASSETS Property, Plant and Equipment [Abstract] NOTE 6 - PROPERTY AND EQUIPMENT Accounts Payable And Accrued Expenses NOTE 7 ACCOUNTS PAYABLE AND ACCRUED EXPENSES Debt Disclosure [Abstract] NOTE 8 - EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES Commitments and Contingencies Disclosure [Abstract] NOTE 9 - COMMITMENTS AND CONTINGENCIES Related Party Transactions [Abstract] NOTE 10 - RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] NOTE 11 - SUBSEQUENT EVENTS Summary Of Significant Accounting Policies Policies PRINCIPLES OF COMBINATION USE OF ESTIMATES REVENUES ACCOUNTS RECEIVABLE PROVISION FOR BAD DEBTS CONCENTRATION OF CREDIT RISKS CASH AND CASH EQUIVALENTS PROPERTY AND EQUIPMENT GOODWILL INCOME TAXES FAIR VALUE MEASUREMENTS RECENT ACCOUNTING STANDARDS Description Of Business Tables DESCRIPTION OF JOINT VENTURE Summary Of Significant Accounting Policies Tables Service fee revenue Schedule of activity in goodwill Schedule of amortization expense Property and equipment and accumulated depreciation and amortization ACCOUNTS PAYABLE AND ACCRUED EXPENSES Maturities of notes payable Future minimum lease payments under capital leases Minimum annual payments under operating leases Owned by parent company Summary Of Significant Accounting Policies Details Revenue Commercial Insurance/Managed Care Capitation Medicare Medicaid Workers Compensation/Personal Injury Other Provision for bad debts Net service fee revenue Goodwill, beginning balance Goodwill acquired Goodwill, ending balance ContractAxis [Axis] 2013 2014 2015 2016 2017 Thereafter Total goodwill and other intangible assets Weighted average amortization period remaining in years Property And Equipment Details Medical equipment Office equipment, furniture and fixtures Leasehold improvements Equipment under capital leases Property and equipment, gross Accumulated depreciation and amortization Property and equipment, net Accounts Payable And Accrued Expenses Detalis Accounts payable Accrued expenses Accrued payroll and vacation Total 2013 2014 2015 2016 Total principal maturies on equipment notes 2013 2014 Total minimum payments Amount representing interest Present value of net minimum lease payments Less current portion Long-term portion 2013 2014 2015 2016 2017 Thereafter Total minimum annual payments under operating leases Provision for bad debta Custom Element. Maturities of notes payable Workers comp arrangement Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Custom Element. Principal maturities of equipment notes due next year Principal maturities of equipment notes due in 4 years Principal maturities of equipment notes due in 3 years Principal maturities of equipment notes due in 2 years Description of joint ventures Service fee revenue Custom Element. Custom Element. Custom Element. Custom Element. Total principal maturies on equipment notes Assets, Current Assets Liabilities, Current Liabilities General Partners' Capital Account Partners' Capital Liabilities and Equity Gain (Loss) on Disposition of Property Operating Income (Loss) Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) Due from Affiliates Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Productive Assets Net Cash Provided by (Used in) Investing Activities Repayments of Long-term Debt, Long-term Capital Lease Obligations, and Capital Securities Payments to Noncontrolling Interests Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Finite-Lived Intangible Assets, Amortization Expense, after Year Five Property, Plant and Equipment, Gross PrincipalMaturitiesOfTheEquipmentNotesNextTwelveMonths PrincipalMaturitiesOfTheEquipmentNotesInTwoYears PrincipalMaturitiesOfTheEquipmentNotesInThreeYears PrincipalMaturitiesOfTheEquipmentNotesInFourYears Capital Leases, Future Minimum Payments Due, Next Twelve Months Capital Leases, Future Minimum Payments Due in Two Years Operating Leases, Future Minimum Payments Receivable, Current Operating Leases, Future Minimum Payments Receivable, in Two Years Operating Leases, Future Minimum Payments Receivable, in Three Years Operating Leases, Future Minimum Payments Receivable, in Four Years Operating Leases, Future Minimum Payments Receivable, in Five Years EX-101.PRE 12 rdnt-20121231_pre.xml XBRL PRESENTATION FILE XML 13 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
9. COMMITMENTS AND CONTINGENCIES (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
2013 $ 3,645
2014 3,068
2015 2,982
2016 2,080
2017 1,489
Thereafter 1,028
Total minimum annual payments under operating leases 14,292
Facilities
  
2013 2,563
2014 2,298
2015 2,343
2016 1,835
2017 1,489
Thereafter 1,028
Total minimum annual payments under operating leases 11,556
Equipment
  
2013 1,082
2014 770
2015 639
2016 245
2017   
Thereafter   
Total minimum annual payments under operating leases $ 2,736
XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 15 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. DESCRIPTION OF BUSINESS (Details)
Dec. 31, 2012
Franklin Imaging Joint Venture [Member]
  
Owned by parent company 49.00%
Carroll County Radiology, LLC [Member]
  
Owned by parent company 40.00%
MRI at St. Joseph Medical Center, LLC [Member]
  
Owned by parent company 49.00%
Greater Baltimore Diagnostic Imaging Partnership [Member]
  
Owned by parent company 50.00%
XML 16 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
4. FACILITY ACQUISITIONS
 12 Months Ended
Dec. 31, 2012
Facility Acquisitions  
NOTE 4 - FACILITY ACQUISITIONS

On February 22, 2012, the members of Carroll County Radiology, LLC completed its acquisition of a multi modality imaging center from RadNet, Inc. located in Westminster, Maryland for $2.3 million. The members made a fair value determination of the assets acquired and the liabilities assumed and approximately $200,000 of fixed assets, $2.1 million of goodwill was recorded with respect to this transaction.

 

On November 1, 2012, the partners of Franklin Imaging Joint Venture completed its acquisition of a multi modality imaging center located in Baltimore, Maryland for $635,000. The members made a fair value determination of the assets acquired and the liabilities assumed and approximately $635,000 of fixed assets was recorded with respect to this transaction.

 

On December 31, 2011, the partners of Greater Baltimore Diagnostic Imaging Partnership (GBDIP) contributed their aggregate 100% interest in MIB Partnership, LLP, valued at $10.2 million, to GBDIP. Immediately prior to this contribution, the partners of GBDIP, who in aggregate held a 50% interest in MIB Partnership, LLP, acquired the remaining 50% interest in MIB Partnership, LLP for $5.6 million. As a result, GBDIP began consolidating this contributed partnership on December 31, 2011, recording all of its assets and liabilities at fair value on the date of contribution. As a result, $1.4 million of current assets, $2.8 million of fixed assets, $522,000 of intangible assets, and $7.6 million of goodwill was recorded with respect to this transaction. Also recorded were approximately $210,000 of accounts payable and accrued expenses, and $2.0 million of equipment notes and leases payable.

 

On December 31, 2011, the partners of Franklin Imaging Joint Venture (Franklin) contributed their aggregate 100% interest in Health Imaging Systems, LLC, valued at $1.0 million, to Franklin. As a result, Franklin began consolidating this contributed partnership on December 31, 2011, recording all of its assets and liabilities. As a result, $861,000 of current assets, $279,000 of fixed assets, and $137,000 of accounts payable and accrued expenses was recorded with respect to this transaction.
EXCEL 17 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]F-S(P.#'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I7;W)K#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/D-/34))3D5$7U-4051%345. M5%-?3T9?4$%25$Y%4CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/34))3D5$7U-4051%345.5%-?3T9?0T%32%]&3#PO>#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C%?1$530U))4%1)3TY? M3T9?0E5324Y%4U,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C1?1D%#24Q)5%E?04-154E3251)3TY3/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E M;%=O#I%>&-E;%=O#I%>&-E;%=O M#I%>&-E;%=O#I%>&-E M;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/C9?4%)/4$525%E?04Y$7T5154E0345.5%]486)L93PO>#I.86UE/@T* M("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/C=?04-#3U5.5%-?4$%904), M15]!3D1?04-#4E5%1#$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/C%?1$530U))4%1)3TY?3T9?0E5324Y%4U-?1&5T83PO M>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/C9?4%)/4$525%E?04Y$7T5154E0345. M5%]$971A:3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/C=?04-#3U5.5%-?4$%904),15]!3D1?04-#4E5%1#(\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K#I% M>&-E;%=O#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/CE?0T]-34E4345.5%-? M04Y$7T-/3E1)3D=%3D-)13(\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F-S(P.#'0O:'1M;#L@8VAA2!) M;F9O2!296=I'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'`@2!S:6=N:69I8V%N="!U;F-O;G-O;&ED871E9"!J M;VEN="!V96YT=7)E6QE/3-$)V9O;G0Z(#AP="!4:6UE2<^5V4@:&%V92!D971E M65A<@T*96YD960@1&5C M96UB97(@,S$L(#(P,3(L(&9O=7(@;V8@;W5R('5N8V]N2!2861I;VQO9WDL($Q,0RP@35))(&%T(%-T+B!*;W-E<&@@365D:6-A;"!# M96YT97(L($Q,0R!A;F0@1W)E871E0T*1&%T82P@86YD('=E(&%R M92!A;65N9&EN9R!)=&5M(#$U("T@17AH:6)I=',@86YD($9I;F%N8VEA;"!3 M=&%T96UE;G0@4V-H961U;&5S+"!T;R!I;F-L=61E(&$@;&ES="!O9B!T:&4@ M9FEN86YC:6%L('-T871E;65N=',@86YD#0IE>&AI8FET&5C=71I=F4@3V9F:6-E&QE>2!!8W0@;V8@,C`P,BX\+W`^#0H- M"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE2P-"G1H:7,@06UE;F1M96YT('-H;W5L9"!B92!R96%D(&EN(&-O;FIU M;F-T:6]N('=I=&@@=&AE($]R:6=I;F%L($9I;&EN9R!A;F0@;W5R(&]T:&5R M(&9I;&EN9W,@=VET:"!T:&4@4T5#('-U8G-E<75E;G0@=&\@=&AE($]R:6=I M;F%L#0I&:6QI;F<\+W`^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^665S/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$2!#;VUM;VX@ M4W1O8VLL(%-H87)E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^1ED\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F-S(P.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^)FYB'0^)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X- M"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP M92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S M/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F-S(P.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E2!O<&5R871I;F<@86-T:79I=&EE'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M M/B@Q+#`Y,2D\'0^ M)FYB6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&IU6QE/3-$)V-O;&]R.B!B;&%C:R<^1G)A;FML:6X@26UA9VEN9R!*;VEN M=`T*5F5N='5R92P@0V%R7-T96US#0IO2!C M;VYT2!P'0M:6YD96YT.B`R-W!T)SXF(S$V M,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`V,B4[('!A9&1I;F6QE/3-$)W=I9'1H.B`S-24[ M(&)O'0@,7!T('-O;&ED.R!P861D:6YG M+7)I9VAT.B`U+C1P=#L@<&%D9&EN9RUL969T.B`U+C1P=#L@9F]N="UW96EG M:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F2P@3$Q#/"]F;VYT/CPO=&0^#0H@("`@/'1D M(&YO=W)A<#TS1&YO=W)A<"!S='EL93TS1"=P861D:6YG+7)I9VAT.B`U+C1P M=#L@<&%D9&EN9RUL969T.B`U+C1P="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M;F]W6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M6QE/3-$)W9E6QE M/3-$)W!A9&1I;FF4Z(#AP="<^1W)E871E6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0Z(#AP="!4:6UE2!W:71H(%4N4RX@9V5N97)A M;&QY(&%C8V5P=&5D(&%C8V]U;G1I;F<@<')I;F-I<&QE'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M M86QI9VXZ(&IU2!T6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&IU2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU M'0M M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^4D5614Y515,@ M)B,Q-3`[($-O;6)I;F5D('-E65R6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU M65R65R0T*;VX@:&ES M=&]R:6-A;"!C;VQL96-T:6]N(&5X<&5R:65N8V4I(')E;&%T960@=&\@<&%T M:65N=',@86YD(&-O<&%Y;65N="!A;F0@9&5D=6-T:6)L92!A;6]U;G1S(&9O M2!P87EE2<^ M)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UE65AF5D(&EN('1H92!F;VQL;W=I;F<-"G1A8FQE("AI;B!T:&]U M'0M:6YD96YT M.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P M(&-E;&QP861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W M(%)O;6%N+"!4:6UEF4Z(#AP M="<^/&(^665A6QE/3-$)W9E6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V)O M'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E M;G1E6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W1E M>'0M86QI9VXZ(&-E;G1EF4Z(#AP="<^*'5N875D:71E9"D\+V9O;G0^/"]T9#X- M"B`@("`\=&0@6QE M/3-$)W=I9'1H.B`T.24G/CQF;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@ M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@6QE/3-$)V9O M;G0M6QE/3-$)W=I M9'1H.B`Q)2<^/&9O;G0@6QE/3-$)V9O;G0MF4Z(#AP="<^365D:6-A6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,2PY-S8\+V9O;G0^/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)W1E>'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^ M,BPV,34\+V9O;G0^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V9O M;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F6QE M/3-$)V)O'0M:6YD96YT.B`M,3%P="<^/&9O;G0@6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M6QE/3-$ M)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^*#(L,C$Q M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#AP="<^*3PO9F]N M=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z M(#AP="<^-#0L,#`Q/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A M9&1I;FF4Z(#AP="<^)#PO9F]N=#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R M+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&IU2<^/&(^/&D^)B,Q-C`[/"]I M/CPO8CX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6]R2!M;VYI=&]R6]R6]R(&-O;&QE8W1I;VX@:7-S=65S('1H870@ M:&%V92!B965N(&ED96YT:69I960@87,@=V5L;"!A6QE/3-$)V9O;G0Z M(#AP="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P M+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^4%)/5DE324].($9/4B!"040@ M1$5"5%,@+2!!;'1H;W5G:"!O=71C;VUE2!E86-H('1Y<&4@;V8@<&%Y97(@;W9E6UE;G1S(&%N9"!D961U8W1I8FQE M6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU2!T:&4@1F5D97)A;"!$97!O2!A;&P@86-C;W5N M=',@2!F6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6EN9R!A;6]U;G0@;V8-"F-A'0M:6YD96YT.B`P+C5I;CL@=&5X M="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F M;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE2P@9G5R M;FET=7)E#0IA;F0@97%U:7!M96YT(&%R92!S=&%T960@870@8V]S="P@;&5S M65A6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^ M1T]/1%=)3$P@)B,Q-3`[($-O;6)I;F5D(&=O;V1W:6QL(&]F('1H92!'2`Q+"`R,#$Q+B!%86-H(&UE;6)E M2!U=&EL:7II;F<@8V5R=&%I;B!Q=6%L:71A M=&EV92!M96%S=7)E6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU2!F961E2!O9B!T:&4@2F]I;G0- M"G!A2X@06-C;W)D:6YG;'DL(&YO(&EN8V]M M92!T87@@<')O=FES:6]N(&ES(')E8V]R9&5D(&)Y(&%N>2!J;VEN="!V96YT M=7)E&5S/"]I/BP@9F]R;65R M;'D@:VYO=VX@87,@1FEN86YC:6%L($%C8V]U;G1I;F<-"E-T86YD87)D2!I;B!);F-O;64@5&%X97,L(&%N(&EN=&5R M<')E=&%T:6]N(&]F($9!4T(@4W1A=&5M96YT/"]I/@T*/&D^3F\N(#$P.2`\ M+VD^*$9)3B`T."DN($%30R`W-#`@"!P;W-I=&EO;B!T;R!B92!R96-O9VYI>F5D(&EN('1H92!F:6YA;F-I M86P@2UT:&%N+6YO="!T;R!B92!S=7-T86EN960@8GD@=&AE('1A>&EN9R!A=71H M;W)I='DN(%1A>"!P;W-I=&EO;G,@;F]T(&1E96UE9"!T;R!M965T('1H92`F M(S$T-SMM;W)E(&QI:V5L>2!T:&%N(&YO="8C,30X.PT*=&AR97-H;VQD('=O M=6QD(&)E(')E8V]R9&5D(&%S(&$@=&%X(&)E;F5F:70@;W(@97AP96YS92!I M;B!T:&4@8W5R7IE(&%L;`T*;W!E;B!T87@@>65A"!Y96%R2!T87AI;F<@875T:&]R:71I M97,L(&%N9"!I;F-L=61E(&%L;"!R971U65A"!P;W-I=&EO;G,@=&%K96X@;W(@97AP96-T960@=&\@8F4@ M=&%K96X@:6X@9G5T=7)E('1A>"!R971U'!E M8W1E9"!T;R!B92!T86ME;BX\+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP M="!4:6UE'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^1D%)4B!604Q512!-14%355)%345. M5%,@)B,Q-3`[5&AE(&-O;6)I;F5D(&)A;&%N8V4-"G-H965T'!E8W1E9"!R96%L:7IA=&EO M;B!O&EM871E('1H96ER(&9A:7(@=F%L=64@8F5C875S92!T:&4@=V5I9VAT M960@879E7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI M(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS M1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU6EN9PT*86UO=6YT+"!T:&5N('!E2X\+W`^#0H-"CQP('-T M>6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^26X@2G5L M>2`R,#$R+"!T:&4@1D%30B!M;V1I9FEE9"!E>&ES=&EN9R!R=6QE2!T:&%N(&YO="`H M=&AA="!I2!I2!T:&%N(&YO="!T:&%T M('1H92!A6QE/3-$)V9O M;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU2P@=VEL;"!N;W0@:&%V92!A;B!I;7!A8W0@;VX@=&AE M($=R;W5P)B,Q-#8[7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'`@'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@ M:G5S=&EF>2<^3VX@1F5B2!2861I;VQO9WDL($Q,0R!C;VUP;&5T960@:71S M(&%C<75I6QA;F0-"F9O&EM M871E;'D-"B0R,#`L,#`P(&]F(&9I>&5D(&%S6QE/3-$)V9O;G0Z(#AP="!4 M:6UE'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG M;CH@:G5S=&EF>2<^3VX@3F]V96UB97(@,2P@,C`Q,BP@=&AE('!A&5D#0IA'0M M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^/&(^)B,Q-C`[ M/"]B/CPO<#X-"@T*/'`@'0M:6YD96YT.B`P M+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^3VX@1&5C96UB97(@,S$L(#(P M,3$L('1H92!P87)T;F5R&5D M(&%S&EM871E;'D@)#(Q,"PP,#`@;V8@86-C;W5N=',@<&%Y86)L92!A M;F0@86-C'!E;G-E6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ M(&IU'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^3VX@1&5C M96UB97(@,S$L(#(P,3$L('1H92!P87)T;F5R6%B;&4@86YD#0IA8V-R=65D(&5X<&5N3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F M-S(P.#'0O:'1M;#L@8VAA'0^/'`@'0M:6YD M96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^0V]M8FEN960@9V]O M9'=I;&P@;V8@=&AE($=R;W5P(&%T($1E8V5M8F5R)B,Q-C`[,S$L#0HR,#$R M('1O=&%L960@)#DN.2!M:6QL:6]N+B!';V]D=VEL;"!I6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W=I9'1H.B`X,R4G/CQF;VYT('-T>6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H M.B`Q)2<^/&9O;G0@6QE/3-$)V9O;G0MF4Z(#AP="<^1V]O9'=I;&P@86-Q=6ER960@=&AR;W5G:"!'0D1)4"=S M(&%C<75I6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M'0M:6YD96YT.B`M,3%P="<^/&9O;G0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,BPQ,#<\+V9O;G0^/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W9E6QE/3-$)V9O;G0M M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IU M2X@06UOF%T:6]N(&5X<&5N65A2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE'0@9FEV92!Y96%R6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A M9&1I;F6QE/3-$)V)OF4Z(#AP="<^,C`Q-#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P M861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#AP="<^,C`Q-SPO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E M;G1E6QE/3-$)V9O;G0M'0M86QI9VXZ(&-E;G1E65A6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`R M,"4[('!A9&1I;FF4Z M(#AP="<^36%N86=E;65N="!S97)V:6-E(&-O;G1R86-T6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE M/3-$)W=I9'1H.B`W)3L@=&5X="UA;&EG;CH@6QE M/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT M+7-I>F4Z(#AP="<^,38\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA;&EG M;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,C(V/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W!A9&1I;FF4Z(#AP="<^0V]V96YA;G0@;F]T M('1O(&-O;7!E=&4@8V]N=')A8W1S/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M'0M86QI M9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,3`U M/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$ M)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^)B,Q-3`[/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M M:6YD96YT.B`M,3%P="<^/&9O;G0@F4Z(#AP="<^)#PO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B M;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@ M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V)O6QE M/3-$)V)O'0M M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^ M,3(Q/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)V9O;G0MF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE M.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I M;FF4Z(#AP="<^)#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U M<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G/B8C,38P.SPO=&0^ M/"]T6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/CQS M<&%N/CPO7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'`@'0M:6YD M96YT.B`T,'!T)SX\8CX\+V(^4')O<&5R='D@86YD(&5Q=6EP;65N="!A;F0@ M86-C=6UU;&%T960@9&5PF%T:6]N(&%R M92!A'0M:6YD96YT.B`P+C5I;B<^)B,Q-C`[/"]P/@T*#0H\ M=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP861D:6YG/3-$,"!S='EL93TS M1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UEF4Z(#AP="<^/&(^1&5C96UB97(@,S$L/"]B/CPO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T.R!F;VYT M+7=E:6=H=#H@8F]L9"<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E6QE M/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E M6QE/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`V-B4G/CQF;VYT('-T>6QE M/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^/&9O;G0@6QE M/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)2<^/&9O;G0@6QE/3-$)V9O;G0MF4Z(#AP="<^3V9F:6-E M(&5Q=6EP;65N="P@9G5R;FET=7)E(&%N9"!F:7AT=7)E6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,RPP-3$\+V9O M;G0^/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9EF4Z M(#AP="<^3&5AF4Z(#AP="<^17%U:7!M96YT('5N9&5R M(&-A<&ET86P@;&5A6QE/3-$ M)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M6QE/3-$)V9O;G0M6QE/3-$)W9E M6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^*#(X+#`T,#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^*3PO9F]N=#X\+W1D/CPO='(^ M#0H\='(@6QE/3-$)W!A9&1I M;F6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI9VXZ(&IUF%T:6]N(&5X<&5N'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)V)O6QE/3-$)W!A9&1I;FF4Z(#AP="<^/&(^,C`Q,3PO8CX\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(&-E;G1E6%B;&4\+V9O;G0^/"]T9#X-"B`@("`\ M=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q M,R4[('1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^.#,Y/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q,R4[('1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^.#6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M7)O;&P@86YD('9A8V%T:6]N/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W9EF4Z(#AP="<^)B,Q-C`[)B,Q-C`[)B,Q-C`[)B,Q-C`[5&]T86P\ M+V9O;G0^/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L M:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$ M)W!A9&1I;F6QE/3-$)V9O;G0Z(#AP="!4:6UE7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!N;W1EF5D(&)Y('1H92!A8W%U:7)E9"!E<75I<&UE M;G0N/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O M;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE M'0M86QI9VXZ(&IU'0M:6YD96YT.B`P+C5I M;B<^)B,Q-C`[/"]P/@T*#0H\=&%B;&4@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`R-B4[('1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^.3`Y/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`R)2<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)W9EF4Z(#AP="<^,C`Q-3PO9F]N=#X\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@F4Z(#AP="<^,C`Q-CPO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)V)O6QE M/3-$)V9O;G0M6QE/3-$)W!A9&1I M;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$ M)V9O;G0Z(#AP="!4:6UE'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG M;CH@:G5S=&EF>2<^5&AE($=R;W5P(&QE87-E65A6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W=I9'1H.B`V-B4G/CQF;VYT('-T>6QE/3-$)V9O;G0M M6QE/3-$ M)W=I9'1H.B`T)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@F4Z(#AP="<^)#PO9F]N M=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,C8E.R!T97AT+6%L M:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)V9O M;G0M6QE M/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$ M)V9O;G0M6UE;G1S/"]F;VYT M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-#0S/"]F;VYT/CPO=&0^#0H@ M("`@/'1D/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O MF4Z(#AP M="<^*3PO9F]N=#X\+W1D/CPO='(^#0H\='(@6QE/3-$)V9O;G0M6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S M='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-#$T/"]F;VYT/CPO=&0^#0H@("`@ M/'1D/B8C,38P.SPO=&0^/"]T6QE/3-$)W!A9&1I;F6QE M/3-$)V9O;G0M6QE M/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V9O;G0MF4Z(#AP="<^3&]N9RUT97)M('!OF4Z(#AP M="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R:6=H="<^ M/&9O;G0@3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F-S(P.#'0O:'1M;#L@ M8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'`@'0M86QI9VXZ(&IU65A&5D M(')E;G0-"F5S8V%L871O&5D(')E;G0@97-C M86QA=&]R'!E;G-E(&]V97(@=&AE('1E6UE;G1S('5N9&5R(&]P97)A=&EN9R!L96%S M97,@9F]R(&9U='5R92!Y96%R6QE M/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9EF4Z(#AP=#L@8V]L;W(Z(&)L86-K)SX\8CY&86-I;&ET:65S/"]B/CPO M9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@ M,7!T.R!F;VYT+7=E:6=H=#H@8F]L9"<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$ M)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$ M)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W=I9'1H.B`T,"4G/CQF M;VYT('-T>6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE M/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V9O M;G0M6QE/3-$)W9EF4Z(#AP=#L@8V]L;W(Z(&)L86-K)SXR,#$U/"]F M;VYT/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP=#L@8V]L;W(Z(&)L86-K)SXR M+#,T,SPO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP=#L@8V]L;W(Z M(&)L86-K)SXR+#DX,CPO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D M/CPO='(^#0H\='(@F4Z(#AP=#L@8V]L;W(Z(&)L86-K)SXR,#$V/"]F;VYT M/CPO=&0^#0H@("`@/'1D/B8C,38P.SPO=&0^#0H@("`@/'1D/B8C,38P.SPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N M="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP=#L@8V]L;W(Z(&)L86-K)SXQ+#@S M-3PO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=T97AT+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP=#L@8V]L;W(Z(&)L M86-K)SXR+#`X,#PO9F]N=#X\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE M/3-$)V9O;G0M6QE/3-$)V9O;G0M6QE M/3-$)W1E>'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP=#L@8V]L;W(Z(&)L86-K)SXF(S$U,#L\+V9O;G0^/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP=#L@8V]L;W(Z(&)L86-K)SXQ M+#`R.#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O M='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D M:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)V)O6QE/3-$)V9O;G0M M6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE/3-$)W!A M9&1I;F6QE/3-$ M)V)O6QE/3-$)V9O;G0M6QE M/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V9O;G0M M65A2X\+W`^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^ M#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F-S(P M.#'0O:'1M;#L@8VAA'0^/'`@'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^4V5E M($YO=&4@-"!W:71H(')E2!F86-I;&ET M>0T*8V]M8FEN871I;VYS+CPO<#X-"@T*/'`@'0M:6YD96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[ M/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N M+"!4:6UE7)O;&P@86YD M(&5M<&QO>65E(&)E;F5F:71S#0IP'0M:6YD M96YT.B`P+C5I;CL@=&5X="UA;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P/@T* M#0H\<"!S='EL93TS1"=F;VYT.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE M7,@ M'0M:6YD96YT.B`P+C5I;CL@=&5X="UA M;&EG;CH@:G5S=&EF>2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT M.B`X<'0@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)V9O;G0Z(#AP="!4:6UE'0M86QI M9VXZ(&IUF5D(&EN(&1U92!F65T(')E;6ET M=&5D('1O('1H92!J;VEN="!V96YT=7)E7)O;&P@86YD(&5M<&QO>65E M#0IB96YE9FET(&-O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2<^5&AE(&UE;6)E M7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0M86QI9VXZ M(&IU2!T'0^/'`@2!A8V-E M<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@'0^/'`@2!U<&]N(&5S=&%B;&ES:&5D(&-O;G1R86-T M=6%L(&)I;&QI;F<@'0M86QI9VXZ(&IU'0M:6YD96YT.B`R-"XU<'0G M/B8C,38P.SPO<#X-"@T*/'`@0T*<&%Y97)S+B!4:&ER9"UP87)T>2!P87EE65R6UE;G0@=&5R;7,@6UE;G0@ M=&5R;7,@:6X@;6%N86=E9"!C87)E(&%G0T*8F%S960@=7!O;B!P'!E6UE;G0@86YD(&1E9'5C=&EB;&4@ M86UO=6YT6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O;F]R M;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU'0M86QI9VXZ(&IU2!F6]R6]R(&-O;&QE8W1I;VX-"FES M6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N M+"!4:6UE2<^06QT:&]U9V@@;W5T8V]M97,@=F%R>2P@=&AE($=R;W5P)B,Q-#8[6EN9R!V86QU92!O9B!S M=6-H(')E8V5I=F%B;&5S('1O('1H96ER(&5S=&EM871E9"!N970@7!E(&]F('!A>65R(&]V97(@86X@,3@M;6]N=&@@;&]O:RUB M86-K('!E2!P871I96YT'0M86QI9VXZ(&IU2!P65A2!N;W)M'!E6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@ M3F5W(%)O;6%N+"!4:6UE2<^5&AE($=R;W5P(&-O;G-I9&5R'0^/'`@2P@9G5R;FET=7)E(&%N9"!E<75I M<&UE;G0@87)E#0IS=&%T960@870@8V]S="P@;&5S65A'0^/'`@'0^/'`@"!P=7)P;W-E2!A;GD@:F]I;G0@=F5N='5R97,@ M:6X@=&AE($=R;W5P+B!%9F9E8W1I=F4@2F%N=6%R>2`Q+"`R,#`Y+"!T:&4- M"D=R;W5P(&%D;W!T960@06-C;W5N=&EN9R!3=&%N9&%R9',@0V]D:69I8V%T M:6]N($%30R`W-#`L)B,Q-C`[/&D^26YC;VUE(%1A>&5S/"]I/BP@9F]R;65R M;'D@:VYO=VX@87,@1FEN86YC:6%L($%C8V]U;G1I;F<@4W1A;F1A"!P;W-I=&EO;B!T;R!B92!R96-O9VYI>F5D M(&EN('1H92!F:6YA;F-I86P@2UT:&%N+6YO="!T;R!B92!S=7-T86EN960@8GD@ M=&AE('1A>&EN9R!A=71H;W)I='DN(%1A>"!P;W-I=&EO;G,@;F]T(&1E96UE M9"!T;R!M965T('1H92`F(S$T-SMM;W)E(&QI:V5L>2!T:&%N(&YO="8C,30X M.PT*=&AR97-H;VQD('=O=6QD(&)E(')E8V]R9&5D(&%S(&$@=&%X(&)E;F5F M:70@;W(@97AP96YS92!I;B!T:&4@8W5R7IE(&%L;`T*;W!E M;B!T87@@>65A"!Y96%R2!T M87AI;F<@875T:&]R:71I97,L(&%N9"!I;F-L=61E(&%L;"!R971U65A2!R97-U M;'1I;F<@9G)O;2!U;G)E8V]G;FEZ960@=&%X(&)E;F5F:71S(')E;&%T:6YG M('1O('5N8V5R=&%I;BUI;F-O;64-"G1A>"!P;W-I=&EO;G,@=&%K96X@;W(@ M97AP96-T960@=&\@8F4@=&%K96X@:6X@9G5T=7)E('1A>"!R971U'!E8W1E9"!T;R!B92!T86ME;BX\+W`^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@&EM871E('1H96ER(&9A M:7(@=F%L=64@8F5C875S92!O9B!T:&4@2!S:&]R="!P97)I M;V0@;V8@=&EM92!B971W965N('1H92!OF%T:6]N(&]R M('!A>6UE;G0N($%D9&ET:6]N86QL>2P@=&AE($=R;W5P(&-O;G-I9&5R6%B;&4@86YD(&-A<&ET86P@;&5A6EN9R!A;6]U;G1S(&%P<')O>&EM871E6QE/3-$)V9O;G0Z(#AP M="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^3VX@2F%N=6%R>2`Q+"`R,#$R M+"!T:&4@1W)O=7`@861O<'1E9`T*05-5(#(P,3$M,#'!E;G-E+B!!9&1I=&EO;F%L(&1I2!T:&%N(&YO="!T M:&%T('1H92!F86ER('9A;'5E(&]F(&$@6EN9PT*86UO=6YT+"!T:&5N('!E2X\ M+W`^#0H-"CQP('-T>6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^)B,Q-C`[/"]P/@T*#0H\<"!S='EL93TS1"=F;VYT.B`X<'0O M;F]R;6%L(%1I;65S($YE=R!2;VUA;BP@5&EM97,L(%-E'0M86QI9VXZ(&IU2!T M:&4@;W!T:6]N('1O(&9I6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O M;6%N+"!4:6UE2<^26X@1F5B3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F-S(P M.#'0O:'1M;#L@8VAA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0M86QI9VXZ(&IU'0M:6YD96YT.B`R-W!T)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!4 M:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`V-"4[ M('!A9&1I;F6QE/3-$)W=I9'1H.B`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`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)3L@9F]N="UW96EG:'0Z(&)O;&0G/B8C,38P.SPO=&0^#0H@("`@/'1D M(&-O;'-P86X],T0Q,"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@9F]N M="UW96EG:'0Z(&)O;&0[('1E>'0M86QI9VXZ(&-E;G1E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@9F]N="UW M96EG:'0Z(&)O;&0G/B8C,38P.SPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7=E:6=H M=#H@8F]L9"<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L'0M86QI9VXZ(&-E M;G1E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E.R!F;VYT+7=E:6=H=#H@8F]L9"<^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D M(&-O;'-P86X],T0R('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT M+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/B8C,38P M.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T M97AT+6%L:6=N.B!C96YT97(G/B8C,38P.SPO=&0^#0H@("`@/'1D(&-O;'-P M86X],T0R('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N M.B!C96YT97(G/BAU;F%U9&ET960I/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ(&-E;G1E'0M86QI9VXZ M(&-E;G1E6QE M/3-$)W=I9'1H.B`U,R4[(&QI;F4M:&5I9VAT.B`Q,34E)SY#;VUM97)C:6%L M($EN6QE/3-$)W=I9'1H.B`R)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@ M,3(E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`R)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3(E.R!L:6YE+6AE:6=H M=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=W:61T:#H@,3(E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA M;&EG;CH@6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SY-961I8V%R93PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXQ M,BPP.#D\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXY+#6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\ M='(@6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SY-961I8V%I9#PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXQ M+#DW-CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^,2PU,C4\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SY7;W)K97)S)R!#;VUP96YS871I;VXO4&5R6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M M86QI9VXZ(')I9VAT)SXQ+#DX-SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H M="<^,2PY.3(\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B!B;&%C:R`Q<'0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W9E M6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E.R!T97AT+6%L:6=N.B!R:6=H="<^-#8L,C$R/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@'0M86QI9VXZ M(')I9VAT)SXT-BPS,C$\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E M6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E M6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SX\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T* M/'`@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W M(%)O;6%N+"!4:6UE2<^06-T:79I='D@:6X@9V]O9'=I;&P@9F]R('1H92!Y96%R6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE6QE/3-$)W=I9'1H.B`X M-"4[(&QI;F4M:&5I9VAT.B`Q,34E)SY"86QA;F-E(&%S(&]F($IA;G5A6QE/3-$)W=I M9'1H.B`R)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,3(E.R!L:6YE+6AE:6=H M=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P M.SPO=&0^/"]T6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SY';V]D=VEL;"!A8W%U:7)E9"!T:')O M=6=H($="1$E0)W,@86-Q=6ES:71I;VX@;V8@34E"(%!A6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L M:6=N.B!R:6=H="<^-RPX,38\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$ M)W9E2=S M(&%C<75I6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXR M+#$P-SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SY"86QA;F-E(&%S(&]F M($1E8V5M8F5R(#,Q+"`R,#$R/"]T9#X-"B`@("`\=&0@6QE/3-$ M)V)O'0M86QI9VXZ(')I9VAT)SXY+#DR,SPO=&0^#0H@("`@/'1D('-T>6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A M8FQE/CQS<&%N/CPOF%T:6]N(&5X<&5N6QE/3-$)VUA6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E'0M86QI9VXZ(&-E;G1E6QE M/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)OF4Z(#AP="<^,C`Q-3PO9F]N=#X\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,7!T)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`Q<'0@'0M86QI9VXZ(&-E;G1E M6QE/3-$)V9O;G0M6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0M86QI9VXZ(&-E;G1E6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF M(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$ M)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V M,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\ M+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T M97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[ M/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$ M)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ M(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,38\+V9O M;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F M;VYT+7-I>F4Z(#AP="<^,38\+V9O;G0^/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H M.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H M.B`Q)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`W)3L@=&5X="UA M;&EG;CH@6QE/3-$)V9O;G0M6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SX\ M9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,3DN,#PO9F]N=#X\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24G/B8C,38P.SPO=&0^/"]T M6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT M)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^,3`T/"]F;VYT/CPO M=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS M1"=F;VYT+7-I>F4Z(#AP="<^,3`U/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T M>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE M/3-$)V)O6QE/3-$)V9O;G0M'0M86QI9VXZ(')I9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I M>F4Z(#AP="<^-#$X/"]F;VYT/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A M9&1I;F6QE M/3-$)W!A9&1I;F6QE/3-$)W1E>'0M86QI9VXZ(')I M9VAT)SX\9F]N="!S='EL93TS1"=F;VYT+7-I>F4Z(#AP="<^-"XP/"]F;VYT M/CPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;FF4Z(#AP="<^5&]T86P@86YN=6%L(&%M;W)T:7IA=&EO;CPO9F]N=#X\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=P861D:6YG+6)O='1O;3H@,BXU<'0G M/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT M+6%L:6=N.B!R:6=H="<^/&9O;G0@6QE/3-$)W!A M9&1I;F6QE/3-$)V9O;G0M M6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O6QE/3-$)V9O;G0M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9&1I;FF4Z(#AP="<^)#PO9F]N=#X\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE.R!T97AT+6%L:6=N.B!R M:6=H="<^/&9O;G0@6QE/3-$)W!A9&1I;F6QE/3-$)W!A9&1I;F6QE/3-$)W9E6QE/3-$)W1E>'0M86QI9VXZ(')I9VAT)SXF(S$V,#L\+W1D/@T* M("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=T97AT+6%L:6=N M.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0@6QE/3-$)W1E>'0M86QI9VXZ M(')I9VAT)SXF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@ M(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT9#XF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0^)B,Q-C`[/"]T9#X-"B`@("`\ M=&0^)B,Q-C`[/"]T9#X-"B`@("`\=&0@7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA6QE/3-$)V9O;G0Z(#AP="]N;W)M86P@ M5&EM97,@3F5W(%)O;6%N+"!4:6UEF%T:6]N(&%R M92!A'0M86QI9VXZ(&-E M;G1E'0M86QI9VXZ(&-E;G1E6QE M/3-$)V)O'0M86QI9VXZ(&-E;G1E M6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!C96YT97(G/B8C M,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L'0M86QI9VXZ(&-E;G1E6QE/3-$)W9E'0M86QI9VXZ(')I9VAT)SXS,2PX,#0\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@("`\=&0@ M'0M M86QI9VXZ(')I9VAT)SXS,2PU,30\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W M:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^ M#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXR+#DT.3PO=&0^#0H@ M("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[ M/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M.R!T97AT+6%L:6=N.B!R:6=H="<^,RPP-3$\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R M('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@'0M86QI M9VXZ(')I9VAT)SXQ-"PR-3,\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE M+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXU,"PY.#@\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG M;CH@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U8FQE M.R!P861D:6YG+6QE9G0Z(#4N-'!T.R!L:6YE+6AE:6=H=#H@,3$U)2<^)#PO M=&0^#0H@("`@/'1D('-T>6QE/3-$)V)O6QE/3-$)W!A9&1I;F6QE/3-$)V)O'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7=E:6=H=#H@ M8F]L9"<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L'0M86QI9VXZ(&-E;G1E M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@9F]N="UW M96EG:'0Z(&)O;&0G/B8C,38P.SPO=&0^#0H@("`@/'1D(&-O;'-P86X],T0R M('-T>6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7=E:6=H M=#H@8F]L9"<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@8V]L'0M86QI9VXZ(&-E M;G1E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E.R!F;VYT+7=E:6=H=#H@8F]L9"<^)B,Q-C`[/"]T9#X\+W1R/@T* M/'1R('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E.R!T97AT+6%L:6=N.B!R:6=H="<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!C;VQS<&%N/3-$,B!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)3L@=&5X="UA;&EG;CH@8V5N=&5R)SXH=6YA=61I=&5D*3PO=&0^#0H@("`@ M/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO M='(^#0H\='(@6QE/3-$)W=I M9'1H.B`V.24[(&QI;F4M:&5I9VAT.B`Q,34E)SY!8V-O=6YT6QE M/3-$)W=I9'1H.B`Q,B4[(&QI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N M.B!R:6=H="<^.#,Y/"]T9#X-"B`@("`\=&0@6QE/3-$)W=I9'1H.B`Q,B4[(&QI M;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^.#6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^,C(Y/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@'0M M86QI9VXZ(')I9VAT)SXQ+#DS-SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SY!8V-R=65D('!A>7)O;&P@86YD('9A8V%T:6]N/"]T9#X-"B`@("`\=&0@ M6QE/3-$)V)O6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT)SXY-S4\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)V)O6QE/3-$)V)O'0M86QI9VXZ(')I9VAT)SXX,#(\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)V)O'0M86QI9VXZ(')I M9VAT)SXR+#`T,SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F-S(P M.#'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA6QE/3-$ M)V9O;G0Z(#AP="]N;W)M86P@5&EM97,@3F5W(%)O;6%N+"!4:6UE2<^5&AE(&9O;&QO M=VEN9R!I65A'0M:6YD M96YT.B`S-G!T)SXF(S$V,#L\+W`^#0H-"CQT86)L92!C96QL6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)W=I9'1H.B`S)3L@;&EN92UH M96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I M9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=W:61T:#H@,C8E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA M;&EG;CH@6QE/3-$)W=I9'1H M.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^/"]T6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXR,#$T/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\='(@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXR,#$U/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@ M6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q M<'0@6QE/3-$)W9E6QE/3-$)V)O'0M86QI9VXZ M(')I9VAT)SXQ+#DQ-3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@'0^/'`@6UE;G1S('5N9&5R(&-A<&ET86P@;&5A M'0M86QI9VXZ(')I9VAT)SXR.34\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T M97AT+6%L:6=N.B!R:6=H="<^-#0S/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SY!;6]U;G0@6QE/3-$)V)O6QE M/3-$)V)O'0M86QI9VXZ(')I9VAT)SXH,CDI/"]T9#X-"B`@("`\ M=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^-#$T/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SY,97-S(&-U6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`Q<'0@ M6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\ M+W1D/CPO='(^#0H\+W1A8FQE/@T*/'`@3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]F-S(P.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0M86QI9VXZ(&IU6UE;G1S('5N9&5R(&]P97)A=&EN9PT*;&5A65A6QE/3-$)V9O;G0Z(#AP="!4:6UE6QE/3-$)W9E6QE/3-$)V)O6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7=E:6=H=#H@8F]L9"<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!F;VYT+7=E:6=H=#H@8F]L9"<^)B,Q M-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)W=I9'1H.B`R)3L@;&EN92UH96EG:'0Z M(#$Q-24G/B8C,38P.SPO=&0^#0H@("`@/'1D('-T>6QE/3-$)W=I9'1H.B`Q M)3L@;&EN92UH96EG:'0Z(#$Q-24G/B0\+W1D/@T*("`@(#QT9"!S='EL93TS M1"=W:61T:#H@,38E.R!L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@ M6QE/3-$)W=I9'1H.B`Q-B4[(&QI M;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^,2PP.#(\+W1D M/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=W:61T:#H@,B4[ M(&QI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=W:61T:#H@,24[(&QI;F4M:&5I9VAT.B`Q,34E)SXD/"]T9#X-"B`@ M("`\=&0@'0M86QI9VXZ(')I9VAT)SXS+#8T-3PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)W=I9'1H.B`Q)3L@;&EN92UH96EG:'0Z(#$Q-24G/B8C,38P.SPO=&0^ M/"]T6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXR,#$T/"]T9#X-"B`@("`\=&0@6QE M/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S M='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT M.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE M:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXW-S`\+W1D/@T* M("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T M9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF M(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U M)3L@=&5X="UA;&EG;CH@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^,BPS-#,\ M+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q M-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)3L@=&5X="UA;&EG;CH@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT M+6%L:6=N.B!R:6=H="<^,BPY.#(\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE M/3-$)W9E6QE/3-$)VQI;F4M:&5I M9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R:6=H="<^,2PX,S4\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X- M"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)3L@ M=&5X="UA;&EG;CH@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L:6=N.B!R M:6=H="<^,BPP.#`\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H M=#H@,3$U)2<^)B,Q-C`[/"]T9#X\+W1R/@T*/'1R('-T>6QE/3-$)W9E6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^ M)B,Q-C`[/"]T9#X-"B`@("`\=&0@'0M86QI9VXZ(')I9VAT)SXQ+#0X.3PO=&0^#0H@("`@/'1D('-T M>6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT M9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@ M("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E.R!T97AT+6%L M:6=N.B!R:6=H="<^)B,Q-3`[/"]T9#X-"B`@("`\=&0@6QE/3-$ M)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL M93TS1"=L:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@ M'0M86QI9VXZ(')I9VAT M)SXQ+#0X.3PO=&0^#0H@("`@/'1D('-T>6QE/3-$)VQI;F4M:&5I9VAT.B`Q M,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V M,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C M:R`Q<'0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)VQI M;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/CPO='(^#0H\='(@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E M)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L:6YE+6AE:6=H=#H@ M,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@(#QT9"!S='EL93TS1"=L M:6YE+6AE:6=H=#H@,3$U)2<^)B,Q-C`[/"]T9#X-"B`@("`\=&0@6QE/3-$)VQI;F4M:&5I9VAT.B`Q,34E)SXF(S$V,#L\+W1D/@T*("`@ M(#QT9"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!B;&%C:R`R+C(U<'0@9&]U M8FQE.R!L:6YE+6AE:6=H=#H@,3$U)2<^)#PO=&0^#0H@("`@/'1D('-T>6QE M/3-$)V)O'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2P@3$Q#(%M-96UB97)=/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM M/5].97AT4&%R=%]F-S(P.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,3D@>65A'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%]F-S(P.#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$2!A;F0@97%U:7!M96YT+"!G7!E.B!T97AT+VAT;6P[(&-H87)S970] M(G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T M<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@ M8VAA'!E;G-E7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)FYB3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]F-S(P.#'0O:'1M;#L@8VAA M&UL;G,Z;STS1")U'1087)T7V8W,C`X-S(W7V)C9F5?-&4V-%]A9C$V7S)F93%B.#EF,S%A-"TM "#0H` ` end XML 18 R29.htm IDEA: XBRL DOCUMENT v2.4.0.6
6. PROPERTY AND EQUIPMENT (Details) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Property And Equipment Details    
Medical equipment $ 31,804 $ 31,514
Office equipment, furniture and fixtures 2,949 3,051
Leasehold improvements 14,253 13,567
Equipment under capital leases 1,982 1,982
Property and equipment, gross 50,988 50,114
Accumulated depreciation and amortization (31,630) (28,040)
Property and equipment, net $ 19,358 $ 22,074
XML 19 R28.htm IDEA: XBRL DOCUMENT v2.4.0.6
5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details 1) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
2013 $ 120  
2014 120  
2015 121  
2016 121  
2017 16  
Thereafter 226  
Total goodwill and other intangible assets 724 844
Management service contracts [Member]
    
2013 16  
2014 16  
2015 16  
2016 16  
2017 16  
Thereafter 226  
Total goodwill and other intangible assets 306  
Weighted average amortization period remaining in years 19 years  
Covenant not to compete contracts [Member]
    
2013 104  
2014 104  
2015 105  
2016 105  
2017     
Thereafter     
Total goodwill and other intangible assets $ 418  
Weighted average amortization period remaining in years 4 years  
XML 20 R30.htm IDEA: XBRL DOCUMENT v2.4.0.6
7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Detalis) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Accounts Payable And Accrued Expenses Detalis    
Accounts payable $ 839 $ 873
Accrued expenses 229 1,937
Accrued payroll and vacation 975 802
Total $ 2,043 $ 3,612
XML 21 R31.htm IDEA: XBRL DOCUMENT v2.4.0.6
8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 1) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Notes to Financial Statements  
2013 $ 909
2014 487
2015 504
2016 15
Total principal maturies on equipment notes $ 1,915
XML 22 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
3. RECENT ACCOUNTING STANDARDS
 12 Months Ended
Dec. 31, 2012
Notes to Financial Statements  
NOTE 3 - RECENT ACCOUNTING STANDARDS

On January 1, 2012, the Group adopted ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for doubtful accounts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. Such additional disclosures are included in Note 2. The adoption of this ASU had no impact on the Group’s combined financial position, results of operations or cash flows, although it did change the financial statement presentation.

On January 1, 2012, each member of the Group adopted ASU 2011-08, “Intangibles—Goodwill and Other (Topic 350): Testing Goodwill for Impairment”, simplifying how a company is required to test goodwill for impairment. Companies will now have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary.

 

In July 2012, the FASB modified existing rules to allow entities to use a qualitative approach to test indefinite-lived intangible asset for impairment.  The revised standard allows an entity the option to first assess qualitatively whether it is more likely than not (that is, a likelihood of more than 50 percent) that an indefinite-lived intangible asset is impaired.  An entity is not required to calculate the fair value of an indefinite-lived intangible asset and perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired.  This guidance will be effective for the Group in 2013.

 

In February 2013, the FASB issued new guidance which requires disclosure of information about significant reclassification adjustments from accumulated other comprehensive income in a single note or on the face of the financial statements.  This guidance will be effective for the Group in 2013.  Adoption of this standard, which is related to disclosure only, will not have an impact on the Group’s combined financial position, results of operations, or cash flows.
XML 23 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 2) (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Notes to Financial Statements    
2013 $ 295  
2014 148  
Total minimum payments 443  
Amount representing interest (29)  
Present value of net minimum lease payments 414  
Less current portion (270) (278)
Long-term portion $ 144 $ 414
XML 24 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMBINED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
CURRENT ASSETS    
Cash and cash equivalents $ 1,778 $ 2,089
Accounts receivable, net 8,597 8,326
Due from affiliates 1,121 2,414
Prepaid expenses and other current assets 602 337
Total current assets 12,098 13,166
PROPERTY AND EQUIPMENT, NET 19,358 22,074
OTHER ASSETS    
Goodwill 9,923 7,816
Other intangible assets 724 844
Total assets 42,103 43,900
LIABILITIES AND PARTNERS' CAPITAL    
Accounts payable and accrued expenses 2,043 3,612
Current portion of deferred rent 167 134
Current portion of equipment notes payable 909 2,698
Current portion of obligations under capital leases 270 278
Total current liabilities 3,389 6,722
LONG-TERM LIABILITIES    
Deferred rent, net of current portion 1,594 1,749
Equipment notes payable, net of current portion 1,006 1,916
Obligations under capital lease, net of current portion 144 414
Total liabilities 6,133 10,801
COMMITMENTS AND CONTINGENCIES      
PARTNERS' CAPITAL    
RadNet, Inc. 17,717 16,458
Other partners 18,253 16,641
Total partners' capital 35,970 33,099
Total liabilities and partners' capital $ 42,103 $ 43,900
XML 25 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. DESCRIPTION OF BUSINESS
 12 Months Ended
Dec. 31, 2012
Notes to Financial Statements  
NOTE 1 - DESCRIPTION OF BUSINESS

Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and Greater Baltimore Diagnostic Imaging Partnership, (collectively, the “Group”), are joint ventures between RadNet, Inc. and, as applicable, hospitals, health systems or radiology practices operating within the state of Maryland and were formed for the purpose of owning and operating diagnostic imaging centers. Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture. Each joint venture within the Group is an affiliate of RadNet, Inc. as follows:

 

    % owned by Radnet, Inc.
     
Franklin Imaging Joint Venture   49%
Carroll County Radiology, LLC   40%
MRI at St. Joseph Medical Center, LLC   49%
Greater Baltimore Diagnostic Imaging Partnership   50%

 

The financial information for 2011 and 2010 included herein has been prepared by management of RadNet, Inc. without audit. Management of RadNet, Inc. believes that such financial information has been prepared in conformity with U.S. generally accepted accounting principles, and includes all adjustments necessary for a fair presentation of the financial position, results of operations and cash flows as of and for the years ended December 31, 2011 and 2010.

 
XML 26 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (IN THOUSANDS) (Tables)
 12 Months Ended
Dec. 31, 2012
Notes to Financial Statements  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
    December 31,  
    2012     2011  
          (unaudited)  
Accounts payable   $ 839     $ 873  
Accrued expenses     229       1,937  
Accrued payroll and vacation     975       802  
    Total   $ 2,043     $ 3,612  

 
XML 27 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
9. COMMITMENTS AND CONTINGENCIES (Tables)
 12 Months Ended
Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]  
Minimum annual payments under operating leases

Minimum annual payments under operating leases for future years ending December 31 follow (in thousands):

 

    Facilities     Equipment     Total  
2013   $ 2,563     $ 1,082     $ 3,645  
2014     2,298       770       3,068  
2015     2,343       639       2,982  
2016     1,835       245       2,080  
2017     1,489       –       1,489  
Thereafter     1,028       –       1,028  
    $ 11,556     $ 2,736     $ 14,292  

 
XML 28 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 29 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2012
Accounting Policies [Abstract]  
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF COMBINATION – Under Rule 3-09 of Regulation S-X, Radnet, Inc. is permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business. The combined financial statements include the assets, liabilities, and operations of each member of the Group. The operating activities of each of these joint ventures are completely separate from one another and are in no way affiliated with one another. Accordingly there are no intercompany transactions and balances to be eliminated when combining each together.

 

USE OF ESTIMATES - The preparation of these financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters including the Group’s reported amounts of assets and liabilities in the combined balance sheets at the dates of the financial statements; disclosure of contingent assets and liabilities at the dates of the financial statements; and reported amounts of revenues and expenses in the combined statements of income during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management’s control. As a result, actual amounts could materially differ from these estimates.

 

REVENUES – Combined service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. This service fee revenue is earned through providing the use of diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

 

The Group's combined service fee revenues are recorded during the period the services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage with third-party payers.

 

The Group’s service fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended December 31, are summarized in the following table (in thousands):

 

    Years Ended December 31,  
    2012     2011     2010  
          (unaudited)     (unaudited)  
Commercial Insurance/Managed Care Capitation   $ 40,220     $ 32,302     $ 32,054  
Medicare     12,089       9,242       9,774  
Medicaid     1,976       1,525       1,529  
Workers' Compensation/Personal Injury     2,615       1,987       1,992  
Other     1,221       1,155       973  
Service fee revenue, net of contractual allowances and discounts     58,122       46,212     46,321  
                         
Provision for bad debts     (2,752 )     (2,211 )     (2,112 )
Net service fee revenue   $ 55,370     $ 44,001     $ 44,209  

 

The break-out of the Group’s combined service fee revenue, net of contractual allowances and discounts, is calculated based upon global payments received from consolidated imaging centers from dates of service from each respective period illustrated.

 

ACCOUNTS RECEIVABLE - Substantially all of the Group’s accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.  Services are generally provided pursuant to one-year contracts with healthcare providers.  Receivables generally are collected within industry norms for third-party payors.  The Group continuously monitors collections from payors and maintains an allowance for bad debts based upon specific payor collection issues that have been identified as well as historical collection experience.

 

PROVISION FOR BAD DEBTS - Although outcomes vary, the Group’s policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service. The Group provides for an allowance against accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Group estimates this allowance based on the aging of accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of the provision for bad debt relates to co-payments and deductibles owed to the Group by patients with insurance. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and the Group’s estimation process. The combined allowance for bad debts at December 31, 2012 and 2011 were $393,000 and $395,000 (unaudited), respectively.

 

CONCENTRATION OF CREDIT RISKS - Financial instruments that potentially subject the Group to credit risk are primarily cash equivalents and accounts receivable. Each joint venture places its cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. The Group continuously monitors collections from its clients and maintains an allowance for bad debts based upon any specific payor collection issues that are identified and historical experience.

 

CASH AND CASH EQUIVALENTS – The Group considers all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates their fair market value.

 

PROPERTY AND EQUIPMENT – Property, furniture and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the shorter of the related lease term or their estimated useful lives which range from 3 to 30 years.

 

GOODWILL – Combined goodwill of the Group at December 31, 2012 totaled $9.9 million. Goodwill is recorded by each member of the Group as a result of business combinations. Management of each member of the Group evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable.  Each member of the Group adopted the provisions of ASU 2011-08 effective January 1, 2011. Each member of the Group evaluated its respective share of the combined goodwill at October 1, 2012 for signs of impairment under the provisions of ASU 2011-08. By utilizing certain qualitative measures outlined in the guidance, each member determined that its respective share of the combined goodwill was not impaired.

 

INCOME TAXES - Each member of the Group is treated as a partnership for federal and state income tax purposes where all taxable income is allocated to the partners in accordance with the respective partnership agreement and so accordingly federal and state taxes on income are the responsibility of the Joint partners individually. Accordingly, no income tax provision is recorded by any joint ventures in the Group. Effective January 1, 2009, the Group adopted Accounting Standards Codification ASC 740, Income Taxes, formerly known as Financial Accounting Standards Board (FASB) Interpretation No. 48, Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109 (FIN 48). ASC 740 requires the impact of a tax position to be recognized in the financial statements if that position is more-likely-than-not to be sustained by the taxing authority. Tax positions not deemed to meet the “more likely than not” threshold would be recorded as a tax benefit or expense in the current year. Management of the Group is required to analyze all open tax years, as defined by the statute of limitations, for all major jurisdictions, which includes federal and certain states. Open tax years are those that are open for exam by taxing authorities, and include all returns subsequent to tax years ending after December 31, 2009, for federal returns and December 31, 2009, for Maryland returns. The Partnership has no examinations in process and has not been notified of any future examinations at this time. Management of the Group has reviewed all open tax years and major jurisdictions, and has concluded that the adoption of ASC 740 did not have a material effect on the Group’s financial position or its results of operations. There is no tax liability resulting from unrecognized tax benefits relating to uncertain-income tax positions taken or expected to be taken in future tax returns. The Group has recognized no interest or penalties related to uncertain tax positions taken or
expected to be taken.

 

FAIR VALUE MEASUREMENTS –The combined balance sheets include the following financial instruments: cash and cash equivalents, receivables, trade accounts payable, capital leases, equipment notes payable and other liabilities. The Group considers the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, the Group considers the carrying amount of its equipment notes payable and capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.
XML 30 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMBINED STATEMENTS OF INCOME (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
NET SERVICE FEE REVENUE      
Service fee revenue, net of contractual allowances and discounts $ 58,122 $ 46,212 $ 46,321
Provision for bad debts (2,752) (2,211) (2,112)
Net service fee revenue 55,370 44,001 44,209
OPERATING EXPENSES      
Cost of operations 38,161 31,557 31,291
Depreciation and amortization 4,607 3,856 3,703
(Gain) loss on sale of equipment (35) 195 125
Total operating expenses 42,733 35,608 35,119
INCOME FROM OPERATIONS 12,637 8,393 9,090
Net interest expense 245 381 702
NET INCOME $ 12,392 $ 8,012 $ 8,388
XML 31 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2012
Summary Of Significant Accounting Policies Policies  
PRINCIPLES OF COMBINATION

Under Rule 3-09 of Regulation S-X, Radnet, Inc. is permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business. The combined financial statements include the assets, liabilities, and operations of each member of the Group. The operating activities of each of these joint ventures are completely separate from one another and are in no way affiliated with one another. Accordingly there are no intercompany transactions and balances to be eliminated when combining each together.
USE OF ESTIMATES

The preparation of these financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters including the Group’s reported amounts of assets and liabilities in the combined balance sheets at the dates of the financial statements; disclosure of contingent assets and liabilities at the dates of the financial statements; and reported amounts of revenues and expenses in the combined statements of income during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management’s control. As a result, actual amounts could materially differ from these estimates.
REVENUES

Combined service fee revenue, net of contractual allowances and discounts, consists of net patient fees received from various payers and patients themselves based mainly upon established contractual billing rates, less allowances for contractual adjustments and discounts. This service fee revenue is earned through providing the use of diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.

 

The Group's combined service fee revenues are recorded during the period the services are provided based upon the estimated amounts due from the patients and third-party payers. Third-party payers include federal and state agencies (under the Medicare and Medicaid programs), managed care health plans, commercial insurance companies and employers. Estimates of contractual allowances under managed care health plans are based upon the payment terms specified in the related contractual agreements. Contractual payment terms in managed care agreements are generally based upon predetermined rates per discounted fee-for-service rates. We also record a provision for doubtful accounts (based primarily on historical collection experience) related to patients and copayment and deductible amounts for patients who have health care coverage with third-party payers.

 

The break-out of the Group’s combined service fee revenue, net of contractual allowances and discounts, is calculated based upon global payments received from consolidated imaging centers from dates of service from each respective period illustrated.
ACCOUNTS RECEIVABLE

Substantially all of the Group’s accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.  Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. The Group continuously monitors collections from payors and maintains an allowance for bad debts based upon specific payor collection issues that have been identified as well as historical collection experience.
PROVISION FOR BAD DEBTS

Although outcomes vary, the Group’s policy is to attempt to collect amounts due from patients, including co-payments and deductibles due from patients with insurance, at the time of service. The Group provides for an allowance against accounts receivable that could become uncollectible by establishing an allowance to reduce the carrying value of such receivables to their estimated net realizable value. The Group estimates this allowance based on the aging of accounts receivable by each type of payer over an 18-month look-back period, and other relevant factors. A significant portion of the provision for bad debt relates to co-payments and deductibles owed to the Group by patients with insurance. There are various factors that can impact collection trends, such as changes in the economy, which in turn have an impact on the increased burden of co-payments and deductibles to be made by patients with insurance. These factors continuously change and can have an impact on collection trends and the Group’s estimation process. The combined allowance for bad debts at December 31, 2012 and 2011 were $393,000 and $395,000 (unaudited), respectively.
CONCENTRATION OF CREDIT RISKS

Financial instruments that potentially subject the Group to credit risk are primarily cash equivalents and accounts receivable. Each joint venture places its cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors. The Group continuously monitors collections from its clients and maintains an allowance for bad debts based upon any specific payor collection issues that are identified and historical experience.
CASH AND CASH EQUIVALENTS

The Group considers all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates their fair market value.
PROPERTY AND EQUIPMENT

Property, furniture and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the shorter of the related lease term or their estimated useful lives which range from 3 to 30 years.
GOODWILL

Combined goodwill of the Group at December 31, 2012 totaled $9.9 million. Goodwill is recorded by each member of the Group as a result of business combinations. Management of each member of the Group evaluates goodwill, at a minimum, on an annual basis and whenever events and changes in circumstances suggest that the carrying amount may not be recoverable.  Each member of the Group adopted the provisions of ASU 2011-08 effective January 1, 2011. Each member of the Group evaluated its respective share of the combined goodwill at October 1, 2012 for signs of impairment under the provisions of ASU 2011-08. By utilizing certain qualitative measures outlined in the guidance, each member determined that its respective share of the combined goodwill was not impaired.
INCOME TAXES

Each member of the Group is treated as a partnership for federal and state income tax purposes where all taxable income is allocated to the partners in accordance with the respective partnership agreement and so accordingly federal and state taxes on income are the responsibility of the Joint partners individually. Accordingly, no income tax provision is recorded by any joint ventures in the Group. Effective January 1, 2009, the Group adopted Accounting Standards Codification ASC 740, Income Taxes, formerly known as Financial Accounting Standards Board (FASB) Interpretation No. 48, Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement No. 109 (FIN 48). ASC 740 requires the impact of a tax position to be recognized in the financial statements if that position is more-likely-than-not to be sustained by the taxing authority. Tax positions not deemed to meet the “more likely than not” threshold would be recorded as a tax benefit or expense in the current year. Management of the Group is required to analyze all open tax years, as defined by the statute of limitations, for all major jurisdictions, which includes federal and certain states. Open tax years are those that are open for exam by taxing authorities, and include all returns subsequent to tax years ending after December 31, 2009, for federal returns and December 31, 2009, for Maryland returns. The Partnership has no examinations in process and has not been notified of any future examinations at this time. Management of the Group has reviewed all open tax years and major jurisdictions, and has concluded that the adoption of ASC 740 did not have a material effect on the Group’s financial position or its results of operations. There is no tax liability resulting from unrecognized tax benefits relating to uncertain-income tax positions taken or expected to be taken in future tax returns. The Group has recognized no interest or penalties related to uncertain tax positions taken or
expected to be taken.
FAIR VALUE MEASUREMENTS

The combined balance sheets include the following financial instruments: cash and cash equivalents, receivables, trade accounts payable, capital leases, equipment notes payable and other liabilities. The Group considers the carrying amounts of cash and cash equivalents, receivables, other current assets and current liabilities to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, the Group considers the carrying amount of its equipment notes payable and capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.
RECENT ACCOUNTING STANDARDS

On January 1, 2012, the Group adopted ASU 2011-07, “Health Care Entities (Topic 954): Presentation and Disclosure of Patient Service Revenue, Provision for Bad Debts, and the Allowance for Doubtful Accounts for Certain Health Care Entities,” which requires health care entities to present the provision for doubtful accounts relating to patient service revenue as a deduction from patient service revenue in the statement of operations rather than as an operating expense. Additional disclosures relating to sources of patient revenue and the allowance for doubtful accounts related to patient accounts receivable are also required. Such additional disclosures are included in Note 2. The adoption of this ASU had no impact on the Group’s combined financial position, results of operations or cash flows, although it did change the financial statement presentation.

On January 1, 2012, each member of the Group adopted ASU 2011-08, “Intangibles—Goodwill and Other (Topic 350): Testing Goodwill for Impairment”, simplifying how a company is required to test goodwill for impairment. Companies will now have the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary.

 

In July 2012, the FASB modified existing rules to allow entities to use a qualitative approach to test indefinite-lived intangible asset for impairment.  The revised standard allows an entity the option to first assess qualitatively whether it is more likely than not (that is, a likelihood of more than 50 percent) that an indefinite-lived intangible asset is impaired.  An entity is not required to calculate the fair value of an indefinite-lived intangible asset and perform the quantitative impairment test unless the entity determines that it is more likely than not that the asset is impaired.  This guidance will be effective for the Group in 2013.

 

In February 2013, the FASB issued new guidance which requires disclosure of information about significant reclassification adjustments from accumulated other comprehensive income in a single note or on the face of the financial statements.  This guidance will be effective for the Group in 2013.  Adoption of this standard, which is related to disclosure only, will not have an impact on the Group’s combined financial position, results of operations, or cash flows.
XML 32 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information (USD $)
 12 Months Ended
Dec. 31, 2012
Mar. 08, 2013
Jun. 29, 2012
Document And Entity Information      
Entity Registrant Name RadNet, Inc.    
Entity Central Index Key 0000790526    
Document Type 10-K    
Document Period End Date Dec. 31, 2012    
Amendment Flag true    
Amendment Description

We are filing this Form 10-K/A (Amendment No. 1) to our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, originally filed with the U.S. Securities and Exchange Commission on March 18, 2013 (the "Original Filing"), solely for the purpose of complying with Rule 3-09 of Regulation S-X.  Rule 3-09 requires that we file financial statements of certain unconsolidated joint ventures in which we hold equity interests of 50% or less and account for them under the equity method to the extent that the unconsolidated joint ventures are individually significant.  Under Rule 3-09 of Regulation S-X, we are permitted to file combined financial statements for individually significant unconsolidated joint ventures which are in the same line of business.

We have determined that as of and for the year ended December 31, 2012, four of our unconsolidated joint venture interests including   Franklin Imaging Joint Venture, Carroll County Radiology, LLC, MRI at St. Joseph Medical Center, LLC and Greater Baltimore Diagnostic Imaging Partnership, (collectively, the “Group”), were significant unconsolidated joint ventures under Rule 3-09.  Accordingly, we are filing in this Amendment No. 1 to include the combined financial statements of the Group under Item 8 – Financial Statements and Supplementary Data, and we are amending Item 15 - Exhibits and Financial Statement Schedules, to include a list of the financial statements and exhibits being filed herewith. We are also filing updated Certificates of our Chief Executive Officer and Chief Financial Officer under Sections 302 and 906 of the Sarbanes Oxley Act of 2002.

Except as described above, no other changes have been made to the Original Filing, and this Form 10-K/A does not amend, update or change any other items or disclosures in the Original Filing.  This Form 10-K/A does not reflect events occurring after the Original Filing.   Accordingly, this Amendment should be read in conjunction with the Original Filing and our other filings with the SEC subsequent to the Original Filing

    
Current Fiscal Year End Date --12-31    
Is Entity a Well-known Seasoned Issuer? No    
Is Entity a Voluntary Filer? No    
Is Entity's Reporting Status Current? Yes    
Entity Filer Category Accelerated Filer    
Entity Public Float     $ 81,917,304
Entity Common Stock, Shares Outstanding   38,990,482  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2012    
XML 33 R18.htm IDEA: XBRL DOCUMENT v2.4.0.6
1. DESCRIPTION OF BUSINESS (Tables)
 12 Months Ended
Dec. 31, 2012
Description Of Business Tables  
DESCRIPTION OF JOINT VENTURE

Each joint venture within the Group is an affiliate of RadNet, Inc. as follows:

 

    % owned by Radnet, Inc.
     
Franklin Imaging Joint Venture   49%
Carroll County Radiology, LLC   40%
MRI at St. Joseph Medical Center, LLC   49%
Greater Baltimore Diagnostic Imaging Partnership   50%

 
XML 34 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMBINED STATEMENTS OF PARTNERS' CAPITAL (USD $)
In Thousands
RadNet, Inc.
Other Partners
Total
Beginning Balance at Dec. 31, 2009 $ 11,168 $ 13,393 $ 24,561
Net Income 3,771 4,617 8,388
Distributions (5,957) (7,128) (13,085)
Ending Balance at Dec. 31, 2010 8,982 10,882 19,864
Net Income 3,714 4,298 8,012
Contributions 6,551 4,652 11,203
Distributions (2,789) (3,191) (5,980)
Ending Balance at Dec. 31, 2011 16,458 16,641 33,099
Net Income 5,757 6,635 12,392
Contributions 920 1,380 2,300
Distributions (5,418) (6,403) (11,821)
Ending Balance at Dec. 31, 2012 $ 17,717 $ 18,253 $ 35,970
XML 35 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES
 12 Months Ended
Dec. 31, 2012
Accounts Payable And Accrued Expenses  
NOTE 7 ACCOUNTS PAYABLE AND ACCRUED EXPENSES
    December 31,  
    2012     2011  
          (unaudited)  
Accounts payable   $ 839     $ 873  
Accrued expenses     229       1,937  
Accrued payroll and vacation     975       802  
    Total   $ 2,043     $ 3,612  

 
XML 36 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
6. PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2012
Property, Plant and Equipment [Abstract]  
NOTE 6 - PROPERTY AND EQUIPMENT

Property and equipment and accumulated depreciation and amortization are as follows (in thousands):

 

    December 31,  
    2012     2011  
          (unaudited)  
Medical equipment   $ 31,804     $ 31,514  
Office equipment, furniture and fixtures     2,949       3,051  
Leasehold improvements     14,253       13,567  
Equipment under capital leases     1,982       1,982  
      50,988       50,114  
Accumulated depreciation and amortization     (31,630 )     (28,040 )
    $ 19,358     $ 22,074  

 

Depreciation and amortization expense on property and equipment, including amortization of equipment under capital leases, for the years ended December 31, 2012, 2011 and 2010 totaled $4.5 million, $3.8 million (unaudited) and $3.7 million (unaudited), respectively.
XML 37 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Tables)
 12 Months Ended
Dec. 31, 2012
Notes to Financial Statements  
Maturities of notes payable

The following is a listing of annual principal maturities of the equipment notes discussed above for years ending December 31 (in thousands):

 

2013   $ 909  
2014     487  
2015     504  
2016     15  
    $ 1,915  

 
Future minimum lease payments under capital leases

The Group leases equipment under capital lease arrangements. Future minimum lease payments under capital leases for years ending December 31 (in thousands) is as follows:

 

2013   $ 295  
2014     148  
Total minimum payments     443  
Amount representing interest     (29)
Present value of net minimum lease payments     414  
Less current portion     (270)
Long-term portion   $ 144  

 
XML 38 R19.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2012
Summary Of Significant Accounting Policies Tables  
Service fee revenue

The Group’s service fee revenue, net of contractual allowances and discounts less the provision for bad debts for the years ended December 31, are summarized in the following table (in thousands):

 

    Years Ended December 31,  
    2012     2011     2010  
          (unaudited)     (unaudited)  
Commercial Insurance/Managed Care Capitation   $ 40,220     $ 32,302     $ 32,054  
Medicare     12,089       9,242       9,774  
Medicaid     1,976       1,525       1,529  
Workers' Compensation/Personal Injury     2,615       1,987       1,992  
Other     1,221       1,155       973  
Service fee revenue, net of contractual allowances and discounts     58,122       46,212     46,321  
                         
Provision for bad debts     (2,752)     (2,211)     (2,112)
Net service fee revenue   $ 55,370     $ 44,001     $ 44,209  

 
XML 39 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
10. RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2012
Related Party Transactions [Abstract]  
NOTE 10 - RELATED PARTY TRANSACTIONS

See Note 4 with respect to related party facility combinations.

 

RadNet, Inc. contracts with each joint venture within the Group to provide certain administrative services including assistance with accounting, payroll and employee benefits processing, and billing and collection functions on behalf of these joint ventures. RadNet Inc. remits to the joint ventures all amounts collected through its administration of the billing and collection functions.

 

RadNet, Inc., as administrator over payroll and employee benefits, pays salary and benefit obligations on behalf of these joint ventures and then bills each joint venture for its respective portion.

 

RadNet, Inc. contracts certain members of its contracted radiologist groups to perform professional services for the joint ventures. RadNet, Inc. assures that these radiologists are adequately covered under medical malpractice insurance policies. RadNet, Inc., on behalf of its contracted radiologist groups, bills each joint venture for its respective share of the professional fees incurred through its utilization of these contracted radiologists. RadNet, Inc. remits to its contracted radiologist groups all amounts collected from the joint ventures for the billed professional fees.

 

Amounts receivable from and payable to RadNet Inc. for the activities listed above are summarized in due from affiliates on the Group’s combined balance sheets and was $1.1 million and $2.4 million (unaudited) at December 31, 2012 and 2011, respectively. Due from affiliates of $1.1 million at December 31, 2012 consists of a receivable from Radnet, Inc. of $4.3 million for amounts collected through its administration of the billing and collection functions not yet remitted to the joint ventures at December 31, 2012. This receivable is offset by amounts payable to Radnet, Inc. of $525,000 for the unpaid portion of billed administrative services performed, $1.2 million for the unpaid portion of professional fees which Radnet must in turn remit to its contracted radiologists, and $1.4 million for unpaid payroll and employee benefit costs.
XML 40 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES
 12 Months Ended
Dec. 31, 2012
Debt Disclosure [Abstract]  
NOTE 8 - EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES

Three members of the Group, MRI at St. Joseph Medical Center, LLC, Franklin Imaging Joint Venture, and Greater Baltimore Diagnostic Partnership hold eleven promissory notes issued by three financing companies for the purpose of acquiring imaging equipment. These notes have interest rates between 3.5% and 9.0%, mature on or before June 2016 and are collateralized by the acquired equipment.

 

The following is a listing of annual principal maturities of the equipment notes discussed above for years ending December 31 (in thousands):

 

2013   $ 909  
2014     487  
2015     504  
2016     15  
    $ 1,915  

 

The Group leases equipment under capital lease arrangements. Future minimum lease payments under capital leases for years ending December 31 (in thousands) is as follows:

 

2013   $ 295  
2014     148  
Total minimum payments     443  
Amount representing interest     (29 )
Present value of net minimum lease payments     414  
Less current portion     (270 )
Long-term portion   $ 144  

 
XML 41 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
9. COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]  
NOTE 9 - COMMITMENTS AND CONTINGENCIES

Leases – The Group leases various operating facilities and certain medical equipment under operating leases with renewal options expiring through 2022. Certain leases contain renewal options from two to ten years and escalation clauses based either on the consumer price index or fixed rent escalators. Leases with fixed rent escalators are recorded on a straight-line basis. The Group records deferred rent for tenant leasehold improvement allowances received from a lessor and amortizes the deferred rent expense over the term of the lease agreement. Minimum annual payments under operating leases for future years ending December 31 follow (in thousands):

 

    Facilities     Equipment     Total  
2013   $ 2,563     $ 1,082     $ 3,645  
2014     2,298       770       3,068  
2015     2,343       639       2,982  
2016     1,835       245       2,080  
2017     1,489       –       1,489  
Thereafter     1,028       –       1,028  
    $ 11,556     $ 2,736     $ 14,292  

 

Total rent expense, including equipment rentals, for the years ended December 31, 2012, 2011 and 2010 was $4.3 million, $3.7 million (unaudited) and $3.9 million (unaudited), respectively.
XML 42 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
11. SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2012
Subsequent Events [Abstract]  
NOTE 11 - SUBSEQUENT EVENTS

The member of the Group evaluated subsequent events through April, 1, 2013 and concluded that no additional disclosures were required.
XML 43 R21.htm IDEA: XBRL DOCUMENT v2.4.0.6
6. PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2012
Property, Plant and Equipment [Abstract]  
Property and equipment and accumulated depreciation and amortization

Property and equipment and accumulated depreciation and amortization are as follows (in thousands):

 

    December 31,  
    2012     2011  
          (unaudited)  
Medical equipment   $ 31,804     $ 31,514  
Office equipment, furniture and fixtures     2,949       3,051  
Leasehold improvements     14,253       13,567  
Equipment under capital leases     1,982       1,982  
      50,988       50,114  
Accumulated depreciation and amortization     (31,630)     (28,040)
    $ 19,358     $ 22,074  

 
XML 44 R26.htm IDEA: XBRL DOCUMENT v2.4.0.6
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Summary Of Significant Accounting Policies Details      
Commercial Insurance/Managed Care Capitation $ 40,220 $ 32,302 $ 32,054
Medicare 12,089 9,242 9,774
Medicaid 1,976 1,525 1,529
Workers Compensation/Personal Injury 2,615 1,987 1,992
Other 1,221 1,155 973
Service fee revenue, net of contractual allowances and discounts 58,122 46,212 46,321
Provision for bad debts 2,752 2,211 2,112
Net service fee revenue $ 55,370 $ 44,001 $ 44,209
XML 45 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
COMBINED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
CASH FLOWS FROM OPERATING ACTIVITIES      
Net income $ 12,392 $ 8,012 $ 8,388
Depreciation and amortization 4,607 3,856 3,703
Provision for bad debt 2,752 2,211 2,112
Deferred rent amortization (122) (112) 1,048
(Gain) loss on sale of equipment (35) 195 125
Changes in operating assets and liabilities      
Accounts receivable (3,022) (3,036) (2,415)
Prepaid expenses and other current assets (264) (31) 748
Due from affiliates 1,293 (372) 4,110
Accounts payable, accrued expenses (1,424) 878 517
Net cash provided by operating activities 16,177 11,601 18,336
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of property and equipment (1,091) (2,576) (2,495)
Purchase of imaging facilities (2,935)    (133)
Proceeds from sale of equipment 35    305
Net cash used in investing activities (3,991) (2,576) (2,323)
CASH FLOWS FROM FINANCING ACTIVITIES      
Principal payments on notes and leases payable (2,976) (2,764) (2,576)
Contributions from partners 2,300      
Distributions to partners (11,821) (5,980) (13,085)
Net cash used in financing activities (12,497) (8,744) (15,661)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (311) 281 352
CASH AND CASH EQUIVALENTS, beginning of period 2,089 1,808 1,456
CASH AND CASH EQUIVALENTS, end of period 1,778 2,089 1,808
Cash paid during the period for interest $ 245 $ 381 $ 702
XML 46 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
5. GOODWILL AND OTHER INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
NOTE 5 - GOODWILL AND OTHER INTANGIBLE ASSETS

Combined goodwill of the Group at December 31, 2012 totaled $9.9 million. Goodwill is recorded as a result of business combinations. Activity in goodwill for the years ended December 31, 2011 and 2012 is provided below (in thousands):

 

Balance as of January 1, 2011 (unaudited)   $ 223  
Goodwill acquired through GBDIP's acquisition of MIB Partnership, LLP     7,593  
Balance as of December 31, 2011 (unaudited)     7,816  
Goodwill acquired through Carroll County Radiology's acquisition of Westminster from RadNet, Inc.     2,107  
Balance as of December 31, 2012   $ 9,923  

 

Other intangible assets are primarily related to the value of management service contracts on the books of MRI at St. Joseph Medical Center, LLC and covenant not to compete contracts acquired through GBDIP’s acquisition of a controlling interest of a previously held non-consolidated joint venture investment and totaled $522,000 on the date of acquisition. Accumulated amortization of the management service contract and covenant not to compete contract intangible assets through December 31, 2012 was $79,000 and $104,000, respectively. Amortization expense for the year ended December 31, 2012 was $120,000.  The value of these covenant not to compete contracts are amortized using the straight-line method over five years.  Management service contracts are amortized over 25 years.

 

The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):

 

    2013     2014     2015     2016     2017     Thereafter     Total     Weighted average amortization period remaining in years  
                                                                 
Management service contracts     16       16       16       16       16       226       306       19.0  
Covenant not to compete contracts     104       104       105       105       –       –       418       4.0  
Total annual amortization   $ 120     $ 120     $ 121     $ 121   $ 16     $ 226     $ 724          
                                                                 
XML 47 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
MIB Partnership, LLP [Member]
Dec. 31, 2012
Westminster [Member]
Goodwill, beginning balance $ 9,923 $ 7,816 $ 223    
Goodwill acquired       7,593 2,107
Goodwill, ending balance $ 9,923 $ 7,816 $ 223    
ZIP 48 0001019687-13-001128-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001019687-13-001128-xbrl.zip M4$L#!!0````(`"UN@4*M%^P5J6,``'^\`P`1`!P`2;=O97.8XJ=SJ-">F;GTY2P!6C:6*QEA[!__3U'LL$8`S8X).E) M5U_,NAT&P?CD^'@RF1QY MXI%.A/]-'MDB7W==$?HVF_7E4\=CP9^F\>O9C]4+LVJ99O7HJ0\\7-``KE<- MTSHV:L>&^6`8)Y9U8E9ST@EH$,H9'>/)B/[HVS\\]7R7G^"_!%3@R9,GR3\> M)%B;6$?"'QQ7#<,\_O?UEZX]9"-:X9X,J&>S@_@NEWO?LNXSV^WVL;H:-UUJ MB<1C&M8Q7NY1.>\9`:YIOX0$KCK![(9DX_JQOKC0E&BF/&[JL%0[R>RC M@7@\A@O0WJQ6#+-BF7%SG_570FXB5C6;Z_C3+>(;0ED94#J>W="G MLJ<:1QLSY1AG@R5.K!/BKQ M#4=/TCF(+B/1CP>28[`X(,=Q5]I3;.$%["D@W/EX<.6+48S-,`.A/L/?.?W9 M;#"=_3K[G3MXI<\A.BF4;$%XL9&==WX]^(1.VVP;]6KCPW'ZYCFYXTQZ M$;4Q"%XXRRC`@_P``\VG.3MQ3_-K2[=!1)S?I/B>DW<6;HE_7P`0_QB)=+6< MS^1M_\W*5L>G($-(\952A62^=2&9SRFDR&/-A,>^38$M>*RYC<>:>_!8XTW* M-F&,QAX\UJH8\+?U=H44,?"L'FLD//9M6M6"QQK;>*RQOS'VSVXX'@L_N/Q/ MR,<":OV:C'_!>3_URD;(#8$A>B2PZ`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`.6,P@P^EC!,J!HD9;:^V.^38XQ`;3&,/'_"30 MW2^$':+W77$)`?X/1OTK^$62R`_N\4'Y=8^YX^VS5RT%>80U8.FFM'E,L7ST/4G=R.2U%*]+)/YG;GNKYZ8>%U0N/"8TY$RA+B^';D5O27)1OS/ M]7RIEUAR4ZS$\7E=;TF*9V!7CK(MEPYRDPG\D&D:"_=G6?^=&@J*\I$<:E;V MEF&-#--FM^,Y[.E7EM\#DC.`E;TMD[MG`RZA">3N=)2?.5V==T@ZGGV4I+?8 MW>I0HH50+)A<_9$52A(]90A3C$;"ZP;"_J8'M=LPP.$>#PY:H)MZV)I@(%07 MHK&0.,SF(^I*".@W5P>?K%:[;=1:U059KR$60XMWJ`TXH$ M_8IU\`F&4<,"A7\X7NPP/QDS%QFKK0X#VD0&AB_J#7C/9?HZF,;ED^V&R/DO M0C@3[KI;\]JLUA8@Y"%6%L!<4FK57@Y@[J7FM1Q81N/%.6,W6SDRL M?-P7;M[:@,VV55^$MH[,KI!RF6RU:C1K6T/2\HR&YNW%4C7:K8S@$O5;F&@N MQDW+;#3R$[WSV9ARY_)I#$DP`[&HRH$=@W?#J*9$OYK(KH!R"<6RFEL#@HDW M+O_)>V8S_DC!V\!@=C6-5KV]B&@=E5T1Y8OQ5K6Q-:)S*H<@1?P/W>J1NJH> M)<#UTRE$(W7XWO9^U&PNNE$N38,EY0CK/C%-9CK-4; MNV/\PFDO.IMD^R!F6HL3T$2G!>GE"]R@'#,OP7,ZY@%UOT"2RFY[+A_0@`M/ MW@C/WG702LWU-E(J!5J^R;JY([0OPAL\,'\$,S`F[^@4@]KV@C)2<\JLWK=% MD,]BVF9Q!!>LST`XSCW(YQS^YT$91E-O+ZIF'95=$>633;/6WAI1PO%V'>@M M*S4N+/>]'?5<4F@TJ]6"U%@649.S951YM8]%W,OK>DGP^\VBDTK<<].-9<]0*9B[PBQ\R MI\284C5J5N94/0?1DO'FR[X:9K4LO(D6<)M:BAP*UV&^U-7P)2XX;B)5!K0M M%RF+0KL=X\X1S)8[GBU&[(N0N1>E-ZQP-%*9=0:E+<%DG5&[(8-M6\^$)>OT MS1R1:TLLT;)$.2JJ59O6"K'$=+8"4E@]%B1VK6<`4E@W5MTTV\6`_$*YARJ[ M]2ZX'`O)<5YPVX^7%$M1E%5?P+2!9`D("VNP8K;WC;&P[_JM_+\T$_=..)2RD64&W6T\ODJRGNBJZPQJM5T]P;NL(:!G#;RTZ? MNE/N/,AJ+^)9H%$80/&YCV&62;^P/EI6J_6\])=.B-H0`9KF\^JC*)[4VN5N M>/(O-XP(IIE8LI[>-"&V7-Z":!TO17&U&BDIHJ;,.'> MB8J/#G,^3[]*YG2\CO?()$YYS^R`/R[O7&P;"2M6N[WD>3D!E`N]^/2V6F\V M7@7TXK/>JE6U2H(.M]B,.1*Q=*G+YG/EI<*C4_Q9/H@S&]KX['FU;AJI,)&??KG(BT^,TU'BI9`7 MGS374OE[N#PR:RI>`L(Q!L0[>P0M,5"H7%LV*4F*V' ME3PY,&&&MS3%RPF@7.B%O=XT&T:N>,/U_ MQ\NSEU/.S-*L+=5);P/F^5@JGK4WTP6]KXNAPJ963V5PS\505+\9;TIO+A;= MVNBJC4TVEP?+\W%4/,NQS%?-4&&;:]8V.5$Y#"W7PY:4,!NI&IT\I,N"NX7Y M&%;Z48K]P=TB,:Z9]9WASO>0,I*J5]RCGOT, MR[$F)/VY4JX,!.5B+S[4M)JUI4V3%X&^115"O='(E2[FP#[/ZJ^Y)WP>3-7# MMU'!5SF)N=FJKEJ.RR*Z.\3"UE!7&S%[1+C%:HS16K5)920Q[X:8$L[1JN\3'_7-A@RG]%^D#JXK]@#^=5=IDES!'O@I`1C>DO<[M64=HA'U?8N M<[AG@UV"M9CUU`,\KX6U8H-?TRJ3BS/;#D>ABV>JYGE"*%]U7A&+@P9JC6'Q MV>A2,.V3UYSEU2VCMA]>D^D7:$N'W@GY*]0!KP_/?AI$)S^S@CU&>G#".`-2##DDEP)?T1, MH_+K\1GY><8+N1%'/_U@6J?F/T@@",S]R9GGA=0E^OAF`CS.[B1]X4-GV"^> M.TNFH',"'3&'7$`,5:?E6^8A0<8/B0#8W*.N.T4M1]X@DULNI MYR@,ET_VD'H#1O`<62[Q:3VD?TU]>TC,ENK8(C]C%S_1T?CT!ZMV>AM1P3.O M@=?9[_\X)%*X#(E'H,>A/Q:2$=$'K8W&+AX.IC'=AS`$616C#=<4D'LVP*B# M]+N5?Q_I3LT&"'S>U&>J@E9"WS0@$R5L_$=MUP$>&;^%42J*$)""-.'0_#(2%5W=>-'D"]QF532 M(U27J,2\CH".PS3;T>TC%@R%@SI6/SX%J'P%';^OA:6@H#EQ3QW]'BJ=2C`Z MWN(#D`I80':NEQ#W[(E"+PII"L0K%! MMEJPF@W%L\33GL%FE$7T0@F?I#Q"1ST>HP\I8OJ?O3OOD#XR"&L!B@@%HA1% ME>I1W;%)HP,JA"N=L(\>#7?A?^ODDS`O[D5'Q,ZUFM!O_*HC$KW7@JB7'9'H M;4>'"DWT5ARB7XM#9N_%.21?OIP?DNO[#@%VNL$1T6]/(='K4XA^?XIJIOB, MWJI!9J_5(//W:LP`)-ZL<4A^MH$P4Q7M[E2CF8<+L]8\_<47X3C^VL(P,0&^ M"]A1N&C@2=O'0C$?)0>D8RN/0K"R.:Y=:2'X$A/-7\N<*:6N]P+0)392;$18 M.G"-M&(>ZZBDV9W=^9TH4,P37/6=^E,%YH(&]%!=BP!31(>05;=FG53(Y=.0 M]WC414;?I&L/F0,2`>-/,$/!NV00(\[D)H[\+*;08TA:CQ>8.6)\/B+1<`9# MO(@%&HZU=LXAL"K%!4S&AGX^Y*P/J&&$04,@MWUH`()"^/K:G(GHFD*AQ=E% M\P$#()915;>TC4;,1)?Z/0IQ@MP^N6P*"E?L04Y8?0V!`\9/-E9QPE%3E![( MA_;$(SLD'HSM6,Q*]`BK#5%%F1YC'E!`X]-C0VI$U<:Q-(5P!+#@B4#;RV&D M#QR4HC&<>M.()`=M2[SBP+3!%3(:ZF;.F2*8]*B'E61]UD<_)^Q1NX6-1_6A M8>BUAO7]KO#9"!&0G+NH'(H0!N$>`XK403^&X/`7A`@UGLVF-"E:2F8J]"H) M:)N5\^;=RW,BPYZ$P5F-PXN25SBB^.T0@93D7/^D@6E++S MJ7-FJO9G!8$=<.0KZ$C/['/B.(?QXK9_CY82EE-K:;7,5/76`HW"`(H?MV+6 M4\_G[P:@>,FC66T7D$"<846E]>54)]72A=L+-+:`L,6I-^EG)7:%4/SI!B/] M<,`&"(OEIVD7*NNXD]1):QO)EH)SBX<5FNL?K7@>G(657%.EW;O@3#[X_6Q5 MHNJ(@56/F^3=$X^-0RVV;3,FK)MQ\ENDTS_#E:7DC,VLX\ MYS.57.(#)4QB1H:_/@"6SZZPO^UE97&>37`/7Y8)WX_JW%N=82`QI!'3@VQ; M^">DYU+[FVJ0O3R@)K3Q$@$I;7E`38X1#E(NNE:PD97#A>X5"XNK"V33R@+F MK*G5@QX+)IAP)=\>AKP<8M9&Q_@F4-R(.B1#(=6R-:ALR("E(9%3B8F4`@+) ME!^+C8SQ!4&0Q$(6%.]VJ4PC7N<*5&+6QW74J:M6"U6VCXL3D%DQ)VN%5$R\ M61HSZ]29"50OQ$5"M95:Y!&!.-IG:MD6LWS]%B9)HB7&Q>6F>5O*,<6G M23"(J>]CZCCQ]Z+`)MP)AB>0FAL_GI(>I-',KZ"'T+%D)R3^=#"'@TC\F,PC MKMR`6\=QIB>"0(R@(W#``4C<403TQ\.OYXH/^?<1`! M:U0!5\1@O)Q2/ZJ-@_FO>DU%_9@ERL`I3M5Z$:+UN0JT($%L8"AB@B9#3%"F M6M$L`.V4H"%4)DPW[,%<:'%@T`Z;.2ZH.R7_+U-V-&O2PP\_8G#1G@W^X\51 M4+'>BUO.XVY"(NJCOW]SVI\VWQ:EDO3QPZ7ZLZM&\AKB^AV,E<;W9A6XB]/6 MVC^^"6_,R\_:J>>[ZA=4;SR[ZO?L^+D2BW\$,&Q?25$*-BUKQ)KG>_L:=;IB0#*G4V[%C M/)#(UW/DT>R]QHF,4Z\;8(HJPH#0T.$0U*Y7M^PQE[/'N%A)AI#M9@*-MH73 M,/2N)[;"4B*UBZEJN`8,_$35X5`;MY[9K!()_6CL`Y-\K,H"D.^(94BC802F M#DI.5P%X#/)X2?WIK,:'DC[E/@*8K8PMUQ'$+VLX)-`L='5Q1+1:@?OW2-.F M$EC%A'Q%^8S,*&!3$!;45?KN/MC28E:4,N-Y(A1M_FZ_DIA>B^S.2UW.9LJZ M@^30YDR^\O7'N_O.S7GG[LMEE]Q>D?/;Z\^=F[.'SNU-LOIE7H*FU+2J#"V9 M?.+BSA;U:"LKXE(U1`K'=O5HY&%C25"R>(BJP\H.H9_9:7F'R54\`*47S/J$ MX9K72!M]LJI(DYRO^M'YT2?Q7;JY7%K=1&Y4;24+L/)28OC`I;(^V`\1'A:% MJ((([>.X$JG9]P29T.E\;2VJ%4W<<90LU$#BOBX)\H2N7$.J6'$20'(GJ3T/ M`#WJ@L0P\@DLXH`X.`(9QCJ9#)D721=95XD>=]E] MZ%R?/8#[5925Z!$B&9]E(D(KF`N&NMLP,J^Y30R*H-<1_0::!;`CM<2K#$O* M<#2>V[LNH.SWL61(^HA;5Z6F`"D30T@>ON=/^8E<0SBF]TA] M+D*-`QJJ1>Y9D>7<[^*M@\9I`E:,$TT7NF"$_5G6FNXDCDZZ(1W3V+7^659FRQ M")*K%QH0)_1C(>K>E<6HD[8R%,2]1^$^0M@*G8'N"8U0P0"K&BOC$,0+1PP4 M`A$>`HGPHTD35;L66"T(4PUL-L:W7,(=<1SKL:F`CW/33"I4[6$(%\*8Q)T* M-5\YQ-"*I?9)<=BJW`SA^ERY!-+$$C(,H<$B/^\1*@'E_O*WRYNO$)D2,X'S MF>WHS2C29RRV-CW+@QE`;.E^K`W$F`P4.R_.MO/V8&`Q*D`()/+4Y.LA0)S/1T M]_1T]_2#SPPD+6X)(H^-3X&:Q?R'+\Y`\.'F@%'C#!,1I9/A88TDDYL?GGVB MRRT84;X64Z1^+(`AF?1]+Q9(>C\`LJT-E@'#PJ^,U8G1-B,`[(\Y+=$L)>%!,^,N!S-I$WA`,;L"Y/&?T"&3'P MY&`";(-#T3XT'GZ@:\0X#`(QL37*R"B0M[AH.N3@FK(_2*LG(04'PU1X,8N8 MCC'>)O%P:Z+5@8<5ODJ+1,U#YP4I,&VB9R("DLG9%/@RJ#-2.?.&Y"^)*=P6 M^/^K0#FFP0`8IV'"UZJ9-K:#W>]V3KOS+H,#W?YWZAC]6VP<&8O;GI14*?&1 M`O"4<8;PR<'JN.;,2'+OD$Y7W*.T.2F/1HKB[*`>ID++ZFRGRQ#J:'B"E]%/ M4AIPYM7=PO=:HQ^)(2I&]#I?X\/1$J"=9GV?9?BP%Q,58GB,__"):>XC;QK_ M8,LC"8UA>$A&$\Q`2R"1-H7#3BMK?@!G/[$J:SN^.I1!IP\)9.N=/DV7RTV& M;>FT?%SF,2F+F[&R!I88;'`XC\&XM`R?1/`HIS`1`P/.*S)!R2ML@B6H"BD!?B!.3MB6(U>H@S%C!;@9D, MCOQ,SJ!T'LH.=$K/!7HR/D#9A0W@3S@Y`YX&^0PZ"(F,3&R1DA0!:PW$#QHM MJ)*8_#8(%1)(Y@MJ](!A`(I5$1#]QN,XY*PC2:B!VB:#$&03H$X%KR\R<2.& M"L20J?P5:1\6:QX2Q<]K'WS(YT]2)&#?0]KV)3E7>;6(U<$X0?[ZR[!X*%Y% M'3<<*/(]_09J"X`0_["#4!;"ZHN+92FZU2CMZ#?=\&8,1OFK`@`:,!3\_963 MQ\?F0SHXZ?S=HB/U^9B.^JM>XQYJ$X11=RLJVL8IC)A9@UJN)M9HE7.) M&KJ`KX8C"8S[764&4?INZ56\7@\T!\.A35)2A$KY(#3;=5MKSKPV4EXL.MNN MW6ZY#3HWA\Y6M[,%=&Y(FBT-K2NY/N58++G"LD2NXLNW=^]M)YSK&[;O=;6&1]$7D@!];O M8?151/'?\.(?HTA(I?[QAFZ!2?O^(XV>CG7/N?:9\PVP8^_B_!M89*_^B;W] MPVR%ZZOL4JF#;D4->>ET%6BSVL&XX>%JF!`.V+?.'O#S;>'8Z985G`V.U]3/ MS]M;Q?"V%8QYJ#ACRG%TV(&ZJ3YQ*DB_V^47_Z5"#H]55>E>V([[XFW2SIGM M.I56^?R8QTIQP$6[]$&V3YWF0+EM#Q`UD->9:=<'TAJZ]TUQH%BCC2^_K'3M M\V[5^Y$:%*IZ)?J-T<)U-F8:-;2H20NGM*:S55IL7T%8!KZ+,&4*NFLL"/+K9EWF67FZ0S,61K%J4>%'PB6,!`GU(@N M6Q=EJN5!P7>CX@FS]I^Q68F"2IE0PITL1^('6.X%6?O)"D),*^2,*YT01^`P M"@LGTKEALK!"&J8QS#0-`Y_*#&3Y?;'"$XY%.YVRB.&_7(-828&Y#+!LUQ,H M,H%RP..8Z8-^'*>J&%36!,A'IN6,2YF-C?\^EX#8%"'(U2?Z_*_K6ZQ']/[S M%^O-Y5OK[;LW=U@MY7*""77W8PO.!*Q<$6-E`*-#V<+&GF%%IB>4ZTEH8=60 MZ8S*3D@B+"8O?(L4FAC"+>&\C>2E3*`TLF,7_U9>6F_E-6`8%S]XW!$TRNA=7( MIFE>%%%IE@=ODC*D*9U.V=[F)DM^9"1MXPD+!_7$_XM@HG>-I1$06?40Z@R5 M`<"[3:8O<]D#K-)2L%9IH1:)0X:Z'\Q"4Y%R<@`@#KDS#\>H*VJCQ) M;=T>C;M(16(B'E#RR;HDI]9EKN84E3_)"J45YXG*=.&866DY=X2/0G6+S`X> M7$F6,9SC%$*;+,JD:E[DZJ<`B*!@S.`K4XXDD0B&QHDCVY.IY%3@C"",D)`'A>:`*IBM@Y7//_=;O7!@NM M15_#'UWZPTC3L`V=;O+4B'<#E*O/GZ[>?;K[PB7GL`+=EW=OK^^L+]>W_X-" M_KU14Q'TA'2JQ2HW(@BQZRKK=7':_T,5H^*]A1L22PK!%O7CK[+LA*P&P'4, ML:H*R*A<3:HY65/8RF`&AJ34W+#'(HVEBR.:@^JJ:U/OCS#*E8@$)"0I+U;/,EZ@(PQ.KS#*"AOXJ$$@;RMAQ:<9;SFN>XG?OI?U+]X* MJO68I<]85V&$`W(-%P#U_=OKJ],"U7F)>DQ`;$M%MBJIQRS@EZK(5@5]V*JD M"UN&XDM`U%)^)6),Q:"DEDLL.?WEKTX=W_^PV,U0_OT'(UBFWE"!\3CZFS"E!\/P8FF/@@;+#RQ(-0 M]:B(*'#>I:H09B2$1?I0K#M<4Y5&X',X9F/62OIB07C)4U+I@5*@J`H;2T6> M-X,=\:?6\%`_I-*S7(5)JH1[)\`!\0*8.#?OOMS]F_@!6>'F(W""R0@W$18/ M39YL:P2*FD]=%=3&-@J#1;(UT=`B2R!.5"&SP2"=2C_64,Q`*OJ>KK(%9`4E M]R^/3Z*WJWXF35N"DC4:SLVOA2A66[V7W9(B#]VJ)U2)579-)U4]7^\IC076 M[YF`D@0H9=4T(BV0A%H;N=3I>087]1H_FQI>N/*?.PH!8O M=063Y2+-LL#2&N""OEQ&+%_]>^F``B4:"3NU,K+Q/0L+YTW3J6W15H+_#ZC2 M(!:6YH9A((0%[@/9<9FDJ;;66,KZ$6Q=U,"X0-\]_):PA$\*9//4>Z)6SM1; MF8,7EU8]/+V-XM[&5Y8@HJQHI_Z5P^6!GH,D\J1 M*O,J9`U)23%+%"G)_Y?W"LM0O7(^B_0B#+''U!6>=Q:.TR3"<'#6CGK=G#N MLD/'Y`RCN!E1J=HJ'SUNQ5=9&[L@\@'SJ9%<[!D2Z>![#$\KWN3+W(J@`#/)DH*!!EE*CHYY(M82? M%%*R=I$&A%F-]5P9<)NK?V>8T`ZO.>F*UL%%\ZQ;$W="+AC&<&4-RQ9'R<7E[99UW6K:E+Z.N&=([Q$=V'65S$\8(FMA7]A?,ZK9Z5_?[]^^M/`,H/ MIPH=605O)X(*!LZ2`T?27@?Y&K5%9:_'\DVC_)M5K%B"]N[@!;W M54R>3N"!X`1E%8\D<7<$+F>-M!4B&2N M^2?UDN')$!HL::_K/U_\+%U`L&[4`:U'Z?;.F)2V/:*@#X?LR$]0O9.%L'4= M;&YN3_K;?*^/G#B1*"9(X:G)TU\D%?A,A"%I'M("J>GH$.8S,(&(3;F[)9;* M9QZ(;7;N@VQAS]`?:>3'6/V:?U2>6=G?PQ0"ZJ0B@DE5Y7,."BD1L/&HMM`) MSA$AP9L2:'D"Z;8&JE(J@@8<"_8&*A[]&'`@B\-G\XB`"PJ/$GDNS[E*<:N; MXE:-A_,L>52W5)7/LA%J-!"BGBX@IG`=2E]#BDK7KK:+QO(LI8LX^,#>">I7 M`D(U)?,X-P;I5'AXP&&UG!UPV$@\^`*]^725/(=Z:1854E7!!>8\]ZK)5#F2 M@U(XJ*T]](>T!/9^ZQ+F4O%2#OH%?W>^6X`6`=A<@[61Q.N?Z MEJ[_GY;[VFWS;M+&ZN$HQ92W>N8]<1OH`56&FK#E+YW%F0^#^E"HA[G-"]T4 M&BT:3HO\N<2FICB4O:Q"AOC(;1>!9E'G:3$<;7]CVQ<"3Y>2U MPX/NG]@5HF*+\&>\B99MM/7M.9P)]U(T9GU(#$*HZS;?V+_RXE=)&WE%"*K* M<.ASL775XWL5]EB"*V0?!RW#!VO(4SSC0<(<>'7KY%NI\\N7ZORGK#PZ2W]'UCEL# M&UXJ_86OMF$7O'9/VYF[ZLX`F^[(/9,CE?<@UYY-R8&!5$+5/7>N:PSVR)&_ M&0PH[P9?@WI%=](PXLC_D[1C;FH%P#D*./PUYXG0NC39KT8[%U:3LKY0^PI* MG'-K]0XI$O$S6HT/K.$Z)M-J*QRM0-DXF<`K;)Y>7K.F]-G0F(?"A&5UL@+&/"B&G`]D<18Y4K9S)?#*MG2UOO_E MS=OKFQ_XCMSOI])]#'SCW=]'XA[/2BP#GVGHP)`?K]^8@Z"0OK&9T>C2YK73 M.G79E&+Y9"/5::93@`*[OC`+S4"/B31':!CXC?GEX>LVM69`-YV&;BPFV%*B M^PR,!`[!J=F==2N\74>L/#<`+I*W7??T+#L59$#_+5SVC$/D[PB M2X?-A?G[W%'4A<-=2@(,50CNN;6&_)EBJ\XSI)FG%3M9*PD+ZS+K)8+/DZ,W M+YE<1Q^:\U:$BA6*D%=5>S5;NQY@H2T3SGGUE9!.YH<:\`"$U^$8E.4D58FS M\WOU3$71]$]NV*(&O7T"U0[#[D&-S$NHC,PR[#C48,UM:O7UTGUMU=_3YM$Y MMZ_GH'E]<>8HWE[>]8F616-MIGZ_:%0S#W,Y8^R#/[*,-6SKSAI2Z18:' MK[7LN:1UO]4-'`_<3EI]P6XMNUR7MS+5+MC+7:+K:2ZYQ1I=CFCHR$`*@FT>[U%Q8-Q`3D_"Q:;"SF08[]4JX7[1+EY=^(YNJ<@_QN0`":_T: M]R^]0K;K5BT+=@CEL3=0P4#+(4/UYA::I##_;<$X+M*]:R;KON2*%.=VMW<4 M%>?JUXK.RYX%[6H-Z5.6BE6I78.:%T[]6[;3*EB`^5-&RD2(VJP5/W7)`37&.7'N#7F5-Z>!J<]!_ MSLZ7@;%7)PW=52\XZN:2[&3PA7*.H+FGTXFG683-8I:8]#SVP_`K[96/7Z[1 M@KU-3JU?PUC,QK(M,XAMNNK@.SYNTON`O<')U\8IN=.92%3G735^L1*9+P,Q M=]5"+X?<\SP+-1E1)V+QX'-2%CF2@S`XR94!R85*RJMEE;##%R;*]-9.T+SG MU0"&`C9U.L=\>@9=BRY';`Y#!$@>2]F#BY15F%I,AT7WSFOI-6(G40M+%K7F M\EZM2Q-8Z1S2]Z3*%6`]XP60TSENBZ^MEI2%T&S&D0M+N,+@N%S6"(<*E4AA M&6&(JTP`*8#DXRH>S^>IT'!N=^O9)(?M^[W+A0"QWR0>AX^Q2I\P&5['9P$? MV126C)QJ#2;XKTR$(YW/#`S5F4I/5O"8_'@52G0O!&=.,U>J.N MWXL1Y-%V;>87@*"J[=R^.00=72>%72.HK"/CFT70=HWK8T<0A;9SCD*#IA5H M0ANDP=`*#/T^%R2Y MTV"XP?``Z(YS<608KCK7^JBIK-/OY49Q M$TD?KEM/MZ/=;7K&-D1IB%*&*$T7WY=-E!(:9'/R;(YT M=0-#F^VT<9I4O[IHB+)UHIR[=;V(^R#*ABRJ+<*[(5.IPD4(VT7=T\X6\+@[ M?#>0-Y`WD#>0-Y"7FZG@G,D*#61%\JI5L2M=3/QP*N!U6H85U=>HH4\W1F-" MLRDB5^HL['](R%QHIZI5C/SDK7,565E+325'$?O/22 MJW#R7E0.PZL=^/N2T=FM7!3D$(K8EES?Y]$(4\ST;C*:MI,U,O+_I(ZIM67* MGN)/7+O7Z>T)^)TMLFVWNF7O!?[Y%8WVM?#/7@`<8)>G8O8NZ M56.;2-1]XWAWML$1W2(^3YAN"RA3-DKXF%?IE-:6C_H4N%SBI;?F/?3-@;#< M90'&U5E[8_'AST]8M3W+-T4,]\)N=0Z"&+L_8G(A-/-Q_73R+,5L$_6UH?#( MGMWNUDVC::+QMA`B:;?.MQV05[#C-]N;H.0-][V3U;PS[?SZY%H.@>`)W3KFXK:;UN&TU3 MC1L)+K3?/CTO^G&N\'Y&FQ(-%4M$BER%TZE/S0NPN^)52,WJ18"MZORX+;=.JM/X^UK(^MNQ;)B MY\#)Y-KMSDN.?"I8\EG[)4<;%M*X?,3)\9V)];O2'P21'/NBO2^9LB^^+*V[ MO90%@V%07PTXW#.Q?G#I09#)L3L7W]@1D5U2?5OKW@RIMWTTU@OE*5CV7CM8 M'D&X5;%3QSVV$K+'C?'*,JE!^W$P^O85F!<;?+8!-^RV0M&*6,FQN]UOOGS? M<=',M<_;#4'L#2@* MRN$]2E,A-51`9.$+PQ>C'AMU@P7IT(R.;YW$$[[?D"AC/'IWGGT M@+;+%V_X222V=1T,3K->9XQ:X0W&UA^A#[OE`<8"WB#X\#>?(S\Y\A)0C[&4 M_E#HH%=O./4#'R,VD9-5O]W8#*R.8_@=@RYY,F\P`"T1>=G&8,@HG$PX!G4Z MFX1/0/2^",3(3SC`%N:#X6)Z&I_JXW;"40,*$)H(XFIKE`;,WAA!VA=C;S*2 M09FQR*\L/K48%8R)2,`>BRDB=CS_)(:+$A#>%"&.U83`>2H&%]\U4<"QXSC4 M2/^A- M^"$@$L8%FP-C=`D$I'XFQJT9A@V'04/9Y\5.%C./)V^,M%`[7CV$$=?>T`=E MZAX8P4+;!B4Y-P.#'X_I_*QVGO?\ M)+96KI75A%5,:,TQ8#Q&H*4`RJ%G)%@FIQ3);DJO-('#\R]3=,7"@(M5%0,W MSZT%Q:BV*4LY*6!2^BI"(``G'PI*:K6:`)[R,^)T"D"!B3,$)K*&J1IY-`+F M@?T1JPP1TA,D3CIG/R.=41^#]_H@EG%OQ&,A$A:RH$X3&*^=4T?KR:0XNZ>= M8JTZLE!,=4%VQS>\!90"#@.]!7!, MPR@@A-;0&%CX+%-OL&GMDTAXW]&XQ9I+`:(PA\;/L8>/RQO%,%S_28,L687` M8';)+[7K=NU6JZ7Y)@UFGC]4AQ\^PCMVJ6HHY;<8VD@+-X>WQ0$)#AAT49P] MCGT0B@R?-86-@+P)RP\8.:ME4LSJ)`#0R0&@)B]03%D<2Y5B$*(L+#+;*AA> M\S;;;=J/X<`!(KY#2L;[MM#<#B=S+S7!@5I\@BL>9CM!/'B3E"RT6*^(=39: MEMX+E[/(G]@6\V=;JLID.-"&\;!'LX5^D(3)/M0H!.H+RAL#,Q].M$)"+,7F M/-I5&>TV84LL%N:N M,I-39J;S"SAJZL[4*C.36W))_Q3>)!E?P2GQ.;KW`JE*?,:TP2]([E249=Z5 MX#BNZ^3@>7[>S4#J&)"6(I'C=+M[@;1E0%J*Q+WS]IJ`1D,0#[^'T5?0W:^P M?SI(.7P61'N,._4Z^".-GC9">/?,8726F[,^A-4)WKLXWRF$E0GM@(!:`\+5 M?'&#IVPZW>@F[YV?E>#(_,R;@K8ZW4$3VANTU7F@Z_:V!2W\+QRPMZS@;5;J MMRY*05T$P8:!K\P?/;?C'@CL:QP-YYU-P7ZM_")?!#E1?%FBH"YS=%HNXM<` MLF"F-8&I3.PVJ$ONEH"I3+VVV^IVJ@)3@<(W>`F`IAA83&^\X5O13S9#4O>\ MN_:6*0)J!VNLS"F@R);19`]IC949$):X53KJQD<#MO_>IE@ZY0;X.AR6)-)_ M/OI]M-$#4'W&_NS#9/:1+-EG[*]NK]@L*H*D+M0%V^<_OXLXF?I!G(BH#+Q@ M-)VO#>]['T86'[!*RGQ[J4NC6M([OGV_Q'#5?PLO>H_>GG5-Z1/7S:N`-8#8 MS7K^\]$+O'LJ^"(9^4I=R=G7:R MR#78:6Z=K>Y!+/1N'(D:$JXV3]+\VU_&OKER5\L\`+[/T_JTN=:K.O#VX MRQ#H'S>=S4!^$_G!P)]YDX]>DD84OO1Y=#<6NDHBAI#'&Y,4O58ONTA;;^XU MP+\.0%8^A_=GG.7F'6756=<#&;6->D!WY4Y=<]ZUP$;EO1[4YGUUY5D72F]S MV7$NH_R>Z@++@L(WLI#PVW1]*Z'3R7LS2\U6'<2;2,3P[[^\22H^CSZ)9.[W M&M["7D7XGP-EL?1Y0.F[+(\PKO=I4U%9/P9A!$O90+WSWR@F^4LZ$5;[I-7# M8*POXCZ5%;UO3_[75F%\6=BG3X%X61#AR,=:S2I:<^2#!!_X&%B=>`EW#^2( MXV#H/_C#U)M,GJP8(/%'_L"C6N<#C2H88"X>D6/U,)14EBK'8+'8FPJ+:GQC MT&`:PZ=85OI>#0@GEP@.6Z6#VH9QO+XL3,RA?;*R-L7\CSB`6L>J:1`H7HVG MS"IQ&Y&PZLVEN0(1P3J;"`H2C\7,@T%DE&@88`/0D"JH4UUQ6C[&M#UZLAN! MBDP=0,'^>&+2_'9Z>VK=BP"8!%G?&PS$C(*D=3H35L5' M83^AZO)TO1(#>$J)0WI,O:]`$8T@8HHX3J>R0#^%/`)/B$&B.=334=T8$,L! MV/A]X<:@`0>2-1"D`(\7XN]XU<0\IVYW``\!ARE4J$2NPOAN#9:"$^.E:4O2 M),:N5(`OC0A/N-R^BM/.+9)`R1;ZLQ$*BL\.5')DLFSRE:-;YLCX9M&J(KZ> MS/H^R*S3Q849!,$\#Q",(.>&=-%&#_+HQ#&DX!80R`\>0M`8@8V']SR2F0.I M8K,#;,:`!!N!`,!>"LQ`@).ACTV)TTG".7N8K9)H&=073R%\S%@S'[`/FGHX M`?$34^![#(/8*!*Q>4$6UIY.."4#P8U\VA(X)T@ZE<]AKJ=0LN2EQ6+^*J$; MXQ7@D#GDT_=*TYW--(Q.5]QB6QB<+@\<%8E.F,PZ42!9D)T)M78N\P!?GO$E M.<6\9]DF^?85:N/.O"207I+,.S"P(_.?.5S)Q^RF*#!2)#C' M5.V6-*8M/O2]^R`$K`\L8)C[?(ZW3-GC-V,EX\5@'%"6EDX]\#!N',/Z=7*I MG&@N(T._$*>HM@##3X`=<"C:0_G$!@Z>#,3$7I+T:>?A4KEC*I$QY/[A<3J; M34A[B<4@$HF'V\JF=(V9[G%$I_T@\F9__UH>$(I\__")7>XC;QK_8,N# M!#@>'QI3I(\U@[-=9C`"NN"8HG,V2Y%D'<67XD^FV""XF?HHS_4"B2ES,)=- MRX>OD`9%?&]_FA,)'5!"9[BT#1 M6B-G$&4DQH-9X!#$321GD46TZ$3Q+L0)2-H3Q6KTT*GU.TPRB4/)9'!09Q(& MY3(6,$E&Z41IIT!/GA945$SDDZ#`TR"907,@86'DFZ%J$P%K#<0/&BVH2)C\ M-@@5$DC:BV$*[V)6F6)5!$2_\3@.K;'WH`F%>)+67EM MQW0TL(TB%0+N[R(;G6E57\.)WY(U;^;LLT2&&#!L64-^MD2_N.S58DT(Y&5 M3)Y4R(-A7F9F90?DR0DRQM(R!NPF6^MYRPZH>Y12`3+C23Q#]HLDZ[$X&\A# MG$Y$&UOB#<'Z'R2P')I2B<%30[#H3[>F)I!Y&+1.,$NC./78@1`&X@1K%\U5 M<"D`!=_%\S2C>FRZ+\AOI7*39:$74+IP$SQ92%F5@)^3QR$K%"RY.=>33>\4 MK`\8=AH">X91;)PEL<+`4R@M$])5X;_X5R8<:+J^AR<)1B$;PD`>U`,>PQB: M]WXZ?S/'G:%9FJIO31WU;!^>/S6-]OE!#L%@I4% MOM]F+"Q\/[)981:*#&(?\&<`YY*E!3S8S!_[> M?\H,Y,Q<,@:G>E2P&G9'P_:+R/.&*=`,:4HG3K8+.6/?CPSM/J",?@\+<>"< M]*ZYM,PQ!!M2BD$-`&\5:3'P08A.N(*UXEKP_$N>9@0::5A<70>6Y%R<3/&& MTIJ$X=<3K.F7,K+2< M.\+'K,@!(Z/_I#E%EZG*N(70)GWERBV26ZS%E+RO3!#6KYQZ#9^5`6UBQ=ITLZ'J2YWSNH#Q8O)I9(KK5;EU> MJ(-S]U^W>VTJ),&E\GI<5:)<4^.E8K;@^@Z50G;K?/'CKU?H"TWPT\%(Y/?: M#8U"*DJGTFWGX4Y*A-2+6.5.^W]0#3RS)-N`EF1%N"8^_*6-!SP0C\E+!@(E M=S\P)QC`ZEZL+P2F-!5RP[,+QU'NJH5!][8 MEF(R'B_>9!@OT'D#1TT8\5)\/*>1"54]D.QNA/<'[C2Z)[/>2Z_&6S$+8Q_K MO"F=[BJ,<$#VR0&H[]]>7YU:B^KGLRHF2[_=J)G6$A638%BB9EH;T"FM"OJD M=GK5T"FM2OHDL>4D\T9HI7+Q@%ZJ6.+UZ5+ETC(52[JY-51*F-#0)9]1(%?( MH,50BGB,M3[AGW?9#CO4BX\)JX0WFC1EP M\Y]:G4)%;.3YD?2(2]VKD(YEB#-/43BD@#F2IYL)[#9X6P?^'"I1%<"V-0(- MQROKWPC-B^4Y3/RW^V MN.03@;(XOQ9D!`A&CK!_/=\Y?BK`U!EFK=HS?3N-!7I')Z!9Q$JGBTAU(N'2 M1HYSNEPE6/:PG^\ESZ)5M8H?FC9*/,;+8UT323E0N3L\]XN/%DP`$Z0E$+5; M$J(B[BS+:$N34H.%Z%?UTX&YB_1]Z[VJ<90K/F66=#,K.A.%2`]-L'(TO/^Z ME]5G/K5TQ22ND<9W-\IB*JIRY647Y&8`DY4K06QE4;SJ&GCI@*IL5JQ79N-J M/&O*,6I40!*/MB"@^UDO]F4A/1"7`KEPV^) MKG^Y($6GWA.5FNOS/1:ZZ%%/+')?O5N*GV$XX\IWA@U('MG+V]\LSLJ^8(Q0 M^`FZ8W_U8&F@+;#)X$C%='6-L55%,`<+O`(+_@S6$XXG[1)=&!QM6`[9`)W, MCXAFV378TB6<6F^>9!E-=D)S:=/_`HW\A*^(I[#U*5XL3),)P2-UWWLX(3,? MA\D9QL404:G:*K%2.=*/5[*D0%KIK;]8MP(=)7?>GX=ZB"WE&K0JP"ZGY16)^NAZUO)\U+"0,B?9?(\(3R?0X+7`05@.%JG!(:Y!(U.BII%!#UI)#R M*UE\:CJIJF4!GKD81)M##S-,:+?.G,!$M7HN3-*L(@Y[NGB[MWID&QJ^925! M+K,8NUO@TZ$7#6,PYH;D<")MX?+VRCKOM.S\Q9V/O,#,:MTA8F@7T+>V134H M(T#BUR!\#%":9X9XT80$UYL0/EK?O[^\??,#&):P16<8JD$P?`I/KW"TF_?S]^^M/ M`.4/IPIE6:@BN:VDIPB+GA*1T8(F;U&HSH+[0-6!71J&Z(^4^X+?EHYZT/(C M`:K95S%Y.H$'@A,443QR#+O7X[!`MN)A=CJ/4M#A(F#94T20'I&EVQ!W!FVR MJ1!\D"D/UOG/.)G%DR$T&'>K`]TN?I;;#M9-BMVC=`!GC$RG.Z)`%Q&/5,2? M#OC#:LI!0DK9W$&?%SFJ3"5YT`-O\O27T+7E06L+:!Y2[:CX^1#F,S"!B$T3 M$O88R\M<$=OLYIY,I-OECS3R8PSSXQ^5GY("/>*E$#+$TC'7:O@$@0->!B,B-@H`TH24<\C`HZ^HDYW",>\)'#^S4G`1+OJPC4MAPD MVD_`W_N!(A*^E6,&DQ`:$A57CVHQ!JX(V*<4.9S%O["QJ0"SBJ%!4=N/K!]U M_$`1=(7JV#*M:B&U$C0ZRE_YR%IE9N0=JCJ6NS:8"_LV7*E66M;7B-R'H M)H7]$RKR!7_&.]6^2!Y1TN&S(,_OI5@SW.UT\&47%/+BR#?VG[S"5-)"7G:! MJJ%+.$_,F^;5V%,]$C1]"!2BD672)T?/7*N/LAC"R1]E%JKER7`T+0PHGR>- M,PF`BB-YN(IIGO,O*L))YV*T-!B^]*:>EP:P+S/U\B8*@Q`EU#1S31ZJ4/@< MS%G[KLD:4O4GA&>V]KEM*'A:Y>7B`1YH>WQ_%\[\@=7K=G[XR9)9 M?YFK\6TN?436H5.W)M87%;15_7C$>#+W$W#6Q5ZJ4)%Z-LK M>684@6H8)9E^JER`2CDWPB8MH5Z4:2`S7EW!9?MB'*AYQJK,`AU;*B/R2?65 ME],XD'&U-/^LRI92>JI6>(SL._AW3#X4CZPL^-\LU4YJU*:(R%5Y-\&-PS0: M<$B?@L:$0I$C?_&S!`.Y>-:E]WTRQ%;6F+=NZ?:N&%#E%/>58N8'W+W,Y>/" M5,](2T2F'GNL=^0B!Y:WT,@.1*5VV,7:&`OMB(^<$:`#N57%_8`I@WJA#!58 M8L,IGF)7_=8"4GNSQ&J5$Q*9,:NEA>$N,V^%YWP'F:.N4'ADGB^57=-U?M:^ M8&0J"OQ2\J3=;8$\N4._/7"E?@Y9[5I[#1<,=-C0[.&+@=836!R^/`X?89^I M/,XY,S'!H^?>'#YS2F(HNKHUII\#&(ET?#J\9\I@'_E1S`EQ<6RZ(\W8'7Q. MNQK1J46+!1Z1YOJ\!9T9',9!*GNDJ*PVS-C&]^E"B%[D((+<0DL)P6*PM3D M-L!DH!$5:3F94!2XK_D^L*1J(+6I3N/(:'3B*!Y*KEW8,4E M-LGWS+TH=ODW?QR2KLVF?4CN%7BVVT*&P^B`'Z2G)2BQ6IA5^_6-I5[JI<@] M8\H3'6>O]PN!DNV9,A-3FICLOH;#_!=#2!39YG=(&L@])Q18B[O;=`PNW]TK M5TVYA>H:A<4A9KUK%[/J*B2=<0&UFODV]^M[T8](WT84&'N6(ETP"/61(,F0 MF5=!\RG7/J7'2XVZCTDC9@@H*%(3(%OFH#>S0[DIEQ$H(&U?.`0B`4(X5F>4 MNE&!URV\XY\(LM'1MI3*$IQBVL(M46Z(`4G1;IOT56IQ5#<=]^MF3?=`R4\V:Q^,E2GU[E&HTG MD9J&DH[A^%%DX8;F,)`W^(J-(8/AB>R8#ALH,89!;I,]T4'!C;S9WU_QOWH% M$K"S#L"E^J53G_:?K.YI!SN7J6\G8I1]B3?P)V/!#SI.][OR3>Q7`^(<"!SM M;D8HU3_^$=@I?$3&LAP@.270U8/V9PLYZ.11?M4/)\/\!N1T/%K4=U;X**^T MS(:"SS2PWPD3[95@+W'R#1'R_[RC_ZM/RF+8WT=>\'6"U^\R>91C(>0Q=C#( MW.C"EV[/3N^[P]V*Q>BZ`A,>.W1>H09#4H5:>X**]>'#U;=&OM8VR+?E#?CQ MRS5>F=^"N?YK&(O96-:6`)+2RKY)0A[?/OR%PNDBZPU>EY,=_S:KU*-DJQ%^ M\8U1M/OLUOR1E/;<5_5-B*7V@LR=*VF_+30H'HS%,)V(SR/E^3X\4^^2:Q=1 M:%W.@8Z6G@X[DN[`PDAQ3E*4V8HN5`'1;5?J7'U5RJ"6'D+ZO&RB7MZPE]\N;M]QTU]VL\9Y?T)9MD;]O@>9EC&+>=VMU>"7P[,,EP)55XB MS">H5Y0)]4FUA1&6$_/".3M(8CZ[X_.*GN.LTK_407F"CSTC&989D(O"PNBY MR'<7IDNXD1KY,\9V6N<'R6A;DAKNWAC`/76[0"&,<)J(&KK$6H,OHW_/[I71 M,FK2/[.9LONL%;;)5K)=L5[SG%>"H> M`\`&'`5_?^6^*BO&EACI."#BTL3K2>S_)0BY+-=:#K,U_I:QY=86=XP(ZC0( M6HV@;H.@U0@Z:Q"T&D'G#8)6((ART#B9L$'3"C1A_8L&0RLPI'K2Z6R@7&D: MF3D5J;YTZ&DFQ_)6<;I],Z@L+3;]G%I$L46Q#X@:R!O(&\@;R%\JY!LZ2Y[U MW:I[LY81&&F<=O.W^.S<7>+)+7%L&S47%HIR5CR;]378^M=[Z[YYOM2Y5@(% ME4VH/2ZT05&#H@9%!_UF@Z+MHLAU&QP]AZ-VJ\'1LUNM=]K:`I(VI">6N'K= M@79X%3Y@A\3$DE7G,-]0).NKB)MPB:UV86W\&G]]_FH=W>5.@^$&PW,8/KK[ MMP;##89S&%8E:B00#:(;1!\YHCO.Q9%AN.I/7-DHNH++NNUQ7A+Q/+N?[Q[M;EQ_70V1"E(I:;!R/N\-W`WD#>0-Y`WD#>;F9"LZ95?6!%O)+\?FY.J]K)+N6 M;F)\>-5_;I;T#.;&]ZKB,&%R97MB[O^@J[TV)7^VG3JLWBA?6JO*7BU3O+3\ MH#H7Z:QT+E*MZJEFS8&MKW4-5??%T+-\;EDM>JY9-J+6&E\*XIQF`Q2.6HMH M!P?CGE>YM4)0N_,CJ-KHO:6%W%2YU:S!WK-+?1EU\.`4O9#1=O4`W.AJCP5U M76=[J-O0]EBSBN#GT0A3QO1^L*U1&@4^=8M`^V#D_TGMS`]<\I63=F;)KEZG M=Z1KVAY6VG:KNXZN<1#"OQBJ#]@AE=J=^U.L:,O-7EX8W9R.[78W7('LB$98 MBI:VW3T[S,)\:TIK[82R8"QL'Y7KZ[P+Y!]164;'[EWLI%)A@]6#V%/K731N M`KD'.<(R`G9;0,&+(UW45M'BE-'RC^>PN#2Z#:[T^S<2+L<)WX/!=]9NK>\% M:="90Z=[8;/6LU`E0C$F?>'ZE+^/F M^:)=XJ*MN79>Q-OY2^U<)]5H2T@]^L!%6^6[9;>Y62ZX-6@?YDW8MW)IG@@'3RD]9'X\#<*H>B/_. M;G6.)/CC>)#:ML\VW>9PMSY1&*I?`$M?@V*V1E_;Z9ESG7[TDC3R$U_$GT>? MPD2H03;157`+:5-W8R%3G:B?36QYP![P,_P1CF1=)2+++/*#@3^#2:=ZA?@( M-E?/TJT"7+$U].-!&L?81J4_EP8/M&$'K&\*/(";LL5GUJ, M`6O**.!1T&](/Q>&\J]E-Y`-H\LW-%9$8T7LVXIP>R5D8F-%O!#]I[/A>,U] M6R%<8%M);26O7YA=TMFT[WB_^_)RBNY+*\)\AQC(Q:VJ$P%_E)!7HEPU$LD37>FE[]V4E+'T0<6P-TBA":LXP/ZFY25_8 ML^?'EDFSA-9A<'\"8GFZ=T(?ICNA0-L+R^( M3^8M0_B/TUIA#1:5:%S7/U#2X_`%1O(FQI"?9R+R4#$X:*>#A%[U=YGS%H1J M#9G/@7T&(W8U/.\Z8"_![FX>7YR#H%:,RSHZP!'E"+P'TDW(9;CKE;X(]+TK M7YVLP=X"]M8-$=MZADH]EV*GM1F7XN&E$U1S*=K=L^T%QK]DS#EVJTSEE@9S M1<&`G<:1?31N$==V>TV!FWFLG)^WCG1%V\-)VVZ=O;!+BQ<8.N7:[6,)<-\A M5L[*Y%4>Y(JVR2F'6ISNP,/L=D@CQ[YH'ZN$VB+GEE$P#W)%V]S-K8L-ZRP' M<#IO.%1[[U1R[,Y%0OAN+2'BC1$2[P/,1W58[=LL] M$D/\B+!Z;*+EB%"[!8;=M\9Q`+0^S`@+Q^YVC\2V.AZLNO9YNT'JQH.!;+=W MU,4(UHD$JA:WDZ_A*J('?R#>"_%%/(@@/>0*!)18)!'4.?LYMF(&WAH)844, MODT$P;#6<$3`1]X@P:@@#V-XO&``<&#Y(2P^P#7F)AA*B?4)L.>-'V/5=XP. MZGM8"KZ?<*P0_JX#A<30,LN94B_8.)W"*OR_X#<_(!B27,T$#M9IBA=\ZU%% M3FM5TXBC[K'*<8...H#OS@LCE<+N\LSMJW`Z%='`!\WW.HC3"/7W'S]Z M@7Y+[>S,K=K79ZG\/; MVA^^,$HY=N_\2"X.=HJ5KMO$A15AY44%D/P>1E]%%/_-`M,`JRR3ZO_C#7P5 M!F0E_)%&3R^,B*Y]=K2!ZEL5@YNNY7I$(ZS`R@[N/W=ZC'].QDVXV`*977<= M]_>A!`\<*E:=[I$(VB/":J],=ZY#U$#RM7X=9U579G73?H*/T:"W!<$)5H7` MA./@P])\N6>V6Z-[RHM#1GO3Q]J^M9<7R[E'O[`&-2\(-?OU M2MP4APXVBN!<14;[O.MNI"9C@TW$INLX#38WADW'V0QO[EOC^`0V1D%D]-X( M?I")`MVNW3Z6*B_'@]5.QVZUCMDO=:A8='Y&K=EDE#F MJ]=^](,P\I.G:UFL_O-C(*)X[,]N1(3A;=Z]>/-TXU%M;#-_Y3+^/,IR5O[S M/O*"KX"SZZD'T-[_&OI!\B]X!_-J*)[^E94&/K\J1WX%>MW`GWJ3^.^OKC^] M?_6/UFFGEZ7G5`!L2VNZ\B+LL'V%'J2G+][0A[/D_NG#9%!E1:U#6M''R+], M;I-?PUC,QGRC/[FB&,:*JSHH.OT2"0\&>.--$G\:1N*M[]T'80RJ@>1&&"*1 M(U=89+<>Z8;"_^EM.$@QC>SN:29*9W\YK9/_^;\_SK\^CSNU)EFH>@5^C,7^ M=OO67.A)^]4_VMW>>0O^+UOKW,AK3.R4FKC=ZO4V/'&KS,1.[^*LL]F)6[TR M$[N=[IFSG8G_`^()5-7K8'$7%V'`<182<=;J;1HB[ M%B#GY\[YEEB$KG[5\Z6`:;=[[2VQ275@6A=;XY7JP)R==3:\DS6_5`?FPNU6 M(M,O`G[$%.?<4[(#^]H'R2+KKIRG-E"E#IG%C5T)J!PMZIZTBW0J&GY=$$JB M8YYORX"`B2-^0NGPE\'P*J3N5B(88#OZ\LCX,_9_"OS)WU\E42I>63_6G&7) M>I^;I9CN.%OD]U.,?XO+*FJKSWJD](H]633QAF!U#%C+<87CME8*D-T"6^W$ M/.MV5TKB+<)>P!358.^Y!\0CU0^>SEEWY8F\8]2OH=]<;`G_;_UXP_+DQ('C MHPRCYZ;>$+25)/'':K8ONX4!;388`JKLK+8;=\D5% MX-WSBY4^@"T"7UMZGW0[SDJC<<=L4UG^G9P[[KX6L)$#"%[J[4LF;N0$.CGK ME-*\5BZ`9GV+C6<'/F5P@/I\.<7NAG_1GQLZ?UQWT7!8,>LFH*Q^[J`JNVLH M*Q\X3JMS40O*-U[L@Q4DF0,K8M6K++9N):S6:=UO%M/ZG.N-J:)DYW2WY>-(_Q3>)!ESD8)WL&+L M\&9]?Q?._('5ZW9^^,F2S7B92!CZ"UMF,`EC;$H8CJP;^`%O$50<\1<50YP/ M-GKC80&H?@)+AS$(&@3X4D45TT-OP[2?C-*))?'/1&O,+V+JM"74&I/0D@VE-3#YRFI#!8RG@(G$A*K5 MT;MRV2J"048O6%YL><"4PW1`^!H!QRQ]EJJL">`9+Q%3!0B@5+:"1/$(_P(# MPV->0$,'69](2_R)F67BU+H<#GU\W)M06#;3)@]N'*81AF[#Z`H:#3&0%,'0 M`=X$Q@H,`&<9"#!^&PC_@\3-B$Z!/QGY,C#T&A@I"RY_.O$%BA4'&_V;IO4$X[?L!##OR M`U@;5NB8A3$!80-T<3I)""D&RF'A`R\>6R-`1\S[!MDG3._'EI\`X$-K`.2X M%S1C-JXFH^(K&N\TNT7F+;C\SKJLK.C!HZWU)49VP:U%A_"`.%,NSA:.]'Y8 M)DTN;*M`DES#BH-['^@?JWK&SL^_A.'PT9],B,M(&"OATNZV0+C%\/?TKIF5Z`\H!^#F"DL??`I)5,!V.,_`@&\>(8:S#^-P7T(G$?Y$X!_@LC M$BA#@?V/@=]``@E:+#`,P(-7I];$_RHF3[R5@S#!#PFS$$"3M3KWL-,]'E"P M,#SJ\'U9^Q%>](%=08Y%M&YOBCOOE*"X'M%8"@D:DICGX7%PVNW`PMN$X*&3 M*+!@0P&RIR1_8.#D,3R)$S$SL,^D\;$!;@"R(XZ!.;>P72INE.=+3^X,E&O8 MLRF0*3O?WU_>O@$*#OV1#]PM_O1Y]T0I;CK:MB'+\=PYE\8@0TV^M;P9G'6X MZ=4&08A`E/F).)G``RB&U6XFOD\6=DZ&)Q31<)CXL<`0']CH7C248A-%*!Y: M!,U3R5T%*RZQ?;YGOD9]@G_SQ[#)D6OI<7R.@.BVD!4QDN`'9G/DW&=7"[/R M8O'LRI9ZJ99)#B^3BWD]2Q7FIBE)-RZ]`P@!>% ME6`5[WO$"$&Q=-^O7/4=GKGWJ3\D18T$91]F'(W$@,!2E6?YO(`#'+N7-CLY MOY/?BWY$"CLBQ]C-?ARGP`@!S*A03/#-Z;##G-+M!\@@4B7OARGHEC`G2(6! M1YK=8`($I3_YD2$"P]W&22,%I2V=IJS+A;33\."(!`CNF!@M@+\9#B"G!Z,' M]\"BP#("]2.I;<'))U@G*]2#XOH\9&X]J02JW42*H!(WME3Y_9R*:N(LF#S9 MZHQ/^(S'_;B^]DAP%&J0=EZ%/#7C")?:F?.&J+*`;KPG5*G1;!T,(N"4#[[7 MEYVX,T-LO4+8QUU#N6H@K4J35<&NE">[B8*H9Z4+HI:O?HISX-,F]D]B_R]! M)-"/]/'#0EWEO@Z=Q=?*95'4QLX:Z00'3=7R96ZW0U5=<7DOU/SVD.U\,UNG M#GG6SY;<-735.&&^=.WSU-\H.>M5ICT[^Z[L.K5C=<9Z1456U_55*XL.77"S M+*2OUP/-:2_/Z7U^T@O9@;?ZM#5JU;Y47,IZ*IO%Y88VU]($ZO+[")5QY8./ M:PN->EK0VD1RW;(,OS)CMUKGQ^14"]0)RI(=^)*$.Z87D7.I`=OD-4= MKZ74;#CK>>-)U&MS2.^\NP?L?$L8OI#ES+>%X6V?"LN@G`?K*3W=A MXDUJHLL`;*.YQMO2.,HD(J]_R-FM3E5=9#,(;;4%0O/(;1`,)3* M'Z_8#7$B_0AS0&3>A#GW[YK>W7DG,0;4U'4"[^P.Y&X<"2&C#&)U;4`N=]OZ M^.7:\A+K-CFU.(.:2"/3J"W.H[:M#Q^N;$NEPULR`]FBA'A+9L13=)$ETY8M MG;=L98G+EI&R;(W#">CP$XR$P>B?J1_'8?1$]QQ\GRIO9_IX9X;@RXL`B@M3 MD0/JZF*61C,`GB[.!WAM@X_Y$DJ\QYGQS>G=6,1\EQ+S180O4Y\QV@>^ZXOD M40!`[=/N=WR/"DOJG;:^LP'U"=]FX!5#7XQP:;^F@<#;DC-:.L;2D(\]P5PL M:O38YXM7A@EM%@U*QII;O1<[M-NXNUS+2S^F&V2^2:=KV@#K7(YPMUR;D:BY*2>-F4QG@'[O5#>:&E6W'BT,I-GR&B[:S?:7,7!#F>^Z&= M^<_P5G(]KT:GMH=H:WX>]ZR.GZ?76M-GMM+S=2!^'J!WYUA].YV+8W![E"=$ M62/]X`C1;=7GH7U9N!6\3ZB#-%ZFY7[([3J9MK]35]I@/UOY,N3=TTYC+V_6 M7G;L7FT>VKN]?"SV`<>A3807PP29K@\[!8/E9+$(^IE-M"C"E``9]O8^)3-M MZ@?^-)WR8^B4YPB\@C'BMI<'+FV5'*A=-FC3PIU1ARKI=,I?<]RU)OWDA*=,#F*,_W(C2B=N,VF M7AYD5SK89`,T6A['=S![7V969_EVV':I6&D\6H&P`??9$0B$#YB&-4@CJJ=+ M&9--P,U*02!KVK]X2;"1P)$/(;R)>7T;8JW&JY+3-.OJXDLBZ;881N>ZYB^@8@V]%BJS-5I]4J M0[-#7&QU!NVXK=ZV%_O1&XS]0$1/E\'PG7+9_A*%<95BNG.E])V+5KZB_?)) MZH%3KK*_TW76!>=]&L'((.GAR??^G_@IKH<9UERQVM*P M?$!#"P/!KJ=8`(I]^/40XW3FZU$OGZ0>..6J$+>[9^=K@B.KY=$+PTNL$E$7 M-_.-"9;-4`>27L](.9B?.LBPW47D%$\0RU02NZF M]GDM6&Z]B1=M`">]\VX1''/#KP]$.09IN16`H.YB=!-PHZ)./U+`J8@_!WIW M?:(XT_7EKL-XJ3`9P/=_?_RS'TW\G_!_X<__#U!+`P04````"``M;H%"K];= M-XD,``#8D```%0`<`')D;G0M,C`Q,C$R,S%?8V%L+GAM;%54"0`#I`L``00E#@``!#D!``#575MSHS@6?M^J_0]:3VUMSX,OV.E+,IV=(C9. MJ'6PUS@]TT]=,LBQJC%X!,YE?_U*V!",N0ALC-(/Z<36.7SG?$?G"$F@K[^_ MK"SPA(B+'?NZ(;4Z#8!LPS&Q_7C=>-";LMY7U09P/6B;T')L=-VPG<;O__[[ MWP#]]_4?S2888F295V#@&$W57CB_`0VNT!6X138BT'/(;^`;M#;L$V>(+41` MWUFM+>0A^L7VPE>@U[HP0+/)H?8;LDV'/$S54.W2\]97[?;S\W/+=I[@LT-^ MNBW#X5.G.QMBH%`7@::-O!]2YS_R/[L#J=N3I&[K94%M&$"/?M_M2+UVYZ+= MD6:=SE6O=R5U.:_C06_CAM?IO'1V_[;B7RUL_[QB/^;018"28KM7+RZ^;D2L M>^ZU'/+8[G8Z4OO/^Y%N+-$*-K'-R#%0(Y!B6I+DI,O+R[;_;=#TH.7+G%C! M-7KM`$ZHF7Z+,]I'D+CXRO7AC1P#>GYLY5X&I+9@?S6#9DWV45/J-GM2Z\4U M&X'S?0\2QT)3M`#L?QHCX56WO-*H6+795VU*SV:%;$^V3<7VL/?*N"(K'RJ% M[^M:$K2X;A#3]N@EI2X+!G;!7WADO=`.U2&/N.[3H6-FG@F3?0 M8I[5EPAY;A[`7,'3H%O-L8U,%MB(N<,=+U2:.58H'UZ>9%7X)I!X-"FY?;C& M'K3*`$U1<2*^362[R(SR%[UV'[K+H>4\\P1`04VGP#]`KD'PFG6#\>)FXU+7 MN;E0,X5.@4K?K%:0O(X7.GZT\0(;D/9.8SYCRZ)Y>>PM M$5%M:ODCGEM(=EV.M,DK?PJL$^*L$:&^H#6$>F/-^F4>OBR94V#:A8P[@:^0 M&6V;]!.R0:;RLF;9)->!W`I.@39T@>9X*'+)76(>(K:GR&E%!5<87C MP\VMH++L-T`>Q%:Y]!>3/5_^XP1=2MDY,B`G_H)JSHA<.A%TJ>K\S>EI#M&S M9'!V30L?G[=C>LZ6K7G#HY2R0A=>`EK&Q_"PZHG_O M2:`7#]DF,@,]#/A14]3T8Z:AT^E(H`D"B>BO=)@"MN)@3[XBT/E3SR'B+H49 MSDG2W_OC^QM54P;@1A[)6E\!^IVBS/1@?C^`:CG&'CR++3`X9)_<'3I_%6$! MW;F_E+!QFX\0KMN,]#:R/#?XQ`^#9D?:K2C\LOOXQS8M]S>$1&9:+#A'EG_9 M'RR$8FW:]:%E<[I^1W.7K!,^0RO/*58P2D;MRX2-C(Q@$-, M1*X;4J<37`828R]<#I=V=BW:+IM@98J:F$9$(+\@SBK5USN_.H7-B!)"K]\` MSP@_+CV*O%8"@PK&)G`I=IHW->3E1%^F"!]=W=KHXC%8.);H,'D-<3"J",9R M^S/$,9:R1?A8ZM7&$H_!PK$TV*`A-5->++"%:8W)[D:IK?FXN:B-FQPSA:,E MLYL4ZQ`55YG$?)5(AV@^#N[;)A;<#A[#$3E*B_]L$2'*2')FRK=4.'J"68`4 M*MZ^%J(N)+D];H%P+HY/K-!P4%X,:\,VM>6XGT]4B+*01$T1RX6C;83AG&T0 MH/?;V>4ZJ:$`X_:#F2=N@PIIJ+D\IAN5-+0OX!/AXC$Z@Y7-7V++FLLF'T\9 M-@K'QP`M$$5H3BG(/OT?Y]P<9[2ON;;R<9-KKW`,12=YQW,+/_J.R$E^>4(U M%UL^KO@L%XZPB''YM5:DTI/$P3LJ+8==6W-LHV`VBXJ(4VSX,MFAN<)Q-'+L MQQDBJVB)3.LDB4W%*3*)O27#/.&X2$FON9V&0TZ<\E*@KKR#[I/RH$1\YBG> MJLZ9&?^!-2L&:7UC%X39`T.#RER#X(BRY:BMONXYQL^E8U$?NFQ.UGO-'URFB(DSXLRT*V486HRO^L9LW+:5BL>O M[;AY(_IW5?M/@]-(VH.@S>:;<*]I,!^,A4#7ZA5+C-I0[!"UOV8<$ MCX-&R'4GQ'G"[*GJH4-NH#E`\]05MY-H MKC'M)./?(2YDKO^DKZ)8;]5S?TF MEX(4LW*R0-WW%6DW0^$-Q@7?#<9$GLXT9:K_"_3EB3J31U7NSB_Z7I#0F(]\ MQO1E_0X,1^,_ZMRXS[814TO\S$I]<_/Z0&U6[;"GRX:'G[)6O8HHJ'49:4V0 M@7>/[+%W:K$>;9ORRB'>KNZD+B?QB-:?NPORN+_JQ.\=X3)]=%0P<#9S;[$) M9F73MYEGB=1?`XZ@DL<;PE%X"['-*M[8UJ&%V`.VD>VJ!V]PB2\L<`K7O,AX M'*W%/"01VX1[[P#:G>/P01;&8H\ M_U-6&1_]']\+_44\^`X"@F>+:^'>GZV,+R`^O9>`*.)!X0,B_B@6+_<)'Z*T'H3#%; MM9^0>\S43**">N_?#81,E^6^A)N;I'=X'M[.\VL0,DZ,5Z<`$%8L[C'$%R MX?Y;,]LI'AAB&]K&$84I44&-=D[I3?CK;KDG>`:`K3F_O:-+1\:&9%E:3(68 MI2F#UVADE_&6>+']UC_OL>U0M*_Z$A*TV^Z9F[V2A<0L2YR\\GE$0"8C0Z4B M7.:*B5E_>-GD](IPH\;D%Y9-$,&.&9](2:&VF(J:DW$9>V-3%D5OFD7<>E^1 M&[)&:T>XH;).7Y$;LI*&,`\J9)][$^ZZ^<3>Y8E=PW+<#4'T#ZD%!HK>GZJ3 MF3K6V(Z;FP==U11=KVS74,&S;T+LG^/8NRV@/]S?R]/O#+>NWFKJ4.W+V@S( M_?[X09NIVBV8C$=J7U6J,R?_?)S0@B]Q"WHM,%7ZRCYB?29K`WDZJ`YRYLDY M(=K+.-J+%AC*?76DSKY3O/]]4'65!4UU.+E/T`DP2YTXYH\M<#L>#_Y01R-` MW0K&LSME"E2-^OA6O1DI0-9U]E;8JDS(/&0GA"W%87]J@+G;\3 M&M*+&_*E]>9QH(UGRKX]NWV58*3(55K#:_.MGLI?=QC M/\,H6L4),>?DGA#SQX-JU&$)<23/:+"P;:S?P6PJ:[KN/XCR0*32IJQ1:-G!2($[;XMBDW1HU,%XH:A10#IO/4JE MYV"XD%&00D($?'?X+4G?$Y6[($ZGZ9$Q3BI.59[DX*T.%#S(,!AN]@WMX M_KO%GZ/WFU"U+V8TX]2#_Y/U!+`P04````"``M;H%" M;M1-(*8,``!IDP``%0`<`')D;G0M,C`Q,C$R,S%?9&5F+GAM;%54"0`#I`L``00E#@``!#D!``#M7=USFT@2?[^J^Q\X;5W=[H.^[63CC6\+ M2]AA3U\G<+)Y/^^IM!0"3$P(!!$)?SD#AHNN?7W3/=T].- M_/'WI[4E/4#B(&Q?-KJM3D."MH%-9"\O&[=:4]8&JMJ0'!?8)K"P#2\;-F[\ M_N^__TVB?S[^H]F4KA&TS`MIB(VF:M_CWZ0)6,,+Z0;:D``7D]^DS\#:LB?X M&EF02`.\WEC0A?2#W<074K]U9DC-I@#;S]`V,;F=JR';E>MN+MKMQ\?'EHT? MP",FWYR6@<78:7A+#!CR(L"TH7O7[?Q'_F=OV.WUN]U>Z^F>RC`$+OV\U^GV MVYVS=J>K=SH7_?Y%MR,21]?]\.%#V_LT&'HT M\FE!K&".?CN`$W*FGYIN2+`_^+R]^W!_*$I@O0?:01>.)\D(&\#UEF$J(HD[ M@OVO&0QKLD?-;J_9[[:>'+,1V,E3-L$6G,-[B?U+EU,XZVX)T`6T;K./VM22 MVS6T7=DV%=M%[C,S*UE[4"E\C]>*P/O+!C%MET[9[;%UPR;\2836?=[03>4@ MMB<:4CL7Q@&V'6PADZY1\PI83+/:"D+720.82E@,NO4"V=!D>P`R=3C3>Y4Z MF35,AY=&61:^&2`N]5_.`&R0"ZP\0#DL"K*W"6T'FOOVVY][`)S5M84?119` M1DY%X!]"QR!HP[;!]/YJZU#5.:E0$XF*0*5MUVM`GJ?W&EK:Z!X9@.Y<&:F*E04PF+0'<-#&11UR<;?VV1@YCY M4H$ET12!Z09C\Q%9%O7+4W<%B6I3R9=H84'9<03D[ MYA$$`H@S,2DH*JV1ZWEA-@WV=B@]FPNX(`'28OR.Q:(%BW//.@&V`PRAW9U& M5XPO7SCPKRU5@?+`])#NM>/'%X%E0H_^!'Z/6=0F5\!![(A`H$-G\\Z#HO$E M'[?2HK;.]D&^V'U(>CI-BT'.P^L4L4D,?38N9<4I,:SIE">)6:JMK_#6H4<@ M01WGYWBRJ"8F2`Y6)4BN".X MX,4Y).$%Q`@@QPW>A\"Y[PZNW=E%][F';$59$&.[@$T347R.=]'L3[2ODY`+ MLMTV'=KVQ[1C&92/.YRL:>(U0!E!'U.?`+$W4W,-UPM(,L(])"T?*["L;`@] M@O)QV=B5LT(+:$ZZ)N$]V%IN[D49D!]BIH^1[5UNCNA_#W##)Q?:)C0#Y(SA MBRI4]#'CT.ETNE)3"BCV?Z19BK0CEP[HR\&<7G@*`?3,=7ZD09 M2E?R2)X,%$G[I"BZ5A[2U!I4"+7/@ZKILJZ,E8FN2=-K29W0#Y13`N;5HD+D M9V+(9_)P.]';./7`6WO;9.LTE M`)LV"[1M:+E.\,0+O]X!+W[SMM=&/3P0I>78GFS48\)E_O5@GN"U\F: M]+6&^=CW]4HA-"1,3$@N&]W.=Q06=J!YV7#I,;P>QF&G4_>9M:I@VSOG/:'4 M]15/4ZCI8H]GB:8Z-$*BPSGB<>S73^O[8[34O;D;@[,"73I"67L MIQ>Q9HB,NBM<_XJ^=W6H^G."#N\$]#!F!IK_1@G3^=G M=5KM_H4UNVSVC%ZGM7> M[=V$M&.N0LJZ@,K:^!I>EIR+798,9.V3=#V:?BGM;BJY)3;$^X[=\R&')=E; M`NE_NBUIJ&B#N3K3U>F$8;VZU:@$6FE(,W;%AM#?1Z'W6I)V.Q[+\Z\,MJ;> M3-1K=2!/=$D>#*:W$UV=W$BSZ4@=J$IITJ0WSH8"_!H5H-^2YLI`.01,%\YD M*,^'I2%.[*@-P7Z(@CUK2=?R0!VI^E<*][^WJJ:R%5,:3.'&V@!RMQ.%?-Z2 M;J;3X1=U-)*H4J6I_DF92^J$:OA&O1HIDJQI)5X7)[;>AJB[4=3O6M)L/ITI M/IP?DO=H?+G3)EH MY6W#;#VYH1S]J!R_MK[K6YI,=>50'/^J6QHIAPMNRSF7&ETC;`%HGQF*BX+7\[VWA#]RP*F]'/`^9>3GEDB[7JA-$?1DW]R MD7[>,2D->*Z&X%"2H]":T2XE"Y>Q7S@0JY#0N'?8+>HI# M<7+':>EG=2+IGZ:W&OU4^Z5T8?/T'8=2OBR*ERZ;>&]R*%'FH%ZZ$$)]RR'^ MXPB?X*Q]+K^\-1"\-1!$+Y2J;R!PH-%:XH>V"='.+O2'J#GHH[L17`)KUS65 MT"!P-*JN+0$<<XC`/([?64T0EOR3-UK9*GU'[ M)RW'7].D^!L=IJ[!DIX`_L!4!Y^I)#1")A:44^DJ*=G'K6&<$731/H6C^`$@ M5"QKP([3SW-@(FSAY?/(2NZ+2*&JIJ:?HG41S%RE%ZSU,4$R#31_T&B\68VA MB0Q@#>@*@"1-\P*4=W'>L6KMB^+F>OR"+7!#(`WSY`I8+EIC`H<(+&WLN,CP M=V50KENA3:)!LC.ZBW.>5=LGIQC<^%!M'\P8V9AX+?Y4)NBXTT`=D= MU!)>/5.)]F)E=)^)<[@[KVW-.:L4`D'G=+7G?&_6AGGVT05UQJO$,/6NZ"Z1 M*]C1W;7P9>+;;<+;;<+;;<+;;<+;;<+;;<)KODT8H\7><75D)9_@.:/KF48E M8#U5ZO2%'B37[*MI(4G4Z]&X6B8^\2AKFM<$9T9>+NI_7..,Y``B3\O5OJ<5 M'LQ9$R"!YG!+6/X+"<)FBN+C2'X`8W!AURH?S/QU/V'&=-0?DS5CDKIO.=-; MSE23G(EWD\_>_P"&FY`3'0ZI:T(4)TCY=1!_TL2#>710!4E/K')BE%=:SE.< M_FJ;VF33\6DS&V"#I2>#!LD#,F"`)?F]VS2R*JJDG)6*LZ$^F7MX@#;P6O!T MS-X;AJZ@Z@4H*RF7IJM?%#G7!-7F2M=,?7"$'J`9/2G*:TQ<]#^O?N!WC$ZH M=]`?H?4`QU3$%2^"OHQIC=].+$"P>F9SV03["@'1'W$AUO=YO1JC[\M3YAWU M26U-I^=E)CFYO2Y[AQ)Q#Y(_F,6O\9;;3):+V:NR=R@0]T#[HYF;CBW.W'3L MZS)W(!#/W-5^P41[%Y)";7[`\=48_E@JGO6K_:*0J"@3Z"I/AK5EOW4S MI1`B0EIC>PK#YQGN7;'9[Q>(EBL7FO(#)#0CWU]3NV+!'#+)*3K59@N+ESUE MYE-C&^63A6>P]U445$1^(4%80SEZ,S?A[<^R6^/2^;DX!>U6\S,K;5OVC]W/3WV9]Z^)\ MJTC6JR)9T!?#^>%H9H'=M_0'_N+J6:=S)]0UA2CK6N[,(';=[MNXT!GPQ$J@ M$&4%Y=4LQA"QX;$B:O>UU*4:L;8UWO(,74X]N*#XM]UL:)X2HJ82^%]Y1\\H MB65,`DV+S%,J'V#'_%WV=F]&HM'1*JGL\TL$BN8%FKVD.%K,ORA4/6L+6<5BM5.B[1\R.\5&?Y0IGH6 MF3/+A!X*W?$AO]=D]P.9ZEEMSB:3OH($`E9*+<3LW]F]&JM'1*IGD3F;2(68 M^M48^*6_KL)_SOY:T.GHD_\#4$L#!!0````(`"UN@4+ITT/%A"X``#68`@`5 M`!P`&UL550)``.ER%E1I],SM!\=&FAR(U)-4> MA^.&`P*+%*9!@`.`:FE__585'@103X!D(;G^8,MD9O(DZB`KZY7UI[^\;'WT MC*/8"X,_O[EY^_X-PH$;KKQ@\^($*\>CR/4#[<['R>8?)'^\"?T\>T/+KJ^-C#[!0>K,'J8CPNS3TFR^_3NW;=O MW]X&X;/S+8R^QF_=T,S<(MQ'+BYL1W'QX^[(F M/@R/;,-J\^_#^_CZYL/UQYNW+_'J3?[PV1.,0A_/\1HQ-S\EKSO" MU]BC='N3??84X;48C!]%[ZC^NP!O2&.OZ`_]2'_HYH_TA_XU^WCB/&+_#:*2 MA(52OWZLV,J4WMD&>X\C+UP-@W:HZ]H=P2?O3I0B&\RJ%36XH`QWZ*Q=W, M=F$]="MV?1HLPTCX1)C)M1,_,KO[^'KC.#MB_^;#.^PGT9M M]*+Q/[T[6.Z.=_=1N,-1\GI/ M4%(W"I=N7Y?DMWLO7BQY!D::-GG7P)4R[PS4P/#.'&N==[GF%6*ZB`P74*%] MA:@V^HWJ_W\8O"RP*6,?)V63;Q*(96[51,#P2(RKSIE""@8E)H2S2C:4!6P2 M@0=6YL#A6S#-ST&JMSP50+^E(D<'A&@5)*Q-Z7"=M2C]Y'[*'S&%*AZ]*C4L-J)ZJ%7>E6Y.!B: MZ3%R_6ZN@;R2RKE[XB(D/P0K'/6=G4:^KU['6PYK"+WI3G4+G!&J" M4IJTHSW50VZJB'RJ:<0D6$.F#U9;XQE'CV$QUV@T=OH@:8@[O/)<\N"+%,5. M0HU/E%`WM6,YH6[G9BVA;F8$1E@X`KDXH<87G5#/\7/H/WO!IA^1]RW)IE=? ME3F/1L=FUF,$OQP>E0J=,[0)RCH;"QU$+!*>A6OD,FU@C*NZI)@@%PG:Y)8< M:)E0O!08%DFA<8&L(@AJ'GN!71(U5P/\J!GH\W)6!_@RF)6!?5T(#%-DR+B! M/`Z\,$)Q*HY(W[=%?N@$P$+,0Q`;TD8H:9,X"JAEZ@C$P)!'CDU"GWVN@((P M.6%&),GK!U[LAOL@F053^G/RQ%TB:"TS5P(M4F^A5.=DT$*KM!?'8?3*?N[>>74>?;P,1V&TQ='BR8G8S!&.%`QI;L,:>=JZ5_"JJ0$8 ME&N)6K"\GYG)8M(N-822$"5/&*V9.127[%F;52P[9C"A*!*W/Y0C%KH40!L@@G`IG.>:`!QG4G5!+EHF=J\#OO,?^%)V\W M\7?R1I>*6FMX#=BB\25R,`B@!L>MNXYO44G\"DTF]V=)8&/LOMV$S^]6V$O[ M&?)'O7LA'_T^P1O''P:)>+5`*&&#'PIHE!:"KSMG@QP3OY&&2*%4[+SQ_Q<< M)UMZLA)'\D`@$+(6`J0`BY>?D^B\H96PZFU=DCOW>.'."9P-2T@6.'KV7-P/ M@R1R7,DF.T,=>[V!(?Q#MZ!1@$$40Y1<1U&HH3C50VZN>/Z].ND/"3H$P?<6 M]];PL$I[9@Y?PFAX`2)^CTLJM;$3XF[.]ELX+VS?YK&;-:WOSY0P>@9(UQAD[4#!-JP:8PN9($F1[*%!'31)GJV3-A)R)N^7VZE^)U M[JR\T`\WKQ-?L22C5;&7,IF!/Z1+:GD8/#(#R:5)J19*U5"A1^??^F=/D2*O MERR2G\,8[YZR3KE/^(LC)9&,U.PE3^9.'#(IO0X,4ID#Y7*L^1@Y"5HD;U&J MC?*L*]6W0K#/$7;(;]TZ?N)MPP@//&<3A''BN5G0+,TXR_G6QHHU^K5WL6!C MH\Q&[^* M'HB9GKV-I0W<..PS-5""0;\&2+E=J)DJZM%Z/NER1TF[B^6N%,4<;SR*/$AH M?4W!.HY8S-;"EPIDOOHEDNF<,!I@W&:(E!('65;NM#M:T"X[0$@:6=!9;ILY:)N+2W:K/"E)F>[W84PZP2H"(%B@@B9E!*I,$DA5JR2 M=A?LZ!$@*S8WZCL;@5^U[VVQ00@K9T'E2Q"M+T)4;_5"!E&A3MMZ@&,W\G8T M654Y4Q&SWO("D!P!2C*P>,`#D].A)-L%*_K[**+,]6+7\7_%3B3O(N2BMMBA M`YLS1"8'@B4:<-PD;RJ.4GE$%3KM,M(4]A?L^W\-PF_!`CMQ&.#5.([WW`R< M@;S=088&=G6P(1$&02(3A'4FC>-\NL)!5//Z*U5%N2Y*E?_2':F^A/X^2)SH ME=V)(MJU*Y&S2R()S"IY:D*`2"-&IB)+H8&82H<,R8+A'--2\%ZP2:^0D0_* M)>*69S:4H&L3'$)90.Q1`I22Z`\Q*C2R>W]09JE#-C$V]TD_N@DC^;Q83%I5*EOL;`P=JO8Y" M`Q"1#&#*)MR9)F*J5RA51B7M+F=FTX%=.ADX(I^)TAF%K.T96BG<^BPM)PB" M23ITTMG:;/R=3=HRE>Y90V<#S#A3DNR&,1Q4,5\*,8!LJ6/3<87-U9R<*2E55T+991K MH]]R?2`5AGIQC)-80\.ZD$W"B0&6J565`$,B(2QN06*Q&"X7D*B0S0\8,8*3 MM4\,"5R>'S5!8#01H^,6)1[F\^%TB2"QIN_$3[U@1?]#C_P\.SZF56L2NDO^ ME>3X[)IIB>^&NG9+EC5PIUJZS$`1#.N:H.7//\1/[""62__`!W48A.RYK%II M/,?3S%2?9^R=Y!I8K5H&8`OA+;%/)@R&8`DNL7,Q44%3I7*,!`[F<< M[/&(-%MOO?9\C^1[:G9)I6T22P.YS"F)*!@ZJ?%QH\,]1O11(">7!Q*G[B.\ M<[S5\&6'@Y@>CF4UO=)T0.*Y6L7N#<1Z\-6KA^7R8(AE`)*O1LQ4$$YU8M8O MAJPXFYOM('&8/@S.59)-DX2TPY1>F\I;Y4T2THJOIGF\A"U+:@0D,:37;9.> M6OJVJ%1`7(=>`F]T#SJ1!Q2,M""Y8#2?W0_GRU]1;SI`P[\]C._OR&CQ"DV' M2Q@L*\53S?R"4-(FIQ10RU02B(%AD!P;5W%C^=-P#FI6X7,8KKYYOLRUP]?#D=SA=_0/W>_7C9FX#CJ=GZG$JA(RX:K-3)I2'RK=F:78EI,#B5 M3[%GMR61MX=\$NWQBG=1,Z]O9*&+590&KHD650S4P?"R.6;IDDM^%1:=RG12 M(\7\)@SJ#O`:$U=6<^)->B.N9@5&+F]U#48'N[(*(Q,&0SD=0MF12G8@)0SH M!JE59@+1+V!PJWR#G)I50DF;?%)`+3-)(`:&0W)L!NPYU"*NW.$'@T>22^+4 ME-(I`;B\3T$TM088SAG!-*!?J+G2#P8/C;.YKI,VL]RLXQ1,.P%BG&Y5UP+] M@QHXVDQ)VS4==(IT.B*3'+Z$5[P"F-!E@I*;XIA-/U\OA_,[>$-0/H,\>&6< M=)95NLWF>?#JA/X@#X9@!B"Y#5;E')YMTJ.=HUOM+V'P;1(&FR6.MN6L4_:F M"46MAC`%V$KD$LB!X9,"G.&-W+`9)'L3WDBT[XQ&LZ&U@7K#!@2OGAE+#:FC2 M0Z\$);DXG'"DQ;('\ M`I;$&R^"`UWT_HP#'#E^?HE$UHEGRU02WS4Z5G<+FL"O;"%4*5AEUS..'L,8 MJ[I"$[!UGLV=U123(>(X<-_"H!C;BE;S0>*P6-3ZEF0)6&Y/W ME4FC0PDA:,6"YO@9!WNL.[S%B]FDCPQDF3=U&3"$D0"K,V4Z7*+%/_-9E`SSR1^:W1L\L<(?IE,2@4P MS#)!R14SP]$SO8I[C3&*4LG#G'<8,(;NZ9$.WP^_.>3)IEWARHO3K:20^7A/ M_DUB;.9B]ASNH_#9B\FWZS"Z=58#_"@]"W2TU>XYW?@1Z%EO;-+.>_%C^EX$ M>$.ZU)4J%SR-.WQYB$P4$5GTZ)!W@TI?W'LQP7%<^#(ZY;LAMPST_=`]BI;O MB,PLK!'3Z1SB,AK2J\1\=P/C39GM<.3019JL-(RV>H%,2F38SNV426$`I"<>X%V$78]!(G_[F!4:#E:]+=U0D@99B=MFJG;W19H[ M4]T?J=<#P[8&8/G]D@?5](Q=20<&'S\[7C`)XW@6#+QXEY6NGJWSDD2R)4&= MEM755S,7*NNO:A5H(Q8SN'7V?4?5OD<^442$?['CX\I1*A@$Y+IZTY2@XP3+ M*+$"$\1DR,0+'F$N#>PP<.%%.GU.7PF=OV7)3OC"0Q4RYB`&:Q@H!\@M:4S[ ML[LA&LUG=RC+QV=3('GX.$@P>3Q)QG[I$DY-RG(I*1'$6M6HL@B8X"+&)1KV M>YED'E=@L(,@TP:4FHS5L]\B>)53WV4!6.%#!$VTPI4&#QAT*!9EEXI#0W6A M3B[F6]RSB58S8HDU.]P]JW)%\1:+ MU,!PS!PK/W]>DH%,O8$7MZ1>3;-[Z@E=T5.OH@:<>B*LW*QY6>9R>O./'?3F MPT`Y;RR#R-_AO#+LR#NY2I7>0C;RPV^ZM7BU2D=7ITK!2ZY,Y>3!O-$&()57 MI+++Y)@6N-W.])(R@HYM8EGAU>WK0XQ7XZ"8_.RYB?>N/SSXL@Q/$V7.\U-6RS:?\6%5ZCN?X7?` MQ+(S.L=5C#[\%$I">E5G^F/LB$#Z%M+/Z?^QJV)WV2^BQ]?2:K)3_-PG&.]L M>=?J(-P_)NM]/E*17\RH4K%\%YH6?.TN-*D\&$X;@#3;>0^#8.Q@>WD;F-E6 M/[V:]6H$!DYPE0D4.F`(9PA460H1]+Z^A>/CPUXQ=L=@47]/\DQ,E;O9Y6?B MD'BSGTH3#"$;P;W,/7\D/XEH5;T!3O]+,A+Z%A[2DO0FPZ!\HP5):_0GVH^S M:OGD^RD>0>V$_#$FP;P`I_&#&Z\_D?_#,4E6RPDI,\6V9H,KY,<_ACP/(JD^ M]IX5FU/,5+NEN]P9-:=Y/<#$E8*5WL@3%9)069C=@YXG0$TNM6]KK%NF-G%8 MS5T32]`FXX[R@A^J,=5B6SF+O"$K_@7QJO2Z[X,]'A&R]-9KTE,XB?2L@H%> MEY26NJ%B+Z<$G:@RP-Q(;H\1?5[(*21ALN_0G:AN?FO<-ZF-P4@23!PV2QM4 MEBX@D3"`K[OL[PKH37_F*W-'+^U!77,];JT5W,[_9KA%ZWM&:PF@Z3L.GG%\ MBBT$2D,`Z&S@J`&M%5;`1.?6T'5;",;3+\-%@RT$-K=>OF;+C#WWGWLOPI5) M2=(;Z6:4FQBPNQ&SJ6/5+8"FVM!.E#=&SHWD"*@GDIK0V>5=ILM&<\"FFD6. MKO;T#<7*J0H#O:YY*G1#1\^*TB6P4@18149OZVQH?K!V7%#3N<05%^-53,>D M@H4=DQC:Q(+EC0A-7:OM2S!5!Y,#-,2XI6.R/5&D2VE>KGHIX[&1%SB!>X+QF-(0`"H;.&I`:845,+&X-73= M>&PTGO:F?8CCL3G>9:G2;)W?NTE+;M([QM*S/@OL[B-59&YFPFY5]^;.52N^ MF^M#RX!;8.<3"X_0?L>N3$E-T9U`Z46K;*,#N[$^GPV&P>=R.G7G!2%Q\'7Q MY$0XNZ3#(`L3JW65!JNG/%!ST>-RT(L85LEQ:X=5ZUP5W+"*.LJ2 MD?B)SG`\.SY].>_9:?3ZLK7D<34S8?=N].;.5:])-]>'1>$6R$5EW+X;#/OS M86\Q_)Y6=&-_D3\0&UBQRXSI'\._/8R_]";TAN..#LB*O>V1MSB*7LE;]\7Q M)?70311AUG5J!ETX-!:UX!5Z+`I!T:4@!N9_9[,"+/#1#'B#1L5T7Z9)7JB#S< MWT^&=X2;O0D:C!?]R6SQ,!^BV0@5DW:DHQG-YG>L[#`,QN9U<>\=;R7=Z5<6 MZ:+>:K?41[I>0)9W&,G0_.2Q`?2Y%H%22L MX6\^9,U./_E]2N?9EF&6^SM^40%'MLQ@K&6#'`U=H'PQ5.F<0LUP(!C-_)VV5'F6R?V8KHZC6,:>^FG2_R2W!(@7R4O M61M#-B-7>T?+\:VYEV&+B[Z\U_I7%O,?X\ M'8_&_=YTB7K]_NQARG9CW\\FXSZ8M?\LSA\\EO42O)S57EH&L]()UX7`<$N& M3$BCCX1&\V%_6*7-8MF;#GKSP=&\D0PU1ND.UU>V5S:]$TPYR%#+6QM>F,`N M!A8JXWP?;J':R@U`PZV`$WD#+R7MB`R%E4$UBJ!8:B9,>.)!)FP3>ZJ`9>I*98$PSPE/+Z*_&," M>4A?=487)*72W1%)&>0DHD"I9!2D_H/D@D7ZA^A'U6C5[]V/Z1[*"=V:#R16 M]<4*Y+AIY+PNG#8U`H[4RN#;S,)ET=HH5/](0G5_=G6@>2QM9@,!,PRC:0!T\7QO&SYOW;-?5I+DNQ@^*PZ!Z,7M'DM3@ZZ>0Q/+@F&;!B!WTJP01ZD\N&!8 M=TB[15DNWR6IU!N19<)@:646LF[8?N/;!1FBT_'Y\(ON$/PQ)]&94) M':[;XVZ83%V2/`%#79N<:^1.F7=&BF"XUP0MM^TFWWA`#YF-O]#5O#,-&E@- MNYB\&.LPNG56=`6RWL4IY*PE_"J813HO$NJ<#CID?#(T^S)>T'/YH]D_!4*Q<2%"N0S;+4_^Q&\_"OE\*"!/I"#=V*W M#,_<597!$+0I8NX(:7;`#@8GQX$;;O'2>3$+D')QRU=1*T'7+IL6RH+ADP9@ MG3[C:7]V-T3+WM^AS'B,'"]BI6SOL$/W!QR"M1FG&NC;)%ECM\JL,U8&0\.F MB+FR*;WQ')%<\&&([H8]6O_U#DY:.,7?2C6HHC`@?[II><@F3&UNQN[U#NV< MK%[RT,P&&/JV!,[/)=NN$U4J$WE8'U[224?EJK^1FK49OP9.%!.`!CJ=LZLA M4/X`4:%)5^MS790JVR#4SZ$7)%_(6T#W[=%?E86X9JK=$$OOC)A<(1QMMBLCXE:%6MT-`1?,$\C#X-D9B`Y/J5::(TQBE(]&`.-0ZF\?"Y( MNP%8I6%U"[`>>F43L%R\Z95OFTP?&LMH50\WP:O> M-HP2[[]91,XJ?2A#VU&6NF%E8U?%;#4V`Y#%3;$KV5VR@7!J!`:[I2M`K5?O MH*W;M5NQ@\=,8ZBRXF[LW#@NJKK1_W-<=[_=IX5IO?'SX*H[ZS\^@]N/1C=6@]I>%NJ33@>E M0YA33&.>ADD_8<=/GBBT6;1Q@FR*]9[\F][_E:ZV9M27/)U&%FPRKX5K948V M4`?#U.:8N30?KTB'$P&)@,%($54\]; MG2D=_R6,OI+Q`@G1="J?P2*#UC@,''\<_&,?U0]?F2I92[.-'2A2:JU&Y[1I M!+-.F$P/E17?W6>:*%6%',=8S8DV4:RJV'T,$SFBCV!EK#781_1H&G-?X[18I9,S_0KPPF/\`GDP M[[T!2/E]SYD.Y!?Y8P_'X>F7E M+^',7\NA\7.2!R'T&_TWD(KI(R_P$CSQGC%73T.PSWF*7Y+E-^P_XSOBT)-L MOOM8HU8+#9SD`52J#QQE$4R\/HD;]?>`L/#C)1+_5^Q$RV_A21Y580LNS6ON MMF=W9NA"25U%+^#R#Q?+9?+SLNFNUM:`\[GL\I&,IJ8NF=,E_`)6_]NELGI$ MGNO)'E)J##:GRPX?1VEJZ8(978(O(/0?+Y;01/9TSX@9`T[HDL-'$IK(7C*A M#_`%A/[W2R1T;YW@Z*2LKEF$2VVAZ^WY73%GA^0_IB0/\(:>#55-.AWO2IWP MRR<<88<*=C3_5_=CBI/AB^OOZ929:F[01`_.;%8KU%Q;A?04SZ:8N`U6**2+ MLL@KK"*'F3W7#A/L;9[H*7WBJ;/!93?]0P@,&HT;[B&2`^XA6;AAY+_2O6$4H MA;S5C%X'NY*ORX3!L$F'D-LZMU[373,%EZ[0.K?`LKAU9@,&Q]B9V:?07XVW MNRA\3DL-JTBF4K#),CWP,LWDTF!XIH58)UJA@+R2!@Q:E6L;K+);)12DDHO; MO3=)#;IZ59)8%@R=-`#K9#HD57#+2$CK=*FHI5,"44E-2C.UAE6R)71"0C7= M8835K(3:%=I0'1BTZQU*N0U*E=S(WSZF?]"Z6N4AM.PQ2![;ZR#286G]@AKD+;*6H-=A'VIEC8_BIY>+.\1FA-PUZ`CQY[2J;'M,4`Q\'R M*=S'!%!,YU5\3SEM=I0Y:]-I)W"ZF&8[PE;G@>A$#@@"#[.(,I-L>BXSBG*K M*+,%IC,O/X3^/E+42Y()6^YH%8!KW:9`LG/N&<&3,@M4"?1\5JM2 MRQ^9O&4*J6'76"06AD0D)4(!EUA`RJJ#PPE$%-7"\9W(E$B<<`OM M'+]<"7GYA`]#`EK66'/VYRA+%A>JCW&UM';=Q@R4(>#Q+ISC6,]1Y"1C@&^A M=#M/E)B*-Y6#("CH:<@XU96%BX2!+6T9_CO(N$@RP)K>$D*(,J1)%S MIIK6V-;,E8)B9FJ=CQF;8Q7OX][EVFB;J2-Z7UFQZ,[N.X$Q,5&YEJ)2>3^O MN3_8:^9-FYGH:HN'J7.R;1\Z?2A!\0CL<*L.&#DC'][=!*^[]\PN;\FMF+H6-V7T/7QQ_CV?K*4YJW[=^ M8'K#L'AL^B":D5QG]8+>`$-7N-65+9W/1Q'=M$3UTV-BZ84XE_*2Y!?XC`-Z MM).>U3WZ]5"9A/5BZ)UO]DK([5W0RZ!U@M\-QMB/GNGKPZZ_Q(GDEK^.UAS+ M3L\>?6_#%D!5RXQJ#5LKB^:G[0WQ\HP]Z[>LM;1ELUG"!?6CC5TZSVTLLW=$<^_YI!&]9`\TS>MN'T7S MW-C%T[SF"-QBD\T\.]0,/,F#*IN#2W+>Z?8[I!*]/.RI^$^0\9%$`YWSY.]>6&4J'?5Z%KK;G(;^WI MDV.3L.+MF%*$9I<0.ET\_(7[A%=['\_6VF/32Q8D\4MR2V+:5ZZ%6EN"U8S' MNL%=Y+2/DW"+ACXK6_6VBS8N[P]F6S@SCS0-:J8&J_4:8>;*(Q;*;&V2JIN< MRSY7LYWCYFA0C64*5W:#M$L4D1-%Y#NLJV9YKD8J]D8_T/ZTO&1WA[>/U;S: M2`%6$QFB!1CT**OV)/$F83NM5%FX(BIT*6FL-D9@->`1'H!M5'R*1FUF!&*C MMO(`8*,.O)@E6K.`]=B25A-*P6H6%42`SYV,0K9>'(?1:R53"D=AM,71XLF) M6-55TM-*FJ2I`5BMU1(]P(:LGL_*'-&E'[PLK.;1`P78$G-G-<5T/Z3DZ=>^ MA_7$Q>``/N49O1_FWHF20!Z;!#*PGK8<(,`G?N<]YE"?O-W$WTF>ND0.UI-7 M@P3X]'_!<;+U@IAD?)+GSDG`>N(R>`"?M?FE\J">L``9P(=[YP1..E6SP-$S M&;?DL&517*<`JQ$,T0)LF'[XC`.'Y5K+D,W')=JV,="!U3SF@`&V4!>7N(%J MO;;P`;9E=@U3415#%OR$8K!:18D1X*-O/VMXH5.%_POF![LMP0BJ-8_R@=^% M4*W5DR]\UJKUH-4>HX"89+=:PB7`:0M]76"S\_"/:7$O0#_H[S'MNLE/6V+P M(AN=PW]DJW^\@%8_66W3RVSQ*OHCV_M#=^T]P+$;>3OZ/&;KGT,O2+X0>"0G MT>Q,,M2#U;K-0-<;M:1-V_(?5!\]IP8Z:;MLBF.$\1P3''M=FVGD8;65&=AZ M&V5::(TQBE*]+EIF%#G!5_+A>.MLR'"X3#7)V$:K`:MU3.$"',OTG8C(^7VZ M3>!U[JR\T`\WKQ-?MF"HD8?5+F9@`;;*7>3UDD7RJ^9Y=O08S>Z-ZOQZ*-7C;7`!5$FT:_Z6H&B>.,Q';?*,.WJTGS'I M\DD'D_7]V0F-[.B:Z&$K%0`]?C.<]0;)M%"N]@>4*:),LZNKH:MNB!JF)O+[ M#V":0H:,FWBL/_3NPTTO6"V2T/V:[>2F25?RJHE!0AU`;X8Q5$6T8O<[IN)= M!2['"R9A3#+A@1?OPMA+)T;S"\.%H4NM`JB)3)%RX8OHH>^HYOD]CN).(46ZL$N'7E6$T:DF@C^@#10;^CAIOB MI._$3ZSXQPJO;E\?8EHSO8@R/3?QGJ6#)'-M0$W9`G2]38D)1&V@W`AZ?$7? M43OD'?T>'6+TP59G.7Y:6F<9]ER2644X[Z_OB4,)B47%E)\X_3?5!M2^+4#S M@X:L(%$2HLQ(D>A<(6;GJLA6=QV4>5#YNMI3TF%Y5ZM5`MZ88JR&;9@I=]M= M2D+0.'C&<>NH*]`&U)`M0#>,NH6I[J/N'.N_!$D=;6GN+!)]L%F*! MW6P7E*B%F^@#:N-6L.NM?#!"AY>'6R.HH:O2_^=S:*SP"RK=19%&YOSKPR]V M'J+OO"`D4%[+Q_C5\5FD`:B]#8&J(C.].(0>=PI]/QW3IK?W``O,(R]P`K=M M8!9H`VK$%J`;!N;"5/>!F:)DT2A^HJG;L^-3(J9GM>I#/%$+-]$'U,:M8'-; M-&@+IZ&5_%&R0S)B9@D)AKH=M3.AG)?@"4GTB'\)\<*CQ1)9RE<^I)=/R=#R MN73W,JTC+6KV(\P!8L$IO*B3(K5YS8RB@U64[U$H&\XGK4@'36TC:AQ1ZUWU MS+)QX>=(,HVLU@#4U(9`!35@RV/57N)N>)VM3A]0$M8*-C_J*DUSD80ZM8,R0ZB82R&FKA#MK5':7:-. M^NM&KJLO86QHXM+:78#\B*:G6P.(/=3E6][QU;)PVO\X_/(-/SH>'&QVO;<: MQ&6LETH(@\C0CA,7%R/.>'_I!9.#=^)T]*"V+XH@9[KV\W+IP?MP,G90TY=% MCO-)&= M6I*NFCZRED1=LN21E%3G*8JARV0!X M[_?A8KWWXM>_/ZX]ZQX%(2;^;Z\ZI^>O+.0[Q,7^ZK=7'^8GW7EO-'IEA9'M MN[9'?/3;*Y^\^OO__N=_6/2?7__KY,0:8N2Y;ZT^<4Y&_BWYFS6QU^BM]0[Y M*+`C$OS-^FA[,?L-&6(/!5:/K#<>BA#]P_;#;ZW+T]>.=7(":/8C\ET2?)B- M#LW>1='F[=G9P\/#J4_N[0<2?`E/'0)K;D[BP$&'M@+;]5'TN7/^>_>_+_J= MB\M.Y^+T\9;JT++\\[EV?GKL_/.XOS\[>7EV\X%\#N1'<7AX3OGC^>[ M?[;5?_6P_^4M^]?2#I%%2?'#MX\A_NU52KN'RU,2K,XNSL\[9_^\'L^=.[2V M3[#/R''0JWTMUDI1O6Z5]Q2?F4)"%^ M&R;BC8EC1TG?$G[&XI9@_W>R+W;"?G72N3BY[)P^ANZK/?@)@@'QT`S=6NR_ MM(\>V5[#-GY'4)1*!)0 M6%&-=.LE]I'+.C9B<(33VQ$=.=9(+)ZH9E/RW=A!1`>EL&=O<&1[503E-*&( M;Q?Y(7+3_*6_W;/#NZ%''B`=0+(E%?+W4>@$>,/,8'I[%8<4NE`H:FDE%5+- MX_7:#IZFMW.\\O$M=FQJN8Y#8FJZ_NJ&HN-@)!13KA45^KO-GC$/,Z!,*5E9'A4SO"'$?L.?1<7D:W:%@Y%/-5WCI MH6X8`H9-:'T5LMX$9(,"B@6=0R@:&V:7(OG*ZJB0:==EPAO[R69*^R[]31`C M=_"X8:.)$$!P`RJD/4`P(1%*?7(W,(^1#9!8JA%%L](:1\DHS#Y#$@NE"V[` M$`2HJF;<\=ALP>:YIT5@^Z'M@*Q;5$_-6+X,T9\QA6!PSW`0C]K%Y57(,J'K M^0`]SUF4DRL[Q&R)$*"0?BU9#T+GEVJM-39K+Y@=5)N[CZN^'-(PD:NT]1)S M$TQZN5::FJ=@LHIKOLB<-?(7=R0.Z1((B''U%E]L5H,I4J&IAF;'1&MH]*C7VTEI">NS8G@0B MR-AO/I?)V5V&44!W@ON&/'N)O*3YSZPNK.I9%6%WH"87"2%R3E?D_LQ%^(S) MSWY(%#DY[^RN$?Y"?_5Y*\,,K3#[-.W#]O.9=$;RXJ)92=.=H1LX%@E<%%"Z M]HW:@7/4!?)7'[L29QL[H`V=.'?8._2>VX"L9;'R-J+8^_HZ=2%G)E@31T#.2!H[<.(O:*+&BS`OO=%@'"?F$4[$5:ZD3[!@68 M4!5<=N$L@#U3%HC_I9'X%^JM@X@NE<9E$@T]>\4A(%,&"/QKHX`OU%,KX*D- MM0CWHZ)`^'\T$_X"K76PT(L#INH0AX[M?4)V4#X$\8L#V?C)*#9$VNM;"/V! M/.]WGSSX<[IU(CYR1V$8HX!#BZ`.D)N?C>(&A(,^@CX2+Z80!D^)-#%)?SP:L"I.6-@;24HZ"/G:27].B0NB)! M^78N4Q*\F3.0C$*E]7%P$R\][`P]8O,.9`K*0?$W<3==H+#&\8FLU\2?1\3Y M,K^CBH?3.$K\JJF5EH]2I16A_)BU[89#HG,SOET/;K>F0_H[WFQ24AY*CYF[ MSG'IC^HN&;BO$3N>'JXH+Z\0Z>"/3 MGWO3ZZO19-"WKKKC[J0WL.;O!X/%O-(=1;I?W=KA,J$H#D]6MKW9=B[D1>'^ M-]E>MOOUYX-TT]LA]JDNF!H!V?JL"JXT8%5KVTQUW;:7S0(MLH5T7FS(D'%T MPE*HJ,J!JRX)N[4ZB(M<6:V7'/4XX>AM!C4L-B*YL`[OV&7VO>TA=B,<]>P@ M>*+KDB2"BWXL]3(>0N(!I$2AK!B,W`=K8>.\EM?=-.XYX MR=!27D7K;0R8&XC:9A!TI!)DB:#Y"@8^:A4IEL*<2GV+Z!_=\599KFR)8!%A M[F6LI&9SVGI-WGCV=H]W\(=#//+*JVB]LJFZS(.@8(9UIL`PO+*GU_J8J M.R4ZFT'*WE.:P\3SG[7>TY3!2(JD-0GBK/,Y-^Y:JY7S_AC;2Q;=CA%S'D]N-.Z(1V$.V=P7/0DF M%WAUO=<]5:<<67C,,+:4U+"CNK(*>B^"I`DH)L_HDSMN"%!>`<%A$*@%O?=( M=0BM`)09#/=W,\.,2M:C_\6"P[V2\E#VFCFGJ,.>$`0SN$H'@)6S5%@2RD\S MAQAU^"E1W`QFTK%XTZ6'5PFH@J%15`G*5S,'%77X@L%A!G7@F:S.A-7,:87: M%B*2K@.^#FS;,$N1+ M%R!Y_%J"D]'X:0?0V]3";HW9D:[\JRO`Z4L&8..^3V8B#U*P^> M]RA8DA#I'SZ36RQ.MN\BSX!<42BG37ENR'!:IJP91@=CHC()33EHR)`@QK^5 MZQ#1N4_%&U$XM\:>C!9S*WIT!I- MZ!\&&B."MO(?)!4LSKBE-=KA#-TC/T8B-[=\,9VQ/P+8TX;%T\^,^>L]LKWH MKD<5G@8KV\?_3N#;RF[HORD.[:Y;CZ-]'&9%S%Z^0 MJEH#IJ18DH'"#/+>V=@?DS"<^GT<;G8[9/;P4^>; M[FPQ&C17=L1DJJ"KX"H+I:W1]V$BY*7/2RA416E^O;C=X"R5WV M975)#\XF\$"-$HWHC[P!L*B@27P<]:-"X%."I_UK30!_VWWHR+8A?N*Z](B% M/!37:1ISQ>FI#V3(>/SA:(9 M:>!G;UI>/,^ZRP[YW'3"]?3A%\O7._3(0T'B]1]AQUZ][OR]-1Q/_S`D!?M! M(_@Q5T$5O1K?Q?C_`SZI>5D7K<8(: M%B&8F,%>Q17TWKNH(9%*#9F,/GL>S>W/?3L=)?P":VL M]6A"#:MR.)G!+5T"!"QY2A]M_TN59GWS6?-M"F(_G=62HB4.W:O7JBD)^T$; M+D48FMHA\@_C@%DOJJKUV$L55:7L\P$SE>+=0R[[G&0R[]A4;4RKD^R+=`,9 M4-N_T<_JGWVW"=I_"NKI]KKZQ;/HV-9WFSI"::\,;V>Q2\ZYT!0 M-6,6@J^Y:Y_CZW[PH8$>((]>VP,Z.!J/_'L4JKC_*6U([[L3BFZ``%"9,330 M06QW6MUUZ+8Y0-RGT+BW[?`&]+Y`48,J4DW?JJ.!:8&213J[,8,+E3^\*:ZG M]UF+YKI$(3Q?04\(B(.0&[(U=,')&V2\D&E![Z,:BGJ'/&1F3`UP]6O/_KJ? MXU##M#Q@7^E"<9=@L/Y"L;0AO<^#*%HH`J`R8S28H[M/VLS1&+$WU MUF5QCIPX*!L/Y)K0^RQ(#;I(58V_QD7"-?8)U>]I?D?J<] M8DF9UW;1VP79&"MH;;U/VJCI'9)0F;'%V.=6N[&QRR'QN(CNAVID/1;SZA4` M_[)!F7T4.@'>;!-[7L4A]E$J$NH0?_F3=6+U<>AX)(P#1/^G;'2S M&$TG+/;RZL-\-!G,JT5>O@51K2&58))S1M.=7ATFY?\WB]MH.GZ>T#^SEKGUOS#]75W]HD9VWST;C(:CGK=R<+J]GK3 M#Y/%:/+.NIF.1[W10&?T(3M8#_^S": MC]@:3VG/+Q)-T.?+J^B]Y"IVXI@[=\B-F9_'T>B9$M]WMXGU;4\XI2C_BDY+ M@]"?N2IK`F+M%OJ.$/]X^/H5N$6U_A9DO^;&[V-Y:.^=9:_WQU'HWG?;_ M&(W'%IVBK.GB_6!FC29TOGHWNAH/K.Y\/ECH7!&FE,SJ]ZR)P/@EV]`9MPN1 M5&3LLHWHM.5*]!Y%\%9"3+OM[L>D0K>]@[UVLO;ZTZEU,YO>#&9L=J7V.J`3 M[`U+8*710KG#J\`J`?5,G)?A=BC7A$XK!%,(FE9-MCMNT%7N69N#$5YDC?#G MT_W>;F[==#]UDWF2&B/]Y>S#@!KE/V\&DWG%*UE)@/N:5UVELY!XVW..&8R)#E.0G[A#4'G==9DWIRRM*C7H\4V'6IB)M/D]'(PT7PI4*(8 MV'@DV]#ZV"I`4I&IR3:BTP(KT7O\@FL5Q+3;ZPQYS#>7)6Q^6@2V'U+U"@]9 M.S_F[L_/V2W#N+N@JTWV6--EB/Z,:6.#>^07G93F758Z[`K]:D[7E6Q1.?C( MIDF=><(S*@C]UWC%M;KD'0LEO!CGE]>:[5M`Q;%KG4!E[;8QL2/:XY_=N8I] M9;B^)YUZOB?6#_N6_ZKTKEQ**=']><7&M"XJ]X\F["5[$B\ARZIHO6FO1>;Q MRE$,BQG>K1]"JO`@C/"Z)#%;MI#>'/O*6"K6W0Q>9H@.XS%B*=I7/H9;%Z"> MWC3VRM@#(V0&H70)ZSYG?,RE!=W*SB$56%=O9GIEQ$HA59=:75\9%&0YFV!6=:IE399"H-,/AEUZ`7!RQG_@+$'X-O1GE M52Y`1*@80E]QG"EL)0FKJS>=O#I*99`R@USN33Z,7WAUK3GBE8ZV4GB9P7*) MI]3^3Z6K&XGZ6A/&J^-9&C$SB-Z^$;6P'V'FRR^N->&[.AI%>)C!VM#&01)V M?8UL=G+V/)[`:)2HKS<[NSIBI2$S@^D)>DA%007$IS\ZVU`1&<+EF]&;5%T= M[U4!U'ZV7A@OO6"[Y8*#]%QH&3]JVOIAVXC2,_,2886>2H":*H\!CC[X#X+] MZ",EC%T]LH^*_9*`M?7Z*8'9.'9:DD)&NX7`!@F>R>2BT23OGAJP(AF%E-P[ M-6EGEQTY_L/&VVKM*3UIE@AR]+@ M:1^/BP(!>6,P/!S0A%'W&XL+K'Q*;LA8JS8&T#Q#$P96C?S%'8E#VW>YBZ#* MH8#6#Z.)M7@__3"G?YW_M9F=AG'Y8'B[B,-P+>1$:?#R\MN6CU> MG*2;\*PO4TAD1KDN9LPR_R\3E"Y^1T&MO^%%ANM[16=OM.N$-=H MO40!!T]`/0-`+NH81YYR8BWJ]F<.[NQ%&>)Y/794]32S74P\LGH:>TXIZL): M+;N&KG8L;T>8L^'B%`'U6P!\B`]4E%V*M%_ M%R`ZE017MA?A-0E0']LKGX01=G:VQQ)E^"@([_"FE(PJ#;6`FRIJI8+P-"XD M]P]T[E_BF3[LQ+Q!`0OBLE?HZNDF`8AG7S(M:#U%XR^:C^Q,'A'M6V.8OQ=W MKYS+"R/I8=C(]EE&)24^AKFV]$?@BU-,98N9[W7(H:P@NK[LL7>Y%_ON4;"D M\Z;^]_I&/K4PVW>2S`%4*O[3P(4E6Y#[`D!O"0AF7$2]1W0BOZ-+730-5K:_ M<[FZH?]&!Y_871_EL"?50@MR8@!8K0":T6P':(W967D%FC-56Y`:HSJ_A3`U ME!CC#Q)\H6NQ'EDS7Y#D^QOZ_\2WO9'_KSC@!?D"ZK4@90:`(S!`)EM>XL%? MQ>Z.*[8@F49EJRN"R&1*J[`I2Z3.%!J5B6P1AX4SN42JHMJMMB#/AMIEDOGY MCR24&5/0#@H-5?86?LLMR-BAML>(0-9^4"4*U.,>4>42L((C]9HXG`*J`8^^ M@[5B@L-!R[P^*C+UW06D<6:^NX`8`?)W%Y!VNX!T.7WG^@,%IC/XQ04(II0;D6H%D@M1DWTOL96[!HTOPZ`N@J.:M*Y?NK M#0HP<>E'@TC_'=9A2<7>E*8:]..`>3@D(HI6NH556N`4`-'9C"TYT'P^7VB^ M=Y+#G8FKQ(8&OINQ(",WP)W\#CB7.4UV!VQU=.R!.VHVP9WON^#F=\$YKKYO M@PW8H36R#>8Y-A,_Z0`EV]SC(JU`\%CDIGS"=Q\IW<5F"QD`7Q'E1>`UO(VU M?7N5L+@[T=Y_-BS?SPJK&81PR=96J$9CG?8>^782'+<@B=M`!$0>5+,5X(,T MJ1O6H"B=-O9QA,;X'N62BA4D!YO0E>GB`7GWZ)JJ<\<;T.LV:OX^7`UL9NSO MY'3YA.Q@\4"4,']HJP7[]5HHM99H^GG>IJ1R:RTX)*B)5%OI'I*8&]]9L3&M MGJI-D9W&J;5'^)']%);Q5%)>ZYJU(DU"]!.1^FQFM MC*:R"EI7F15Y$@-@!E'I=*WN[MW.$IKXQ;6N`"N2)%+>#(JX#PB4$26JI'5- M5Y$N&!"5U^X187U!^UZMZSCQ.O;8QK&/J`8.WH7V;#R4L.,?/=W"!873,=0U MKS4>JF(74@VNX2,$W>/*C@])%2"US;QJK'IT2(&@>%]OV.LL#"0/Y[>-E[F' MZ>!OLNS:5+J+E'EF9O=]P>ZR5HMZQ_JTW+TX*$F-QBNL\\9<`969X;D$#S,& MVYV"8VPOL9>\B2&DC5=>Z]6W>NK*83&*O;GMV0&4NEQAK;?8S?#&`<08THI5 MEC%">`M:C^^:'5$AT"G=0!GX;A8W*.(R]WBDY,M9S81&F/?T`_=V`-/O;&PO M_5S4X@X=LP+T(ZS:6`M?5JJ'FX%WE3"%Z$#V0,JN*N6;T9O[L$'R\UBUF7;F M+Z>$^%1#>M,B-DM]#J\6D\_\YU1PGVI';[;%1JG/H64@\PNV[,LH1-7QCW7A MT`VMK#?_8B6.Y7#1[H@BLW9^CI\^K)US[SY77#M??.5K9_77MN'1`X4:Z)%BZKJV#4_ISP(*V%2V_I5EJX\JZ(U#?21>ITC%:NQJ50,>-<5"SR M+CGH1]N+T?1V@J+,WRNS+&ZXA:MR=7BVI7_LGR4:^L-TZ>%5`KO@XD1426\Z]=J,\G%H?]`/1\\)\9TJE*?KZ4V>KI+U/!JM M]A$J>^2=$U1R>9G=N;\YM7K3Z^O1@FW=Y]O=^C1YI6TP:>Z)-K'H@BV[3`,F MI)AJ6=8O>7Z^Y_MJG!0#TEXWX+9Z];2@WR[)&@:JV0IZ0)JH3*+=`%U,T-(\ M9:":!M`ET2%!'*;5JYGH3-%P%V\V)(@.`K(@,MO9N0&5)N@"U329PGPG/1HE M(>J9888'&4OYRI5J+S`L``00E#@`` M!#D!``#M7-USHS@2?[ZKNO^!<]75[C[X>V9VDDUV"]LXPYZ_QI#YV)WE7NM*FM=5:U(O_S\C[]+\'/SSVI5ZA-LF==2CQE5E<[93](( MV?A:NL,4<^0R_I/T`5F>&&%]8F$N=9F]LK"+86*[TK74KKTRI&HUA]@/F)J, MWT_5G=BEZZZNZ_7'Q\<:90_HD?$O3LU@^<1IS.,&WLGBR*38_;W9^+?\KU:O MV6HWFZW:>@XV])`+\ZU&LUUOO*HWFGJC<=UN7S=;.==QD>LYNW4:ZT;PDX]] M2!QCQWR%%J_9C^LI^;3TZ%NO^QLUC8_('FZ,L;G^;5K'OUD=YVZ]F:$OZ-/F M_1^=\?#30NOT'YS&Q^&G]^/MDC>.L<0VD@!QZMQ6(EY\;-<87]1;C4:S_FDX MT'RZRI;P>FT1^B6-O'EU=57W9T/2/2898;$V/$= M9XHS@`YB.%T[?R9%.V[2)R"V9PA.H.U3BD,$4<3"-J9NGW&[A^?(LX#^JX5(EE248"/U\@N>[C#K,(B8$6+.#+''$M27&KK-U>_9TML\A*/L1 M%P=.[XZ''76D]*2./)!'7472WBF*KI72V?:,4&SNO..,YRH\X6T<>CMS/MO= M[2QW:[JL*T-EI&O2N"^I(YA0_G*Z[]0)XBXD2$X7K8B+K&SO)PFS87B5#X:) M/-5'RE3[3NK*$U67!Z5$A)J8@L!H=(EZO8N<9=]BCT]!*"]]-CZO\^'3E;5W M4G\P_EC&^-3#CL')2JPPGG<\!TZ#$V"0/I7M[C?B:0MYL\4HK6 MG:H371V/A*L[]QH`H)71T9IGVXAOQG.-+"AD80:"S,8PF`> MSTF;#<6/22A:-4F['P[EZ6C=2^VI5'NB1WN^/[D:Z.[J3)>*!V5:6, MZ$RQ@:,^AK!!3<3-`)#LZ6P,WB8Q:->DJ=)5XCZ'4#3JR=->&9W>1P:Q(!^7 MC:\>)N0I6T06965AVG%W2?Y0JT_G-1M+YKVO2W7C<^Z@.!A)L;FFLOU.FD(S" M3K]3.P-%DC6MG,7`A+,5YK"MH:*%C;T2>-4/DV4D5;*1^MN/X^8BR/>#NJK`48[2/*19L/23L+R MMO9T$J316%?BZ`3UF#10Y')B`_6O35R_I!)N9GYR@^E3)GJ((!N'5TD3,'?_7`&.5![.BPV$J,9KMXO\)MBKJJHT&0$1%& M^2"V=PD].T(N..3IE@!B10;)1>5ZQ*WT?+O%#"8%+O>/1 MQ6/WT"500)`-R5[MFWT5)'V_E59&[^<[`E$X"G%DX[-7,!<\,N6%[%BA'`4K M)VTF3*U32^LR`Y1624=!.3"?#43^>KO,KC]:4:M47S+/0=2,G9,3^+*A.KDT ME[Y71Y+^;GROP:SV0YF!S%6'1Q$LPI`-W?/*]S(#=J!,C\)TG"P;G,(U?9GQ M2,V:>]A%Q#J45X<4V2CL%_D'$NM`7!D!R)+`12\P!*>W<)15&2FF7$*:W.B9V?0P39:.S= M'!RHA$I\2HZ6-,(W%LE;`(74F;BT]ZX*\I<]@?`RPI2K;HE'M&(LV8#M72D4 M+'9*'=R*@-`JCEOK`&Y[]PLGXM8J(VX'"M#8LRD'739">]<(QRO5_[\GE?@E MFKVF>"[Y36+7HI?HMN(0T0M8"<:6',]O*Z*;J!JV^_P.IM76MA62"-$'FL1\ M6)/>"!8.12!N[$G9:V(#(7X^`A#70^5#`2YQ!7NT#I/$.K!;ZB]ALH5F14T& M%FQ]0UL'0OZ+&@F[KZB1B0W[C4SM/JWRH@;#T2EJ[M%HN8MU MIXZZX.]DU]T-&,ZX*]&]YKU#+9S;YM,!,WQ1!UC$7]60KRJ&JLU6M=VLK1WS M2=,B2CRYH9@2(=\)2J3WIN9([1GF%=\* M/RT[A9=8EDBV;RLNU+00#$7?^34$2<),W8_EIL>#OM]M;-\V7U^;S$:$JBZV M!1EXQILY$$,]07K'F;>ZK6QE$2`Y9/-.S7MJ8A[-^./VY:`[NRU;#/`S\"O, M>W:;138O+DC&U"_>XD9E39Y=ZPEG-G$Q37+0 MG=V6+GO`%/G10F?BP87=+'/RD9[=HB$V"534.(R#"4RR9L^N=^$TXT^56_0Y MHE^@U%1MM"!T\2LCU/T`%*!EW*H\A&>WIHLX9Y;5%0G1!IY=A%ELL1E8B:?: M<;*S6S+D1'8U]U?FX-4R.!Q=H,!\SYI\I&>WZ(YC!#IUD.42FW'<(VA!&<@R M@BT5>0CR)\^SV'OK^)AEDBO"\2^)ST:+@4VA3<1NW%"`%G/8")OJI+&3F M!!X_!D'6TS>4)`W,0WEQYJ6UX2<-.TQS<28=_5=[TKX"#!=G;+$6J[TM>R+W MQ;D!"NH'(K[W$D)*!YD]/!.]?[MB.VWNU.#IXK7;L9CQY27B9W;KU5[XS$-Z M<;C$M([F4[[F>NC*5",/DE\">D4ZM4X[>1>/;U!<]C&>8JC0O`QO7[M,.ZQWQQ MI_4CXU_$UQZ*^Q/J^"O!Z@ZCR%+I'Q[?[*Z^!0P+EQ M&VU&P7U\\Q)%6+X7DI,@%V:[.'CSOHE]HN7-"S8]O`N4UV27]\7'_LJ.97O^65Y4OUP]/D&O/S-.5DL76S*#YBC!99MQEWRGVW)X*LQQ6(E MX2[Z&2.^0^84QJ/6;E]H2825T`4O4V)DO4R?/%"Y2"_N#!7IT0U>*"]<21\2 M<7$.F8`<@ZR0%`/B1Q0[["7Q_=@\L.<:G^2#*^2?W0I]Y_"0G1!DOU`LH7%3 M0L-S4U^HM<=?U4\^!XIPG#'LW]2W;^+!Q_\"4$L!`AX#%`````@`+6Z!0JT7 M[!6I8P``?[P#`!$`&````````0```*2!`````')D;G0M,C`Q,C$R,S$N>&UL M550%``.ER%E1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+6Z!0J_6W3>) M#```V)```!4`&````````0```*2!]&,``')D;G0M,C`Q,C$R,S%?8V%L+GAM M;%54!0`#I`Q0````(`"UN@4)NU$T@ MI@P``&F3```5`!@```````$```"D@`L``00E#@``!#D!``!02P$"'@,4````"``M;H%"Z=-# MQ80N```UF`(`%0`8```````!````I('!?0``&UL550%``.ER%E1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`+6Z!0ONR M$`;0'```A[D!`!4`&````````0```*2!E*P``')D;G0M,C`Q,C$R,S%?<')E M+GAM;%54!0`#I`Q0````(`"UN@4*" MA+G!@PL``*=G```1`!@```````$```"D@;/)``!R9&YT+3(P,3(Q,C,Q+GAS M9%54!0`#I XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 33 140 1 false 12 0 false 5 false false R1.htm 0001 - Document - Document and Entity Information Sheet http://radnet.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0002 - Statement - COMBINED BALANCE SHEETS Sheet http://radnet.com/role/ConsolidatedBalanceSheets COMBINED BALANCE SHEETS false false R3.htm 0003 - Statement - COMBINED STATEMENTS OF INCOME Sheet http://radnet.com/role/CombinedStatementsOfIncome COMBINED STATEMENTS OF INCOME false false R4.htm 0004 - Statement - COMBINED STATEMENTS OF PARTNERS' CAPITAL Sheet http://radnet.com/role/CombinedStatementsOfPartnersCapital COMBINED STATEMENTS OF PARTNERS' CAPITAL false false R5.htm 0005 - Statement - COMBINED STATEMENTS OF CASH FLOWS Sheet http://radnet.com/role/CondensedConsolidatedStatementsOfCashFlows COMBINED STATEMENTS OF CASH FLOWS false false R6.htm 0006 - Disclosure - 1. DESCRIPTION OF BUSINESS Sheet http://radnet.com/role/DescriptionOfBusiness 1. DESCRIPTION OF BUSINESS false false R7.htm 0007 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://radnet.com/role/SummaryOfSignificantAccountingPolicies 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES false false R8.htm 0008 - Disclosure - 3. RECENT ACCOUNTING STANDARDS Sheet http://radnet.com/role/RecentAccountingStandards 3. RECENT ACCOUNTING STANDARDS false false R9.htm 0009 - Disclosure - 4. FACILITY ACQUISITIONS Sheet http://radnet.com/role/FacilityAcquisitions 4. FACILITY ACQUISITIONS false false R10.htm 0010 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://radnet.com/role/GoodwillAndOtherIntangibleAssets 5. GOODWILL AND OTHER INTANGIBLE ASSETS false false R11.htm 0011 - Disclosure - 6. PROPERTY AND EQUIPMENT Sheet http://radnet.com/role/PropertyAndEquipment 6. PROPERTY AND EQUIPMENT false false R12.htm 0012 - Disclosure - 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://radnet.com/role/AccountsPayableAndAccruedExpenses 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES false false R13.htm 0013 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES Notes http://radnet.com/role/EquipmentNotesPayableAndCapitalLeases 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES false false R14.htm 0014 - Disclosure - 9. COMMITMENTS AND CONTINGENCIES Sheet http://radnet.com/role/CommitmentsAndContingencies 9. COMMITMENTS AND CONTINGENCIES false false R15.htm 0015 - Disclosure - 10. RELATED PARTY TRANSACTIONS Sheet http://radnet.com/role/RelatedPartyTransactions 10. RELATED PARTY TRANSACTIONS false false R16.htm 0016 - Disclosure - 11. SUBSEQUENT EVENTS Sheet http://radnet.com/role/SubsequentEvents 11. SUBSEQUENT EVENTS false false R17.htm 0017 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationPolicies 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) false false R18.htm 0018 - Disclosure - 1. DESCRIPTION OF BUSINESS (Tables) Sheet http://radnet.com/role/DescriptionOfBusinessTables 1. DESCRIPTION OF BUSINESS (Tables) false false R19.htm 0019 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationTables 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) false false R20.htm 0020 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://radnet.com/role/GoodwillAndOtherIntangibleAssetsTables 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) false false R21.htm 0021 - Disclosure - 6. PROPERTY AND EQUIPMENT (Tables) Sheet http://radnet.com/role/PropertyAndEquipmentTables 6. PROPERTY AND EQUIPMENT (Tables) false false R22.htm 0022 - Disclosure - 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (IN THOUSANDS) (Tables) Sheet http://radnet.com/role/AccountsPayableAndAccruedExpensesInThousandsTables 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (IN THOUSANDS) (Tables) false false R23.htm 0023 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Tables) Notes http://radnet.com/role/EquipmentNotesPayableAndCapitalLeasesTables 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Tables) false false R24.htm 0024 - Disclosure - 9. COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://radnet.com/role/CommitmentsAndContingenciesTables 9. COMMITMENTS AND CONTINGENCIES (Tables) false false R25.htm 0025 - Disclosure - 1. DESCRIPTION OF BUSINESS (Details) Sheet http://radnet.com/role/DescriptionOfBusinessDetails 1. DESCRIPTION OF BUSINESS (Details) false false R26.htm 0026 - Disclosure - 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://radnet.com/role/NatureOfBusinessAndBasisOfPresentationDetails 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) false false R27.htm 0027 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details) Sheet http://radnet.com/role/GoodwillAndOtherIntangibleAssetsDetails 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details) false false R28.htm 0028 - Disclosure - 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details 1) Sheet http://radnet.com/role/GoodwillAndOtherIntangibleAssetsDetails1 5. GOODWILL AND OTHER INTANGIBLE ASSETS (Details 1) false false R29.htm 0029 - Disclosure - 6. PROPERTY AND EQUIPMENT (Details) Sheet http://radnet.com/role/PropertyAndEquipmentDetails 6. PROPERTY AND EQUIPMENT (Details) false false R30.htm 0030 - Disclosure - 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Detalis) Sheet http://radnet.com/role/AccountsPayableAndAccruedExpensesDetalis 7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Detalis) false false R31.htm 0031 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 1) Notes http://radnet.com/role/EquipmentNotesPayableAndCapitalLeasesDetails1 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 1) false false R32.htm 0032 - Disclosure - 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 2) Notes http://radnet.com/role/EquipmentNotesPayableAndCapitalLeasesDetails2 8. EQUIPMENT NOTES PAYABLE AND CAPITAL LEASES (Details 2) false false R33.htm 0033 - Disclosure - 9. COMMITMENTS AND CONTINGENCIES (Details) Sheet http://radnet.com/role/CommitmentsAndContingenciesDetails 9. COMMITMENTS AND CONTINGENCIES (Details) false false All Reports Book All Reports Process Flow-Through: 0002 - Statement - COMBINED BALANCE SHEETS Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Dec. 31, 2009' Process Flow-Through: 0003 - Statement - COMBINED STATEMENTS OF INCOME Process Flow-Through: 0005 - Statement - COMBINED STATEMENTS OF CASH FLOWS rdnt-20121231.xml rdnt-20121231.xsd rdnt-20121231_cal.xml rdnt-20121231_def.xml rdnt-20121231_lab.xml rdnt-20121231_pre.xml true true XML 50 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
5. GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2012
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of activity in goodwill

Activity in goodwill for the years ended December 31, 2011 and 2012 is provided below (in thousands):

 

Balance as of January 1, 2011 (unaudited)   $ 223  
Goodwill acquired through GBDIP's acquisition of MIB Partnership, LLP     7,593  
Balance as of December 31, 2011 (unaudited)     7,816  
Goodwill acquired through Carroll County Radiology's acquisition of Westminster from RadNet, Inc.     2,107  
Balance as of December 31, 2012   $ 9,923  
Schedule of amortization expense

 

    2013     2014     2015     2016     2017     Thereafter     Total     Weighted average amortization period remaining in years  
                                                                 
Management service contracts     16       16       16       16       16       226       306       19.0  
Covenant not to compete contracts     104       104       105       105       –       –       418       4.0  
Total annual amortization   $ 120     $ 120     $ 121     $ 121   $ 16     $ 226     $ 724